ID	Gene Name	Species	BIOCARTA	COG_ONTOLOGY	GOTERM_BP_DIRECT	GOTERM_CC_DIRECT	GOTERM_MF_DIRECT	INTERPRO	KEGG_PATHWAY	PIR_SUPERFAMILY	SMART	UP_KEYWORDS	UP_SEQ_FEATURE
Alyref	Aly/REF export factor(Alyref)	Mus musculus	NA	NA	GO:0006397~mRNA processing,GO:0006810~transport,GO:0008380~RNA splicing,GO:0051028~mRNA transport,	GO:0005634~nucleus,GO:0005681~spliceosomal complex,GO:0005737~cytoplasm,GO:0016607~nuclear speck,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003697~single-stranded DNA binding,GO:0003723~RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,IPR025715:Friend of PRMT1 duplication,	mmu03013:RNA transport,mmu03015:mRNA surveillance pathway,mmu03040:Spliceosome,mmu05168:Herpes simplex infection,	NA	SM00360:RRM,SM01218:SM01218,	3D-structure,Acetylation,Alternative splicing,Chaperone,Citrullination,Complete proteome,Cytoplasm,Methylation,mRNA processing,mRNA splicing,mRNA transport,Nucleus,Phosphoprotein,Reference proteome,RNA-binding,Spliceosome,Transport,	chain:THO complex subunit 4,compositionally biased region:Ala/Arg/Gly-rich,domain:RRM,helix,modified residue,splice variant,strand,
Celf1	CUGBP, Elav-like family member 1(Celf1)	Mus musculus	NA	NA	GO:0006376~mRNA splice site selection,GO:0006397~mRNA processing,GO:0007286~spermatid development,GO:0008380~RNA splicing,GO:0040018~positive regulation of multicellular organism growth,GO:0043484~regulation of RNA splicing,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016020~membrane,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0031369~translation initiation factor binding,GO:0042835~BRE binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,	NA	NA	SM00360:RRM,	Acetylation,Activator,Alternative splicing,Complete proteome,Cytoplasm,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,RNA-binding,	chain:CUG-BP- and ETR-3-like factor 1,compositionally biased region:Ser-rich,domain:RRM 1,domain:RRM 2,domain:RRM 3,modified residue,mutagenesis site,sequence conflict,splice variant,
Dazap1	DAZ associated protein 1(Dazap1)	Mus musculus	NA	NA	GO:0001893~maternal placenta development,GO:0007275~multicellular organism development,GO:0007283~spermatogenesis,GO:0008283~cell proliferation,GO:0030154~cell differentiation,GO:0048026~positive regulation of mRNA splicing, via spliceosome,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005844~polysome,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0035613~RNA stem-loop binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,	mmu03015:mRNA surveillance pathway,	NA	SM00360:RRM,	Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Developmental protein,Differentiation,Methylation,Nucleus,Proteomics identification,Reference proteome,Repeat,RNA-binding,Spermatogenesis,	chain:DAZ-associated protein 1,compositionally biased region:Pro-rich,domain:RRM 1,domain:RRM 2,modified residue,sequence conflict,splice variant,
Ddx1	DEAD (Asp-Glu-Ala-Asp) box polypeptide 1(Ddx1)	Mus musculus	NA	NA	GO:0006302~double-strand break repair,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006388~tRNA splicing, via endonucleolytic cleavage and ligation,GO:0006397~mRNA processing,GO:0007275~multicellular organism development,GO:0008033~tRNA processing,GO:0009615~response to virus,GO:0010501~RNA secondary structure unwinding,GO:0032508~DNA duplex unwinding,GO:0043330~response to exogenous dsRNA,GO:1903608~protein localization to cytoplasmic stress granule,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0010494~cytoplasmic stress granule,GO:0016020~membrane,GO:0030529~intracellular ribonucleoprotein complex,GO:0071920~cleavage body,GO:0072669~tRNA-splicing ligase complex,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003712~transcription cofactor activity,GO:0003723~RNA binding,GO:0003725~double-stranded RNA binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0004518~nuclease activity,GO:0004527~exonuclease activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008026~ATP-dependent helicase activity,GO:0008143~poly(A) binding,GO:0016787~hydrolase activity,GO:0033677~DNA/RNA helicase activity,GO:0044822~poly(A) RNA binding,	IPR001650:Helicase, C-terminal,IPR001870:B30.2/SPRY domain,IPR003877:SPla/RYanodine receptor SPRY,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	NA	NA	SM00449:SPRY,SM00487:DEXDc,SM00490:HELICc,	Acetylation,Activator,ATP-binding,Complete proteome,Cytoplasm,DNA-binding,Exonuclease,Helicase,Hydrolase,mRNA processing,Nuclease,Nucleotide-binding,Nucleus,Phosphoprotein,Reference proteome,RNA-binding,Transcription,Transcription regulation,tRNA processing,	chain:ATP-dependent RNA helicase DDX1,domain:B30.2/SPRY,domain:Helicase ATP-binding,domain:Helicase C-terminal,modified residue,nucleotide phosphate-binding region:ATP,short sequence motif:DEAD box,
Ddx17	DEAD (Asp-Glu-Ala-Asp) box polypeptide 17(Ddx17)	Mus musculus	NA	NA	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0009791~post-embryonic development,GO:0010501~RNA secondary structure unwinding,GO:0033148~positive regulation of intracellular estrogen receptor signaling pathway,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0072358~cardiovascular system development,GO:2001014~regulation of skeletal muscle cell differentiation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0016020~membrane,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003713~transcription coactivator activity,GO:0003723~RNA binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0030331~estrogen receptor binding,GO:0044822~poly(A) RNA binding,	IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site,IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	NA	NA	SM00487:DEXDc,SM00490:HELICc,	Alternative splicing,ATP-binding,Complete proteome,Helicase,Hydrolase,Isopeptide bond,Methylation,Nucleotide-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,RNA-binding,Transcription,Transcription regulation,Ubl conjugation,	chain:Probable ATP-dependent RNA helicase DDX17,domain:Helicase ATP-binding,domain:Helicase C-terminal,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,short sequence motif:DEAD box,short sequence motif:Q motif,splice variant,
Ddx19a	DEAD (Asp-Glu-Ala-Asp) box polypeptide 19a(Ddx19a)	Mus musculus	NA	NA	GO:0006406~mRNA export from nucleus,GO:0006810~transport,GO:0010501~RNA secondary structure unwinding,GO:0015031~protein transport,GO:0043065~positive regulation of apoptotic process,GO:0051028~mRNA transport,	GO:0005634~nucleus,GO:0005643~nuclear pore,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0031965~nuclear membrane,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0016787~hydrolase activity,	IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	NA	NA	SM00487:DEXDc,SM00490:HELICc,	Acetylation,ATP-binding,Complete proteome,Cytoplasm,Helicase,Hydrolase,Isopeptide bond,Membrane,mRNA transport,Nuclear pore complex,Nucleotide-binding,Nucleus,Protein transport,Reference proteome,RNA-binding,Translocation,Transport,Ubl conjugation,	chain:ATP-dependent RNA helicase DDX19A,compositionally biased region:Poly-Glu,domain:Helicase ATP-binding,domain:Helicase C-terminal,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,short sequence motif:DEAD box,short sequence motif:Q motif,
Ddx21	DEAD (Asp-Glu-Ala-Asp) box polypeptide 21(Ddx21)	Mus musculus	NA	NA	GO:0001649~osteoblast differentiation,GO:0006351~transcription, DNA-templated,GO:0006364~rRNA processing,GO:0006366~transcription from RNA polymerase II promoter,GO:0009615~response to virus,GO:0010501~RNA secondary structure unwinding,GO:0043330~response to exogenous dsRNA,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0016020~membrane,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003724~RNA helicase activity,GO:0003725~double-stranded RNA binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0019843~rRNA binding,GO:0030515~snoRNA binding,GO:0044822~poly(A) RNA binding,GO:0097322~7SK snRNA binding,	IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR012562:GUCT,IPR012677:Nucleotide-binding, alpha-beta plait,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	NA	NA	SM00487:DEXDc,SM00490:HELICc,	3D-structure,Acetylation,ATP-binding,Complete proteome,Helicase,Hydrolase,Nucleotide-binding,Nucleus,Phosphoprotein,Reference proteome,Repeat,RNA-binding,rRNA processing,Transcription,	chain:Nucleolar RNA helicase 2,compositionally biased region:Poly-Lys,domain:Helicase ATP-binding,domain:Helicase C-terminal,modified residue,nucleotide phosphate-binding region:ATP,region of interest:3 X 37 AA tandem repeats,region of interest:3 X 5 AA repeats,repeat:1-1,repeat:1-2,repeat:1-3,repeat:2-1,repeat:2-2,repeat:2-3,sequence conflict,short sequence motif:DEVD box,short sequence motif:Q motif,
Ddx39b	DEAD (Asp-Glu-Ala-Asp) box polypeptide 39B(Ddx39b)	Mus musculus	NA	NA	GO:0000245~spliceosomal complex assembly,GO:0000398~mRNA splicing, via spliceosome,GO:0001889~liver development,GO:0006397~mRNA processing,GO:0006406~mRNA export from nucleus,GO:0006810~transport,GO:0006974~cellular response to DNA damage stimulus,GO:0008380~RNA splicing,GO:0010468~regulation of gene expression,GO:0010501~RNA secondary structure unwinding,GO:0032786~positive regulation of DNA-templated transcription, elongation,GO:0045727~positive regulation of translation,GO:0046784~viral mRNA export from host cell nucleus,GO:0051028~mRNA transport,GO:0061051~positive regulation of cell growth involved in cardiac muscle cell development,GO:1904707~positive regulation of vascular smooth muscle cell proliferation,GO:2000002~negative regulation of DNA damage checkpoint,GO:2000573~positive regulation of DNA biosynthetic process,	GO:0000346~transcription export complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005687~U4 snRNP,GO:0005688~U6 snRNP,GO:0005737~cytoplasm,GO:0016363~nuclear matrix,GO:0016607~nuclear speck,GO:0043234~protein complex,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0008186~RNA-dependent ATPase activity,GO:0016787~hydrolase activity,GO:0016887~ATPase activity,GO:0017070~U6 snRNA binding,GO:0030621~U4 snRNA binding,GO:0032403~protein complex binding,GO:0042802~identical protein binding,GO:0043008~ATP-dependent protein binding,GO:0044822~poly(A) RNA binding,	IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	mmu03013:RNA transport,mmu03015:mRNA surveillance pathway,mmu03040:Spliceosome,mmu05164:Influenza A,	NA	SM00487:DEXDc,SM00490:HELICc,	Acetylation,ATP-binding,Complete proteome,Cytoplasm,Direct protein sequencing,Helicase,Hydrolase,Isopeptide bond,mRNA processing,mRNA splicing,mRNA transport,Nucleotide-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,RNA-binding,Spliceosome,Transport,Ubl conjugation,	chain:Spliceosome RNA helicase BAT1,domain:Helicase ATP-binding,domain:Helicase C-terminal,modified residue,nucleotide phosphate-binding region:ATP,short sequence motif:DECD box,short sequence motif:Q motif,
Ddx42	DEAD (Asp-Glu-Ala-Asp) box polypeptide 42(Ddx42)	Mus musculus	NA	NA	GO:0008104~protein localization,GO:0010501~RNA secondary structure unwinding,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0015030~Cajal body,GO:0016020~membrane,GO:0016607~nuclear speck,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0044822~poly(A) RNA binding,	IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site,IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	mmu03040:Spliceosome,	NA	SM00487:DEXDc,SM00490:HELICc,	Acetylation,Alternative splicing,ATP-binding,Coiled coil,Complete proteome,Cytoplasm,Direct protein sequencing,Helicase,Hydrolase,Methylation,Nucleotide-binding,Nucleus,Phosphoprotein,Reference proteome,RNA-binding,	chain:ATP-dependent RNA helicase DDX42,compositionally biased region:Gly-rich,compositionally biased region:Poly-Asn,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Gly,compositionally biased region:Poly-Ser,domain:Helicase ATP-binding,domain:Helicase C-terminal,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,short sequence motif:DEAD box,short sequence motif:Q motif,splice variant,
Ddx5	DEAD (Asp-Glu-Ala-Asp) box polypeptide 5(Ddx5)	Mus musculus	m_akap95Pathway:AKAP95 role in mitosis and chromosome dynamics,	NA	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000381~regulation of alternative mRNA splicing, via spliceosome,GO:0001701~in utero embryonic development,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006397~mRNA processing,GO:0007623~circadian rhythm,GO:0008380~RNA splicing,GO:0009299~mRNA transcription,GO:0010501~RNA secondary structure unwinding,GO:0033148~positive regulation of intracellular estrogen receptor signaling pathway,GO:0043517~positive regulation of DNA damage response, signal transduction by p53 class mediator,GO:0045069~regulation of viral genome replication,GO:0045667~regulation of osteoblast differentiation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048511~rhythmic process,GO:0060765~regulation of androgen receptor signaling pathway,GO:0072332~intrinsic apoptotic signaling pathway by p53 class mediator,GO:2001014~regulation of skeletal muscle cell differentiation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005730~nucleolus,GO:0016020~membrane,GO:0030529~intracellular ribonucleoprotein complex,GO:0031012~extracellular matrix,GO:0070062~extracellular exosome,GO:0071013~catalytic step 2 spliceosome,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003712~transcription cofactor activity,GO:0003713~transcription coactivator activity,GO:0003723~RNA binding,GO:0003724~RNA helicase activity,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005516~calmodulin binding,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0019899~enzyme binding,GO:0030331~estrogen receptor binding,GO:0036002~pre-mRNA binding,GO:0044822~poly(A) RNA binding,GO:0048306~calcium-dependent protein binding,GO:0050681~androgen receptor binding,	IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site,IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR012587:P68HR,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	mmu03040:Spliceosome,mmu05202:Transcriptional misregulation in cancer,mmu05205:Proteoglycans in cancer,	NA	SM00487:DEXDc,SM00490:HELICc,SM01414:SM01414,	Acetylation,ATP-binding,Biological rhythms,Complete proteome,Helicase,Hydrolase,Isopeptide bond,Methylation,mRNA processing,mRNA splicing,Nucleotide-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,RNA-binding,Spliceosome,Transcription,Transcription regulation,Ubl conjugation,	chain:Probable ATP-dependent RNA helicase DDX5,domain:Helicase ATP-binding,domain:Helicase C-terminal,modified residue,nucleotide phosphate-binding region:ATP,short sequence motif:DEAD box,short sequence motif:Q motif,
Ddx6	DEAD (Asp-Glu-Ala-Asp) box polypeptide 6(Ddx6)	Mus musculus	NA	NA	GO:0006417~regulation of translation,GO:0007283~spermatogenesis,GO:0010501~RNA secondary structure unwinding,GO:0019074~viral RNA genome packaging,GO:0019827~stem cell population maintenance,GO:0033962~cytoplasmic mRNA processing body assembly,GO:0045665~negative regulation of neuron differentiation,GO:0098609~cell-cell adhesion,	GO:0000792~heterochromatin,GO:0000932~cytoplasmic mRNA processing body,GO:0001520~outer dense fiber,GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005913~cell-cell adherens junction,GO:0010494~cytoplasmic stress granule,GO:0016020~membrane,GO:0016442~RISC complex,GO:0043186~P granule,GO:0043231~intracellular membrane-bounded organelle,GO:0097227~sperm annulus,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0019904~protein domain specific binding,GO:0044822~poly(A) RNA binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site,IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	mmu03018:RNA degradation,	NA	SM00487:DEXDc,SM00490:HELICc,	ATP-binding,Complete proteome,Cytoplasm,Helicase,Hydrolase,Nucleotide-binding,Nucleus,Phosphoprotein,Reference proteome,RNA-binding,Ubl conjugation,	chain:Probable ATP-dependent RNA helicase DDX6,domain:Helicase ATP-binding,domain:Helicase C-terminal,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,short sequence motif:DEAD box,short sequence motif:Q motif,
Ddx3x	DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 3, X-linked(Ddx3x)	Mus musculus	NA	NA	GO:0002376~immune system process,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006413~translational initiation,GO:0006417~regulation of translation,GO:0006915~apoptotic process,GO:0007059~chromosome segregation,GO:0008625~extrinsic apoptotic signaling pathway via death domain receptors,GO:0009615~response to virus,GO:0010468~regulation of gene expression,GO:0010501~RNA secondary structure unwinding,GO:0010628~positive regulation of gene expression,GO:0016055~Wnt signaling pathway,GO:0017148~negative regulation of translation,GO:0030307~positive regulation of cell growth,GO:0030308~negative regulation of cell growth,GO:0031333~negative regulation of protein complex assembly,GO:0034063~stress granule assembly,GO:0035556~intracellular signal transduction,GO:0042254~ribosome biogenesis,GO:0042256~mature ribosome assembly,GO:0043065~positive regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0043154~negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0043280~positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0045070~positive regulation of viral genome replication,GO:0045087~innate immune response,GO:0045727~positive regulation of translation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0045948~positive regulation of translational initiation,GO:0071243~cellular response to arsenic-containing substance,GO:0071470~cellular response to osmotic stress,GO:0097193~intrinsic apoptotic signaling pathway,GO:1900087~positive regulation of G1/S transition of mitotic cell cycle,GO:1903608~protein localization to cytoplasmic stress granule,GO:2001243~negative regulation of intrinsic apoptotic signaling pathway,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005741~mitochondrial outer membrane,GO:0005852~eukaryotic translation initiation factor 3 complex,GO:0005913~cell-cell adherens junction,GO:0010494~cytoplasmic stress granule,GO:0016020~membrane,GO:0016607~nuclear speck,GO:0022627~cytosolic small ribosomal subunit,GO:0036464~cytoplasmic ribonucleoprotein granule,GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0003924~GTPase activity,GO:0004003~ATP-dependent DNA helicase activity,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0008134~transcription factor binding,GO:0008143~poly(A) binding,GO:0008190~eukaryotic initiation factor 4E binding,GO:0016787~hydrolase activity,GO:0016887~ATPase activity,GO:0017111~nucleoside-triphosphatase activity,GO:0031369~translation initiation factor binding,GO:0035613~RNA stem-loop binding,GO:0043024~ribosomal small subunit binding,GO:0043273~CTPase activity,GO:0044822~poly(A) RNA binding,GO:0048027~mRNA 5'-UTR binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site,IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	mmu04622:RIG-I-like receptor signaling pathway,mmu05161:Hepatitis B,mmu05203:Viral carcinogenesis,	NA	SM00487:DEXDc,SM00490:HELICc,	Acetylation,Apoptosis,ATP-binding,Chromosome partition,Complete proteome,Cytoplasm,Direct protein sequencing,DNA-binding,Helicase,Hydrolase,Immunity,Innate immunity,Isopeptide bond,Membrane,Methylation,Mitochondrion,Mitochondrion outer membrane,Nucleotide-binding,Nucleus,Phosphoprotein,Reference proteome,Ribosome biogenesis,RNA-binding,Transcription,Transcription regulation,Translation regulation,Ubl conjugation,	chain:ATP-dependent RNA helicase DDX3X,compositionally biased region:Gly/Ser-rich,compositionally biased region:Poly-Gly,compositionally biased region:Poly-Ser,domain:Helicase ATP-binding,domain:Helicase C-terminal,modified residue,nucleotide phosphate-binding region:ATP,region of interest:Necessary for interaction with XPO1,short sequence motif:DEAD box,short sequence motif:Q motif,
Dhx36	DEAH (Asp-Glu-Ala-His) box polypeptide 36(Dhx36)	Mus musculus	NA	Defense mechanisms,	GO:0001503~ossification,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006396~RNA processing,GO:0009615~response to virus,GO:0010501~RNA secondary structure unwinding,GO:0032206~positive regulation of telomere maintenance,GO:0043330~response to exogenous dsRNA,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0000781~chromosome, telomeric region,GO:0005634~nucleus,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,GO:0001047~core promoter binding,GO:0002151~G-quadruplex RNA binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0003725~double-stranded RNA binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008026~ATP-dependent helicase activity,GO:0008094~DNA-dependent ATPase activity,GO:0016787~hydrolase activity,GO:0042826~histone deacetylase binding,GO:0044212~transcription regulatory region DNA binding,GO:0044822~poly(A) RNA binding,GO:0051880~G-quadruplex DNA binding,	IPR001650:Helicase, C-terminal,IPR002464:DNA/RNA helicase, ATP-dependent, DEAH-box type, conserved site,IPR007502:Helicase-associated domain,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR011709:Domain of unknown function DUF1605,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	mmu03018:RNA degradation,	NA	SM00487:DEXDc,SM00490:HELICc,SM00847:SM00847,	Acetylation,ATP-binding,Chromosome,Coiled coil,Complete proteome,Cytoplasm,DNA-binding,Helicase,Hydrolase,Nucleotide-binding,Nucleus,Phosphoprotein,Reference proteome,RNA-binding,Telomere,Transcription,Transcription regulation,	chain:Probable ATP-dependent RNA helicase DHX36,compositionally biased region:Gly-rich,domain:Helicase ATP-binding,domain:Helicase C-terminal,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,short sequence motif:DEAH box,
Dhx9	DEAH (Asp-Glu-Ala-His) box polypeptide 9(Dhx9)	Mus musculus	NA	NA	GO:0001649~osteoblast differentiation,GO:0006396~RNA processing,GO:0007623~circadian rhythm,GO:0034605~cellular response to heat,GO:0048511~rhythmic process,GO:0070934~CRD-mediated mRNA stabilization,GO:1903608~protein localization to cytoplasmic stress granule,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0016020~membrane,GO:0030529~intracellular ribonucleoprotein complex,GO:0036464~cytoplasmic ribonucleoprotein granule,GO:0070937~CRD-mediated mRNA stability complex,GO:0097165~nuclear stress granule,	GO:0000166~nucleotide binding,GO:0001085~RNA polymerase II transcription factor binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008026~ATP-dependent helicase activity,GO:0016787~hydrolase activity,GO:0044822~poly(A) RNA binding,	IPR001650:Helicase, C-terminal,IPR002464:DNA/RNA helicase, ATP-dependent, DEAH-box type, conserved site,IPR007502:Helicase-associated domain,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR011709:Domain of unknown function DUF1605,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014720:Double-stranded RNA-binding-like domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	NA	NA	SM00358:DSRM,SM00487:DEXDc,SM00490:HELICc,SM00847:SM00847,	3D-structure,Acetylation,Activator,Alternative splicing,ATP-binding,Biological rhythms,Complete proteome,Cytoplasm,DNA-binding,Helicase,Hydrolase,Methylation,Nucleotide-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,RNA-binding,	chain:ATP-dependent RNA helicase A,compositionally biased region:Arg/Gly/Ser/Tyr-rich,domain:DRBM 1,domain:DRBM 2,domain:Helicase ATP-binding,domain:Helicase C-terminal,helix,modified residue,nucleotide phosphate-binding region:ATP,region of interest:Interaction with BRCA1,region of interest:Interaction with CREBBP,region of interest:MTAD,sequence conflict,short sequence motif:DEAH box,short sequence motif:Nuclear localization signal,splice variant,strand,turn,
Dis3l2	DIS3 like 3'-5' exoribonuclease 2(Dis3l2)	Mus musculus	NA	Transcription,	GO:0000291~nuclear-transcribed mRNA catabolic process, exonucleolytic,GO:0006364~rRNA processing,GO:0006402~mRNA catabolic process,GO:0007049~cell cycle,GO:0007067~mitotic nuclear division,GO:0008285~negative regulation of cell proliferation,GO:0010587~miRNA catabolic process,GO:0016075~rRNA catabolic process,GO:0019827~stem cell population maintenance,GO:0034427~nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5',GO:0051301~cell division,GO:0051306~mitotic sister chromatid separation,GO:1990074~polyuridylation-dependent mRNA catabolic process,	GO:0000176~nuclear exosome (RNase complex),GO:0000177~cytoplasmic exosome (RNase complex),GO:0000932~cytoplasmic mRNA processing body,GO:0005737~cytoplasm,	GO:0000175~3'-5'-exoribonuclease activity,GO:0000287~magnesium ion binding,GO:0003723~RNA binding,GO:0004518~nuclease activity,GO:0004527~exonuclease activity,GO:0004540~ribonuclease activity,GO:0008266~poly(U) RNA binding,GO:0016787~hydrolase activity,GO:0046872~metal ion binding,	IPR012340:Nucleic acid-binding, OB-fold,IPR022966:Ribonuclease II/R, conserved site,	NA	NA	NA	3D-structure,Acetylation,Alternative splicing,Cell cycle,Cell division,Complete proteome,Cytoplasm,Exonuclease,Hydrolase,Magnesium,Metal-binding,Mitosis,Nuclease,Phosphoprotein,Proteomics identification,Reference proteome,RNA-binding,Tumor suppressor,	chain:DIS3-like exonuclease 2,modified residue,splice variant,
Elavl1	ELAV (embryonic lethal, abnormal vision)-like 1 (Hu antigen R)(Elavl1)	Mus musculus	NA	NA	GO:0006417~regulation of translation,GO:0045727~positive regulation of translation,GO:0048255~mRNA stabilization,GO:0060965~negative regulation of gene silencing by miRNA,GO:0070935~3'-UTR-mediated mRNA stabilization,GO:2000036~regulation of stem cell population maintenance,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016020~membrane,GO:1990904~ribonucleoprotein complex,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003725~double-stranded RNA binding,GO:0003729~mRNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0005515~protein binding,GO:0017091~AU-rich element binding,GO:0019901~protein kinase binding,GO:0035925~mRNA 3'-UTR AU-rich region binding,GO:0042803~protein homodimerization activity,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR002343:Paraneoplastic encephalomyelitis antigen,IPR006548:Splicing factor ELAV/HuD,IPR012677:Nucleotide-binding, alpha-beta plait,	mmu04152:AMPK signaling pathway,	NA	SM00360:RRM,	Acetylation,Complete proteome,Cytoplasm,Methylation,Nucleus,Phosphoprotein,Reference proteome,Repeat,RNA-binding,	chain:ELAV-like protein 1,domain:RRM 1,domain:RRM 2,domain:RRM 3,modified residue,
Ewsr1	Ewing sarcoma breakpoint region 1(Ewsr1)	Mus musculus	NA	NA	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0005516~calmodulin binding,GO:0008270~zinc ion binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR000504:RNA recognition motif domain,IPR001876:Zinc finger, RanBP2-type,IPR012677:Nucleotide-binding, alpha-beta plait,	mmu05202:Transcriptional misregulation in cancer,	NA	SM00360:RRM,SM00547:ZnF_RBZ,	Acetylation,Calmodulin-binding,Cell membrane,Complete proteome,Cytoplasm,Membrane,Metal-binding,Methylation,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Repressor,RNA-binding,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:RNA-binding protein EWS,compositionally biased region:Arg/Gly/Pro-rich,domain:IQ,domain:RRM,modified residue,region of interest:31 X approximate tandem repeats,region of interest:EAD (Gln/Pro/Thr-rich),repeat:1,repeat:10,repeat:11,repeat:12,repeat:13,repeat:14,repeat:15,repeat:16,repeat:17,repeat:18,repeat:19,repeat:2,repeat:20,repeat:21,repeat:22,repeat:23,repeat:24,repeat:25,repeat:26,repeat:27,repeat:28,repeat:29,repeat:3,repeat:30,repeat:31,repeat:4,repeat:5,repeat:6,repeat:7,repeat:8,repeat:9,zinc finger region:RanBP2-type,
Fip1l1	FIP1 like 1 (S. cerevisiae)(Fip1l1)	Mus musculus	NA	NA	GO:0006378~mRNA polyadenylation,GO:0006397~mRNA processing,	GO:0005634~nucleus,GO:0005847~mRNA cleavage and polyadenylation specificity factor complex,	GO:0003723~RNA binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR007854:Pre-mRNA polyadenylation factor Fip1,	mmu03015:mRNA surveillance pathway,	NA	NA	Alternative splicing,Complete proteome,mRNA processing,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,RNA-binding,	chain:Pre-mRNA 3'-end-processing factor FIP1,compositionally biased region:Arg-rich,compositionally biased region:Glu-rich,compositionally biased region:Pro-rich,modified residue,region of interest:Necessary for stimulating PAPOLA activity,region of interest:Sufficient for interaction with CPSF1 and CSTF3,region of interest:Sufficient for interaction with CPSF4,region of interest:Sufficient for interaction with PAPOLA,splice variant,
G3bp1	GTPase activating protein (SH3 domain) binding protein 1(G3bp1)	Mus musculus	NA	NA	GO:0006810~transport,GO:0090090~negative regulation of canonical Wnt signaling pathway,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0010494~cytoplasmic stress granule,GO:0016020~membrane,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0004386~helicase activity,GO:0004518~nuclease activity,GO:0004519~endonuclease activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR002075:Nuclear transport factor 2,IPR012677:Nucleotide-binding, alpha-beta plait,IPR018222:Nuclear transport factor 2, Eukaryote,	NA	NA	SM00360:RRM,	Acetylation,ATP-binding,Cell membrane,Complete proteome,Cytoplasm,Direct protein sequencing,DNA-binding,Endonuclease,Helicase,Hydrolase,Membrane,Methylation,Nuclease,Nucleotide-binding,Nucleus,Phosphoprotein,Reference proteome,RNA-binding,Transport,	chain:Ras GTPase-activating protein-binding protein 1,compositionally biased region:Glu-rich,compositionally biased region:Gly-rich,domain:NTF2,domain:RRM,modified residue,
G3bp2	GTPase activating protein (SH3 domain) binding protein 2(G3bp2)	Mus musculus	NA	NA	GO:0006810~transport,GO:0007264~small GTPase mediated signal transduction,GO:0051028~mRNA transport,	GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0030529~intracellular ribonucleoprotein complex,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR002075:Nuclear transport factor 2,IPR012677:Nucleotide-binding, alpha-beta plait,IPR018222:Nuclear transport factor 2, Eukaryote,	NA	NA	SM00360:RRM,	Alternative splicing,Complete proteome,Isopeptide bond,Methylation,mRNA transport,Phosphoprotein,Proteomics identification,Reference proteome,RNA-binding,Transport,Ubl conjugation,	chain:Ras GTPase-activating protein-binding protein 2,compositionally biased region:Glu-rich,compositionally biased region:Gly-rich,domain:NTF2,domain:RRM,modified residue,sequence conflict,splice variant,
Khdrbs1	KH domain containing, RNA binding, signal transduction associated 1(Khdrbs1)	Mus musculus	m_sam68Pathway:Regulation of Splicing through Sam68,	NA	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006397~mRNA processing,GO:0007049~cell cycle,GO:0007166~cell surface receptor signaling pathway,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045948~positive regulation of translational initiation,GO:0046831~regulation of RNA export from nucleus,GO:0046833~positive regulation of RNA export from nucleus,GO:0048024~regulation of mRNA splicing, via spliceosome,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0070618~Grb2-Sos complex,	GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0005070~SH3/SH2 adaptor activity,GO:0005515~protein binding,GO:0008143~poly(A) binding,GO:0008266~poly(U) RNA binding,GO:0017124~SH3 domain binding,GO:0032403~protein complex binding,GO:0042802~identical protein binding,GO:0044822~poly(A) RNA binding,	IPR004087:K Homology domain,IPR004088:K Homology domain, type 1,	NA	NA	SM00322:KH,	Acetylation,Cell cycle,Complete proteome,Direct protein sequencing,Isopeptide bond,Membrane,Methylation,mRNA processing,Nucleus,Phosphoprotein,Reference proteome,RNA-binding,SH3-binding,Transcription,Transcription regulation,Ubl conjugation,	chain:KH domain-containing, RNA-binding, signal transduction-associated protein 1,compositionally biased region:Arg/Gly-rich,compositionally biased region:Pro-rich,domain:KH,modified residue,sequence conflict,
Khsrp	KH-type splicing regulatory protein(Khsrp)	Mus musculus	NA	NA	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006397~mRNA processing,GO:0006402~mRNA catabolic process,GO:0006810~transport,GO:0008380~RNA splicing,GO:0043488~regulation of mRNA stability,GO:0045019~negative regulation of nitric oxide biosynthetic process,GO:0051028~mRNA transport,GO:0061014~positive regulation of mRNA catabolic process,GO:0061158~3'-UTR-mediated mRNA destabilization,GO:0071345~cellular response to cytokine stimulus,GO:2000628~regulation of miRNA metabolic process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0010494~cytoplasmic stress granule,GO:0016020~membrane,GO:0030425~dendrite,GO:0043025~neuronal cell body,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0035925~mRNA 3'-UTR AU-rich region binding,GO:0044822~poly(A) RNA binding,	IPR004087:K Homology domain,IPR004088:K Homology domain, type 1,IPR015096:Domain of unknown function DUF1897,	NA	NA	SM00322:KH,	Acetylation,Complete proteome,Cytoplasm,DNA-binding,Isopeptide bond,Methylation,mRNA processing,mRNA splicing,mRNA transport,Nucleus,Phosphoprotein,Reference proteome,Repeat,RNA-binding,Transcription,Transcription regulation,Transport,Ubl conjugation,	chain:Far upstream element-binding protein 2,compositionally biased region:Ala/Gly/Pro-rich,compositionally biased region:Gly-rich,compositionally biased region:Gly/Pro-rich,domain:KH 1,domain:KH 2,domain:KH 3,domain:KH 4,modified residue,region of interest:4 X 12 AA imperfect repeats,repeat:1,repeat:2,repeat:3,repeat:4,sequence conflict,
Lsm2	LSM2 homolog, U6 small nuclear RNA and mRNA degradation associated(Lsm2)	Mus musculus	NA	NA	GO:0000244~spliceosomal tri-snRNP complex assembly,GO:0000398~mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0006402~mRNA catabolic process,GO:0008380~RNA splicing,	GO:0000932~cytoplasmic mRNA processing body,GO:0005634~nucleus,GO:0005681~spliceosomal complex,GO:0005688~U6 snRNP,GO:0005737~cytoplasm,GO:0030529~intracellular ribonucleoprotein complex,GO:0046540~U4/U6 x U5 tri-snRNP complex,GO:0071011~precatalytic spliceosome,GO:0071013~catalytic step 2 spliceosome,GO:1990726~Lsm1-7-Pat1 complex,	GO:0003723~RNA binding,GO:0005515~protein binding,GO:0017160~Ral GTPase binding,GO:0019901~protein kinase binding,GO:0044822~poly(A) RNA binding,	IPR001163:Ribonucleoprotein LSM domain,IPR010920:Like-Sm (LSM) domain,IPR016654:U6 snRNA-associated Sm-like protein LSm2,	mmu03018:RNA degradation,mmu03040:Spliceosome,	PIRSF016394:U6 snRNA-associated Sm-like protein LSm2,	SM00651:Sm,	Complete proteome,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Ribonucleoprotein,RNA-binding,Spliceosome,	chain:U6 snRNA-associated Sm-like protein LSm2,modified residue,
Lsm3	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated(Lsm3)	Mus musculus	NA	NA	GO:0000398~mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0033962~cytoplasmic mRNA processing body assembly,	GO:0000932~cytoplasmic mRNA processing body,GO:0005634~nucleus,GO:0005681~spliceosomal complex,GO:0005688~U6 snRNP,GO:0030529~intracellular ribonucleoprotein complex,GO:0046540~U4/U6 x U5 tri-snRNP complex,GO:0071011~precatalytic spliceosome,GO:0071013~catalytic step 2 spliceosome,GO:1990726~Lsm1-7-Pat1 complex,	GO:0003723~RNA binding,GO:0030629~U6 snRNA 3'-end binding,GO:0044822~poly(A) RNA binding,	IPR001163:Ribonucleoprotein LSM domain,IPR010920:Like-Sm (LSM) domain,	mmu03018:RNA degradation,mmu03040:Spliceosome,	NA	SM00651:Sm,	Acetylation,Complete proteome,mRNA processing,mRNA splicing,Nucleus,Reference proteome,Ribonucleoprotein,RNA-binding,Spliceosome,	chain:U6 snRNA-associated Sm-like protein LSm3,modified residue,
Lsm5	LSM5 homolog, U6 small nuclear RNA and mRNA degradation associated(Lsm5)	Mus musculus	NA	NA	GO:0000398~mRNA splicing, via spliceosome,GO:0000956~nuclear-transcribed mRNA catabolic process,GO:0006397~mRNA processing,GO:0006402~mRNA catabolic process,GO:0008380~RNA splicing,	GO:0005634~nucleus,GO:0005681~spliceosomal complex,GO:0005688~U6 snRNP,GO:0005737~cytoplasm,GO:0030529~intracellular ribonucleoprotein complex,GO:0046540~U4/U6 x U5 tri-snRNP complex,GO:1990726~Lsm1-7-Pat1 complex,	GO:0003723~RNA binding,GO:0005515~protein binding,GO:0046982~protein heterodimerization activity,	IPR001163:Ribonucleoprotein LSM domain,IPR010920:Like-Sm (LSM) domain,	mmu03018:RNA degradation,mmu03040:Spliceosome,	NA	SM00651:Sm,	Acetylation,Complete proteome,mRNA processing,mRNA splicing,Nucleus,Proteomics identification,Reference proteome,Ribonucleoprotein,RNA-binding,Spliceosome,	chain:U6 snRNA-associated Sm-like protein LSm5,modified residue,
Lsm8	LSM8 homolog, U6 small nuclear RNA associated(Lsm8)	Mus musculus	NA	NA	GO:0000398~mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0008380~RNA splicing,	GO:0005634~nucleus,GO:0005681~spliceosomal complex,GO:0030529~intracellular ribonucleoprotein complex,GO:0046540~U4/U6 x U5 tri-snRNP complex,	GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR001163:Ribonucleoprotein LSM domain,IPR010920:Like-Sm (LSM) domain,	mmu03018:RNA degradation,mmu03040:Spliceosome,	NA	SM00651:Sm,	Acetylation,Complete proteome,mRNA processing,mRNA splicing,Nucleus,Proteomics identification,Reference proteome,Ribonucleoprotein,RNA-binding,Spliceosome,	chain:U6 snRNA-associated Sm-like protein LSm8,modified residue,
Larp1	La ribonucleoprotein domain family, member 1(Larp1)	Mus musculus	NA	NA	GO:0006413~translational initiation,GO:0008283~cell proliferation,GO:0016239~positive regulation of macroautophagy,GO:0031929~TOR signaling,GO:0045070~positive regulation of viral genome replication,GO:0098609~cell-cell adhesion,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005913~cell-cell adherens junction,GO:0016020~membrane,GO:0031931~TORC1 complex,	GO:0000339~RNA cap binding,GO:0003723~RNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0008190~eukaryotic initiation factor 4E binding,GO:0008494~translation activator activity,GO:0031369~translation initiation factor binding,GO:0044822~poly(A) RNA binding,GO:0048027~mRNA 5'-UTR binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR006607:Protein of unknown function DM15,IPR006630:RNA-binding protein Lupus La,IPR011991:Winged helix-turn-helix DNA-binding domain,	NA	NA	SM00684:DM15,SM00715:LA,	Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Isopeptide bond,Methylation,Phosphoprotein,Proteomics identification,Reference proteome,RNA-binding,Ubl conjugation,	chain:La-related protein 1,compositionally biased region:Pro-rich,domain:HTH La-type RNA-binding,modified residue,splice variant,
Larp4	La ribonucleoprotein domain family, member 4(Larp4)	Mus musculus	NA	NA	GO:0007010~cytoskeleton organization,GO:0022604~regulation of cell morphogenesis,	GO:0016020~membrane,	GO:0000166~nucleotide binding,GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR006630:RNA-binding protein Lupus La,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR012677:Nucleotide-binding, alpha-beta plait,	NA	NA	SM00715:LA,	Acetylation,Complete proteome,Methylation,Phosphoprotein,Proteomics identification,Reference proteome,RNA-binding,	chain:La-related protein 4,domain:HTH La-type RNA-binding,domain:RRM,modified residue,
Larp4b	La ribonucleoprotein domain family, member 4B(Larp4b)	Mus musculus	NA	NA	GO:0006417~regulation of translation,GO:0045727~positive regulation of translation,	GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0010494~cytoplasmic stress granule,GO:0016020~membrane,GO:0042788~polysomal ribosome,	GO:0000166~nucleotide binding,GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR006630:RNA-binding protein Lupus La,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR012677:Nucleotide-binding, alpha-beta plait,	NA	NA	SM00715:LA,	Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Methylation,Phosphoprotein,Proteomics identification,Reference proteome,RNA-binding,Translation regulation,	chain:La-related protein 4B,domain:HTH La-type RNA-binding,domain:RRM,modified residue,sequence conflict,splice variant,
Nhp2	NHP2 ribonucleoprotein(Nhp2)	Mus musculus	NA	NA	GO:0000469~cleavage involved in rRNA processing,GO:0000470~maturation of LSU-rRNA,GO:0006364~rRNA processing,GO:0006412~translation,GO:0031118~rRNA pseudouridine synthesis,GO:0031120~snRNA pseudouridine synthesis,GO:0042254~ribosome biogenesis,GO:1904874~positive regulation of telomerase RNA localization to Cajal body,	GO:0000784~nuclear chromosome, telomeric region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005697~telomerase holoenzyme complex,GO:0005730~nucleolus,GO:0005732~small nucleolar ribonucleoprotein complex,GO:0005737~cytoplasm,GO:0015030~Cajal body,GO:0030529~intracellular ribonucleoprotein complex,GO:0031429~box H/ACA snoRNP complex,GO:0090661~box H/ACA telomerase RNP complex,	GO:0003723~RNA binding,GO:0005515~protein binding,GO:0030515~snoRNA binding,GO:0034513~box H/ACA snoRNA binding,GO:0044822~poly(A) RNA binding,GO:0070034~telomerase RNA binding,	IPR002415:H/ACA ribonucleoprotein complex, subunit Nhp2, eukaryote,IPR004038:Ribosomal protein L7Ae/L30e/S12e/Gadd45,IPR018492:Ribosomal protein L7Ae/L8/Nhp2 family,	mmu03008:Ribosome biogenesis in eukaryotes,	NA	NA	Complete proteome,Isopeptide bond,Nucleus,Phosphoprotein,Reference proteome,Ribonucleoprotein,Ribosome biogenesis,RNA-binding,rRNA processing,Ubl conjugation,	chain:H/ACA ribonucleoprotein complex subunit 2,
Nsun2	NOL1/NOP2/Sun domain family member 2(Nsun2)	Mus musculus	NA	NA	GO:0007049~cell cycle,GO:0007067~mitotic nuclear division,GO:0007286~spermatid development,GO:0008033~tRNA processing,GO:0030488~tRNA methylation,GO:0032259~methylation,GO:0033313~meiotic cell cycle checkpoint,GO:0051301~cell division,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005819~spindle,GO:0005856~cytoskeleton,GO:0033391~chromatoid body,	GO:0000049~tRNA binding,GO:0003723~RNA binding,GO:0008168~methyltransferase activity,GO:0016428~tRNA (cytosine-5-)-methyltransferase activity,GO:0016740~transferase activity,GO:0044822~poly(A) RNA binding,	IPR001678:Bacterial Fmu (Sun)/eukaryotic nucleolar NOL1/Nop2p,IPR023267:RNA (C5-cytosine) methyltransferase,IPR023270:tRNA (C5-cytosine) methyltransferase, NCL1,	NA	NA	NA	Acetylation,Alternative splicing,Cell cycle,Cell division,Complete proteome,Cytoplasm,Cytoskeleton,Isopeptide bond,Methyltransferase,Mitosis,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,RNA-binding,S-adenosyl-L-methionine,Transferase,tRNA processing,tRNA-binding,Ubl conjugation,	active site:Nucleophile,binding site:S-adenosyl-L-methionine,chain:tRNA (cytosine-5-)-methyltransferase NSUN2,modified residue,region of interest:S-adenosyl-L-methionine binding,sequence conflict,splice variant,
Park7	Parkinson disease (autosomal recessive, early onset) 7(Park7)	Mus musculus	NA	NA	GO:0001933~negative regulation of protein phosphorylation,GO:0001963~synaptic transmission, dopaminergic,GO:0006469~negative regulation of protein kinase activity,GO:0006508~proteolysis,GO:0006517~protein deglycosylation,GO:0006914~autophagy,GO:0006954~inflammatory response,GO:0006979~response to oxidative stress,GO:0007005~mitochondrion organization,GO:0007338~single fertilization,GO:0008283~cell proliferation,GO:0008344~adult locomotory behavior,GO:0009438~methylglyoxal metabolic process,GO:0010273~detoxification of copper ion,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0018323~enzyme active site formation via L-cysteine sulfinic acid,GO:0019243~methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione,GO:0019249~lactate biosynthetic process,GO:0031397~negative regulation of protein ubiquitination,GO:0032091~negative regulation of protein binding,GO:0032435~negative regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0032757~positive regulation of interleukin-8 production,GO:0033138~positive regulation of peptidyl-serine phosphorylation,GO:0033234~negative regulation of protein sumoylation,GO:0034599~cellular response to oxidative stress,GO:0034614~cellular response to reactive oxygen species,GO:0036471~cellular response to glyoxal,GO:0042177~negative regulation of protein catabolic process,GO:0042542~response to hydrogen peroxide,GO:0042743~hydrogen peroxide metabolic process,GO:0043066~negative regulation of apoptotic process,GO:0043523~regulation of neuron apoptotic process,GO:0043524~negative regulation of neuron apoptotic process,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046295~glycolate biosynthetic process,GO:0046826~negative regulation of protein export from nucleus,GO:0050727~regulation of inflammatory response,GO:0050787~detoxification of mercury ion,GO:0050821~protein stabilization,GO:0051091~positive regulation of sequence-specific DNA binding transcription factor activity,GO:0051444~negative regulation of ubiquitin-protein transferase activity,GO:0051583~dopamine uptake involved in synaptic transmission,GO:0051881~regulation of mitochondrial membrane potential,GO:0051899~membrane depolarization,GO:0060081~membrane hyperpolarization,GO:0060548~negative regulation of cell death,GO:0060765~regulation of androgen receptor signaling pathway,GO:0070301~cellular response to hydrogen peroxide,GO:0090073~positive regulation of protein homodimerization activity,GO:1900182~positive regulation of protein localization to nucleus,GO:1901215~negative regulation of neuron death,GO:1901671~positive regulation of superoxide dismutase activity,GO:1901984~negative regulation of protein acetylation,GO:1902177~positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,GO:1902236~negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,GO:1902958~positive regulation of mitochondrial electron transport, NADH to ubiquinone,GO:1903094~negative regulation of protein K48-linked deubiquitination,GO:1903122~negative regulation of TRAIL-activated apoptotic signaling pathway,GO:1903168~positive regulation of pyrroline-5-carboxylate reductase activity,GO:1903178~positive regulation of tyrosine 3-monooxygenase activity,GO:1903181~positive regulation of dopamine biosynthetic process,GO:1903189~glyoxal metabolic process,GO:1903190~glyoxal catabolic process,GO:1903197~positive regulation of L-dopa biosynthetic process,GO:1903200~positive regulation of L-dopa decarboxylase activity,GO:1903202~negative regulation of oxidative stress-induced cell death,GO:1903204~negative regulation of oxidative stress-induced neuron death,GO:1903206~negative regulation of hydrogen peroxide-induced cell death,GO:1903208~negative regulation of hydrogen peroxide-induced neuron death,GO:1903377~negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,GO:1903384~negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,GO:1903428~positive regulation of reactive oxygen species biosynthetic process,GO:1905259~negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,GO:2000157~negative regulation of ubiquitin-specific protease activity,GO:2000277~positive regulation of oxidative phosphorylation uncoupler activity,GO:2000679~positive regulation of transcription regulatory region DNA binding,GO:2000825~positive regulation of androgen receptor activity,GO:2001237~negative regulation of extrinsic apoptotic signaling pathway,GO:2001268~negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005747~mitochondrial respiratory chain complex I,GO:0005758~mitochondrial intermembrane space,GO:0005759~mitochondrial matrix,GO:0005783~endoplasmic reticulum,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005913~cell-cell adherens junction,GO:0016020~membrane,GO:0016605~PML body,GO:0030424~axon,GO:0043005~neuron projection,GO:0044297~cell body,GO:0045121~membrane raft,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,GO:0098793~presynapse,	GO:0003713~transcription coactivator activity,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0005102~receptor binding,GO:0005507~copper ion binding,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0008233~peptidase activity,GO:0016532~superoxide dismutase copper chaperone activity,GO:0016684~oxidoreductase activity, acting on peroxide as acceptor,GO:0016787~hydrolase activity,GO:0019172~glyoxalase III activity,GO:0019899~enzyme binding,GO:0019900~kinase binding,GO:0019955~cytokine binding,GO:0036470~tyrosine 3-monooxygenase activator activity,GO:0036478~L-dopa decarboxylase activator activity,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0044388~small protein activating enzyme binding,GO:0044390~ubiquitin-like protein conjugating enzyme binding,GO:0045340~mercury ion binding,GO:0050681~androgen receptor binding,GO:0051920~peroxiredoxin activity,GO:0070491~repressing transcription factor binding,GO:0097110~scaffold protein binding,GO:0098641~cadherin binding involved in cell-cell adhesion,GO:1903135~cupric ion binding,GO:1903136~cuprous ion binding,GO:1990381~ubiquitin-specific protease binding,GO:1990422~glyoxalase (glycolic acid-forming) activity,	IPR002818:ThiJ/PfpI,IPR006287:DJ-1,	mmu05012:Parkinson's disease,	NA	NA	Acetylation,Autophagy,Cell membrane,Chaperone,Complete proteome,Copper,Cytoplasm,Direct protein sequencing,Fertilization,Hydrolase,Inflammatory response,Isopeptide bond,Lipoprotein,Membrane,Mitochondrion,Nucleus,Oxidation,Palmitate,Phosphoprotein,Protease,Proteomics identification,Reference proteome,RNA-binding,Stress response,Tumor suppressor,Ubl conjugation,Zymogen,	chain:Protein DJ-1,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),modified residue,sequence conflict,
Rnmt	RNA (guanine-7-) methyltransferase(Rnmt)	Mus musculus	NA	NA	GO:0006370~7-methylguanosine mRNA capping,GO:0006397~mRNA processing,GO:0032259~methylation,GO:0036265~RNA (guanine-N7)-methylation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005845~mRNA cap binding complex,GO:0043235~receptor complex,	GO:0003723~RNA binding,GO:0004482~mRNA (guanine-N7-)-methyltransferase activity,GO:0008168~methyltransferase activity,GO:0016740~transferase activity,	IPR004971:mRNA (guanine-N(7))-methyltransferase domain,IPR016899:mRNA (guanine-N(7))-methyltransferase,	mmu03015:mRNA surveillance pathway,	PIRSF028762:mRNA (guanine-N(7))-methyltransferase,	NA	Alternative splicing,Complete proteome,Methyltransferase,mRNA capping,mRNA processing,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,RNA-binding,S-adenosyl-L-methionine,Transferase,	binding site:mRNA cap,binding site:S-adenosyl-L-methionine,binding site:S-adenosyl-L-methionine; via carbonyl oxygen,chain:mRNA cap guanine-N7 methyltransferase,modified residue,region of interest:mRNA cap binding,sequence conflict,short sequence motif:Nuclear localization signal,splice variant,
Rbm3	RNA binding motif protein 3(Rbm3)	Mus musculus	NA	NA	GO:0006412~translation,GO:0006417~regulation of translation,GO:0009409~response to cold,GO:0035196~production of miRNAs involved in gene silencing by miRNA,GO:0045727~positive regulation of translation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0015934~large ribosomal subunit,GO:0030425~dendrite,GO:0042995~cell projection,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0043023~ribosomal large subunit binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,	NA	NA	SM00360:RRM,	Cell projection,Complete proteome,Cytoplasm,Methylation,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,RNA-binding,Stress response,	chain:Putative RNA-binding protein 3,compositionally biased region:Gly-rich,domain:RRM,modified residue,
Rbm38	RNA binding motif protein 38(Rbm38)	Mus musculus	NA	NA	GO:0006397~mRNA processing,GO:0007049~cell cycle,GO:0008380~RNA splicing,GO:0010830~regulation of myotube differentiation,GO:0030154~cell differentiation,GO:0043484~regulation of RNA splicing,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,	NA	NA	SM00360:RRM,	Cell cycle,Complete proteome,Cytoplasm,Differentiation,mRNA processing,mRNA splicing,Nucleus,Proteomics identification,Reference proteome,RNA-binding,	chain:RNA-binding protein 38,domain:RRM,sequence conflict,
Rbm39	RNA binding motif protein 39(Rbm39)	Mus musculus	NA	NA	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006397~mRNA processing,GO:0008380~RNA splicing,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005815~microtubule organizing center,GO:0015630~microtubule cytoskeleton,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003713~transcription coactivator activity,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR003954:RNA recognition motif domain, eukaryote,IPR006509:Splicing factor, CC1-like,IPR012677:Nucleotide-binding, alpha-beta plait,	NA	NA	SM00360:RRM,SM00361:RRM_1,	3D-structure,Acetylation,Activator,Alternative splicing,Complete proteome,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,RNA-binding,Transcription,Transcription regulation,	chain:RNA-binding protein 39,compositionally biased region:Arg/Ser-rich (RS domain),compositionally biased region:Poly-Ala,domain:RRM 1,domain:RRM 2,domain:RRM 3,modified residue,region of interest:Activating domain,region of interest:Interaction with ESR1 and ESR2,region of interest:Interaction with JUN,region of interest:Interaction with NCOA6,sequence conflict,splice variant,
Rbm8a	RNA binding motif protein 8a(Rbm8a)	Mus musculus	NA	NA	GO:0000184~nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,GO:0000381~regulation of alternative mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0006417~regulation of translation,GO:0008380~RNA splicing,GO:0051028~mRNA transport,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016607~nuclear speck,GO:0030425~dendrite,GO:0035145~exon-exon junction complex,GO:0043025~neuronal cell body,GO:0071013~catalytic step 2 spliceosome,	GO:0000166~nucleotide binding,GO:0003729~mRNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR008111:RNA-binding motif protein 8,IPR012677:Nucleotide-binding, alpha-beta plait,	mmu03013:RNA transport,mmu03015:mRNA surveillance pathway,mmu03040:Spliceosome,	NA	SM00360:RRM,	Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Isopeptide bond,mRNA processing,mRNA splicing,mRNA transport,Nonsense-mediated mRNA decay,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,RNA-binding,Spliceosome,Translation regulation,Transport,Ubl conjugation,	chain:RNA-binding protein 8A,domain:RRM,modified residue,sequence conflict,splice variant,
Rbmxl1	RNA binding motif protein, X-linked like-1(Rbmxl1)	Mus musculus	NA	NA	GO:0000381~regulation of alternative mRNA splicing, via spliceosome,GO:0001649~osteoblast differentiation,GO:0006366~transcription from RNA polymerase II promoter,GO:0006376~mRNA splice site selection,GO:0006397~mRNA processing,GO:0006509~membrane protein ectodomain proteolysis,GO:0008380~RNA splicing,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048025~negative regulation of mRNA splicing, via spliceosome,GO:0048026~positive regulation of mRNA splicing, via spliceosome,GO:0051260~protein homooligomerization,GO:0071347~cellular response to interleukin-1,	GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005719~nuclear euchromatin,GO:0016020~membrane,GO:0030529~intracellular ribonucleoprotein complex,GO:0044530~supraspliceosomal complex,GO:0070062~extracellular exosome,GO:0071013~catalytic step 2 spliceosome,	GO:0000166~nucleotide binding,GO:0001047~core promoter binding,GO:0003676~nucleic acid binding,GO:0003682~chromatin binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0005515~protein binding,	IPR000504:RNA recognition motif domain,IPR003954:RNA recognition motif domain, eukaryote,IPR012604:RBM1CTR,IPR012677:Nucleotide-binding, alpha-beta plait,	mmu03040:Spliceosome,	NA	SM00360:RRM,SM00361:RRM_1,	Acetylation,Complete proteome,Isopeptide bond,Methylation,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Reference proteome,Ribonucleoprotein,RNA-binding,Ubl conjugation,	chain:Heterogeneous nuclear ribonucleoprotein G,domain:RRM,modified residue,
Ssb	Sjogren syndrome antigen B(Ssb)	Mus musculus	m_RNApol3Pathway:RNA polymerase III transcription,	NA	GO:0006396~RNA processing,GO:0008033~tRNA processing,GO:0075522~IRES-dependent viral translational initiation,GO:1903608~protein localization to cytoplasmic stress granule,	GO:0000784~nuclear chromosome, telomeric region,GO:0005634~nucleus,GO:0030529~intracellular ribonucleoprotein complex,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR002344:Lupus La protein,IPR006630:RNA-binding protein Lupus La,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR012677:Nucleotide-binding, alpha-beta plait,IPR014886:RNA-binding motif,	mmu05322:Systemic lupus erythematosus,	NA	SM00360:RRM,SM00715:LA,	Acetylation,Complete proteome,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,RNA-binding,	chain:Lupus La protein homolog,domain:HTH La-type RNA-binding,domain:RRM,modified residue,
Son	Son DNA binding protein(Son)	Mus musculus	NA	NA	GO:0000226~microtubule cytoskeleton organization,GO:0000281~mitotic cytokinesis,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006397~mRNA processing,GO:0007049~cell cycle,GO:0008380~RNA splicing,GO:0043066~negative regulation of apoptotic process,GO:0043484~regulation of RNA splicing,GO:0048024~regulation of mRNA splicing, via spliceosome,GO:0051726~regulation of cell cycle,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0016607~nuclear speck,GO:0071011~precatalytic spliceosome,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,GO:0050733~RS domain binding,	IPR000467:G-patch domain,IPR014720:Double-stranded RNA-binding-like domain,IPR017986:WD40-repeat-containing domain,	NA	NA	SM00358:DSRM,SM00443:G_patch,	Acetylation,Alternative splicing,Cell cycle,Complete proteome,DNA-binding,Isopeptide bond,Methylation,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,RNA-binding,Transcription,Transcription regulation,Ubl conjugation,	chain:Protein SON,domain:DRBM,domain:G-patch,modified residue,region of interest:11 X 7 AA tandem repeats of [DR]-P-Y-R- [LI][AG][QHP],region of interest:13 X 10 AA tandem repeats of L-A-[ST]- [NSG]-[TS]-MDSQM,region of interest:14 X 6 AA repeats of [ED]-R-S-M-M-S,region of interest:2 X 19 AA repeats of P-S-R-R-R-R-S-R-S-V- V-R-R-R-S-F-S-I-S,region of interest:3 X 11 AA tandem repats of P-P-L-P-P-E-E- P-P-[TME]-[MTG],region of interest:3 X tandem repeats of [ST]-P-[VLI]-R- [RL]-[RK]-[RF]-S-R,region of interest:7 X 7 AA repeats of P-S-R-R-S-R-[TS],repeat:1-1,repeat:1-10,repeat:1-11,repeat:1-12,repeat:1-13,repeat:1-14,repeat:1-2,repeat:1-3,repeat:1-4,repeat:1-5,repeat:1-6,repeat:1-7,repeat:1-8,repeat:1-9,repeat:2-1,repeat:2-2,repeat:2-3,repeat:2-4,repeat:2-5,repeat:2-6,repeat:2-7; approximate,repeat:3-1,repeat:3-2; approximate,splice variant,
Tardbp	TAR DNA binding protein(Tardbp)	Mus musculus	m_compPathway:Complement Pathway,m_lectinPathway:Lectin Induced Complement Pathway,	General function prediction only,	GO:0001933~negative regulation of protein phosphorylation,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0010629~negative regulation of gene expression,GO:0030264~nuclear fragmentation involved in apoptotic nuclear change,GO:0032024~positive regulation of insulin secretion,GO:0034976~response to endoplasmic reticulum stress,GO:0043922~negative regulation by host of viral transcription,GO:0051726~regulation of cell cycle,GO:0070935~3'-UTR-mediated mRNA stabilization,GO:0071765~nuclear inner membrane organization,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005726~perichromatin fibrils,GO:0005737~cytoplasm,GO:0016607~nuclear speck,GO:0035061~interchromatin granule,	GO:0000166~nucleotide binding,GO:0001205~transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003690~double-stranded DNA binding,GO:0003723~RNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0005515~protein binding,GO:0042802~identical protein binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,	NA	NA	SM00360:RRM,	3D-structure,Complete proteome,Direct protein sequencing,DNA-binding,Isopeptide bond,Methylation,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Repressor,RNA-binding,Transcription,Transcription regulation,Ubl conjugation,	chain:TAR DNA-binding protein 43,compositionally biased region:Gly-rich,domain:RRM 1,domain:RRM 2,helix,modified residue,strand,
Thumpd3	THUMP domain containing 3(Thumpd3)	Mus musculus	NA	NA	GO:0030488~tRNA methylation,GO:0032259~methylation,	GO:0005730~nucleolus,GO:0005737~cytoplasm,	GO:0000049~tRNA binding,GO:0003723~RNA binding,GO:0008168~methyltransferase activity,GO:0016423~tRNA (guanine) methyltransferase activity,GO:0016740~transferase activity,	IPR000241:Putative RNA methylase domain,IPR004114:THUMP,	NA	NA	SM00981:SM00981,	Alternative splicing,Complete proteome,Methyltransferase,Proteomics identification,Reference proteome,RNA-binding,Transferase,	chain:THUMP domain-containing protein 3,compositionally biased region:Poly-Lys,domain:THUMP,sequence conflict,splice variant,
Tial1	Tia1 cytotoxic granule-associated RNA binding protein-like 1(Tial1)	Mus musculus	NA	General function prediction only,	GO:0006915~apoptotic process,GO:0007281~germ cell development,GO:0008284~positive regulation of cell proliferation,GO:0017145~stem cell division,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0010494~cytoplasmic stress granule,GO:0030529~intracellular ribonucleoprotein complex,GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0017091~AU-rich element binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR003954:RNA recognition motif domain, eukaryote,IPR012677:Nucleotide-binding, alpha-beta plait,	NA	NA	SM00360:RRM,SM00361:RRM_1,	Acetylation,Apoptosis,Complete proteome,Cytoplasm,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,RNA-binding,	chain:Nucleolysin TIAR,domain:RRM 1,domain:RRM 2,domain:RRM 3,modified residue,
Snrpc	U1 small nuclear ribonucleoprotein C(Snrpc)	Mus musculus	NA	NA	GO:0000387~spliceosomal snRNP assembly,GO:0000395~mRNA 5'-splice site recognition,GO:0000398~mRNA splicing, via spliceosome,	GO:0000243~commitment complex,GO:0005634~nucleus,GO:0005685~U1 snRNP,GO:0015030~Cajal body,GO:0019013~viral nucleocapsid,GO:0030529~intracellular ribonucleoprotein complex,GO:0071004~U2-type prespliceosome,GO:0071010~prespliceosome,	GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003727~single-stranded RNA binding,GO:0003729~mRNA binding,GO:0008270~zinc ion binding,GO:0030619~U1 snRNA binding,GO:0030627~pre-mRNA 5'-splice site binding,GO:0046872~metal ion binding,GO:1990446~U1 snRNP binding,	IPR000690:Zinc finger, C2H2-type matrin,IPR003604:Zinc finger, U1-type,IPR013085:Zinc finger, U1-C type,IPR017340:U1 small nuclear ribonucleoprotein C,	mmu03040:Spliceosome,	PIRSF037969:U1 small nuclear ribonucleoprotein C,	SM00451:ZnF_U1,	Acetylation,Complete proteome,Metal-binding,Nucleus,Phosphoprotein,Reference proteome,Ribonucleoprotein,RNA-binding,Viral nucleoprotein,Virion,Zinc,Zinc-finger,	chain:U1 small nuclear ribonucleoprotein C,modified residue,zinc finger region:Matrin-type,
Snrpb2	U2 small nuclear ribonucleoprotein B(Snrpb2)	Mus musculus	NA	NA	GO:0000398~mRNA splicing, via spliceosome,GO:0002230~positive regulation of defense response to virus by host,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0098792~xenophagy,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005686~U2 snRNP,GO:0005730~nucleolus,GO:0030529~intracellular ribonucleoprotein complex,GO:0030532~small nuclear ribonucleoprotein complex,GO:0071013~catalytic step 2 spliceosome,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0017069~snRNA binding,GO:0035614~snRNA stem-loop binding,GO:0070990~snRNP binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,IPR024888:U1 small nuclear ribonucleoprotein A/U2 small nuclear ribonucleoprotein B'',	mmu03040:Spliceosome,	NA	SM00360:RRM,	Acetylation,Complete proteome,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Ribonucleoprotein,RNA-binding,Spliceosome,	chain:U2 small nuclear ribonucleoprotein B'',domain:RRM 1,domain:RRM 2,modified residue,sequence conflict,
U2af1	U2 small nuclear ribonucleoprotein auxiliary factor (U2AF) 1(U2af1)	Mus musculus	NA	NA	GO:0000398~mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0008380~RNA splicing,	GO:0005634~nucleus,GO:0005681~spliceosomal complex,GO:0016607~nuclear speck,GO:0019013~viral nucleocapsid,GO:0030529~intracellular ribonucleoprotein complex,GO:0089701~U2AF,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0030628~pre-mRNA 3'-splice site binding,GO:0046872~metal ion binding,GO:0050733~RS domain binding,	IPR000504:RNA recognition motif domain,IPR000571:Zinc finger, CCCH-type,IPR003954:RNA recognition motif domain, eukaryote,IPR009145:U2 auxiliary factor small subunit,IPR012677:Nucleotide-binding, alpha-beta plait,	mmu03040:Spliceosome,	NA	SM00356:ZnF_C3H1,SM00360:RRM,SM00361:RRM_1,	Acetylation,Complete proteome,Metal-binding,Methylation,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Ribonucleoprotein,RNA-binding,Spliceosome,Viral nucleoprotein,Virion,Zinc,Zinc-finger,	chain:Splicing factor U2AF 35 kDa subunit,compositionally biased region:Arg/Gly/Ser-rich (RS domain),domain:RRM,modified residue,sequence conflict,zinc finger region:C3H1-type 1,zinc finger region:C3H1-type 2,
U2af2	U2 small nuclear ribonucleoprotein auxiliary factor (U2AF) 2(U2af2)	Mus musculus	NA	NA	GO:0000398~mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0033120~positive regulation of RNA splicing,GO:0048025~negative regulation of mRNA splicing, via spliceosome,GO:1903146~regulation of mitophagy,GO:1903955~positive regulation of protein targeting to mitochondrion,	GO:0000243~commitment complex,GO:0000974~Prp19 complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0016607~nuclear speck,GO:0019013~viral nucleocapsid,GO:0030529~intracellular ribonucleoprotein complex,GO:0071004~U2-type prespliceosome,GO:0089701~U2AF,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0008187~poly-pyrimidine tract binding,GO:0019899~enzyme binding,GO:0030628~pre-mRNA 3'-splice site binding,GO:0044822~poly(A) RNA binding,GO:0070742~C2H2 zinc finger domain binding,	IPR000504:RNA recognition motif domain,IPR006529:U2 snRNP auxilliary factor, large subunit, splicing factor,IPR012677:Nucleotide-binding, alpha-beta plait,	mmu03040:Spliceosome,	NA	SM00360:RRM,	3D-structure,Acetylation,Complete proteome,Hydroxylation,Isopeptide bond,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Repressor,Ribonucleoprotein,RNA-binding,Ubl conjugation,Viral nucleoprotein,Virion,	chain:Splicing factor U2AF 65 kDa subunit,compositionally biased region:Arg/Ser-rich (RS domain),domain:RRM 1,domain:RRM 2,domain:RRM 3,modified residue,
Upf1	UPF1 regulator of nonsense transcripts homolog (yeast)(Upf1)	Mus musculus	NA	DNA replication, recombination, and repair,	GO:0000184~nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,GO:0000294~nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay,GO:0000723~telomere maintenance,GO:0000956~nuclear-transcribed mRNA catabolic process,GO:0006260~DNA replication,GO:0006281~DNA repair,GO:0006449~regulation of translational termination,GO:0009048~dosage compensation by inactivation of X chromosome,GO:0032201~telomere maintenance via semi-conservative replication,GO:0061014~positive regulation of mRNA catabolic process,GO:0061158~3'-UTR-mediated mRNA destabilization,GO:0071044~histone mRNA catabolic process,GO:0071222~cellular response to lipopolysaccharide,GO:0071347~cellular response to interleukin-1,	GO:0000784~nuclear chromosome, telomeric region,GO:0000785~chromatin,GO:0000932~cytoplasmic mRNA processing body,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0035145~exon-exon junction complex,GO:0044530~supraspliceosomal complex,	GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003723~RNA binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0008270~zinc ion binding,GO:0016787~hydrolase activity,GO:0042162~telomeric DNA binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR006935:Helicase/UvrB domain,IPR018999:RNA helicase UPF1, UPF2-interacting domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	mmu03013:RNA transport,mmu03015:mRNA surveillance pathway,	NA	NA	Alternative splicing,ATP-binding,Complete proteome,Cytoplasm,Helicase,Hydrolase,Metal-binding,Methylation,Nonsense-mediated mRNA decay,Nucleotide-binding,Nucleus,Phosphoprotein,Reference proteome,Repeat,RNA-binding,Zinc,Zinc-finger,	chain:Regulator of nonsense transcripts 1,compositionally biased region:Ala/Gly/Pro-rich,compositionally biased region:Gln/Ser-rich,modified residue,nucleotide phosphate-binding region:ATP,region of interest:Sufficient for interaction with RENT2,sequence conflict,short sequence motif:[ST]-Q motif 1,short sequence motif:[ST]-Q motif 2,splice variant,zinc finger region:C2H2-type; atypical,zinc finger region:C4-type,
Ybx1	Y box protein 1(Ybx1)	Mus musculus	m_dbpbPathway:Transcriptional activation of dbpb from mRNA,	NA	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001701~in utero embryonic development,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006397~mRNA processing,GO:0008284~positive regulation of cell proliferation,GO:0008380~RNA splicing,GO:0043066~negative regulation of apoptotic process,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046627~negative regulation of insulin receptor signaling pathway,GO:0051154~negative regulation of striated muscle cell differentiation,GO:0051781~positive regulation of cell division,GO:0070934~CRD-mediated mRNA stabilization,GO:1903608~protein localization to cytoplasmic stress granule,	GO:0005576~extracellular region,GO:0005634~nucleus,GO:0005689~U12-type spliceosomal complex,GO:0005737~cytoplasm,GO:0010494~cytoplasmic stress granule,GO:0030425~dendrite,GO:0030529~intracellular ribonucleoprotein complex,GO:0031965~nuclear membrane,GO:0043231~intracellular membrane-bounded organelle,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,GO:0070937~CRD-mediated mRNA stability complex,GO:0071204~histone pre-mRNA 3'end processing complex,GO:1990124~messenger ribonucleoprotein complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0002039~p53 binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003697~single-stranded DNA binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0043565~sequence-specific DNA binding,GO:0044822~poly(A) RNA binding,GO:0051020~GTPase binding,	IPR002059:Cold-shock protein, DNA-binding,IPR011129:Cold shock protein,IPR012340:Nucleic acid-binding, OB-fold,IPR019844:Cold-shock conserved site,	NA	NA	SM00357:CSP,	Acetylation,Activator,Complete proteome,Cytoplasm,DNA-binding,Isopeptide bond,Mitogen,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repressor,RNA-binding,Secreted,Transcription,Transcription regulation,Ubl conjugation,	chain:Nuclease-sensitive element-binding protein 1,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),domain:CSD,modified residue,region of interest:Interaction with ss-DNA,sequence conflict,site:Cleavage; by 20S proteasomal protease,
Ybx3	Y box protein 3(Ybx3)	Mus musculus	NA	NA	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001701~in utero embryonic development,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007283~spermatogenesis,GO:0008584~male gonad development,GO:0009566~fertilization,GO:0043066~negative regulation of apoptotic process,GO:0046622~positive regulation of organ growth,GO:0048642~negative regulation of skeletal muscle tissue development,GO:0060546~negative regulation of necroptotic process,GO:0071356~cellular response to tumor necrosis factor,GO:0071474~cellular hyperosmotic response,GO:1902219~negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005844~polysome,GO:0005921~gap junction,GO:0030529~intracellular ribonucleoprotein complex,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0001227~transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003697~single-stranded DNA binding,GO:0003723~RNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR002059:Cold-shock protein, DNA-binding,IPR011129:Cold shock protein,IPR012340:Nucleic acid-binding, OB-fold,IPR019844:Cold-shock conserved site,	mmu04530:Tight junction,	NA	SM00357:CSP,	Acetylation,Alternative splicing,Complete proteome,Cytoplasm,DNA-binding,Methylation,Nucleus,Phosphoprotein,Reference proteome,Repressor,RNA-binding,Transcription,Transcription regulation,	chain:DNA-binding protein A,compositionally biased region:Ala-rich,compositionally biased region:Arg-rich,domain:CSD,modified residue,sequence conflict,splice variant,
Aco1	aconitase 1(Aco1)	Mus musculus	NA	NA	GO:0006099~tricarboxylic acid cycle,GO:0006101~citrate metabolic process,GO:0006417~regulation of translation,GO:0006879~cellular iron ion homeostasis,GO:0008152~metabolic process,GO:0009791~post-embryonic development,GO:0010040~response to iron(II) ion,GO:0010468~regulation of gene expression,GO:0050892~intestinal absorption,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0043231~intracellular membrane-bounded organelle,GO:0070062~extracellular exosome,	GO:0003723~RNA binding,GO:0003994~aconitate hydratase activity,GO:0016829~lyase activity,GO:0030350~iron-responsive element binding,GO:0046872~metal ion binding,GO:0048027~mRNA 5'-UTR binding,GO:0051536~iron-sulfur cluster binding,GO:0051539~4 iron, 4 sulfur cluster binding,	IPR000573:Aconitase A/isopropylmalate dehydratase small subunit, swivel,IPR001030:Aconitase/3-isopropylmalate dehydratase large subunit, alpha/beta/alpha,IPR006249:Aconitase/iron regulatory protein 2,IPR015928:Aconitase/3-isopropylmalate dehydratase, swivel,IPR015931:Aconitase/3-isopropylmalate dehydratase large subunit, alpha/beta/alpha, subdomain 1/3,IPR015932:Aconitase/3-isopropylmalate dehydratase large subunit, alpha/beta/alpha, subdomain 2,IPR015937:Aconitase/isopropylmalate dehydratase,IPR018136:Aconitase family, 4Fe-4S cluster binding site,	mmu00020:Citrate cycle (TCA cycle),mmu00630:Glyoxylate and dicarboxylate metabolism,mmu01100:Metabolic pathways,mmu01130:Biosynthesis of antibiotics,mmu01200:Carbon metabolism,mmu01210:2-Oxocarboxylic acid metabolism,mmu01230:Biosynthesis of amino acids,	NA	NA	4Fe-4S,Complete proteome,Cytoplasm,Iron,Iron-sulfur,Lyase,Metal-binding,Reference proteome,RNA-binding,Tricarboxylic acid cycle,	chain:Cytoplasmic aconitate hydratase,metal ion-binding site:Iron-sulfur (4Fe-4S),sequence conflict,
Aars	alanyl-tRNA synthetase(Aars)	Mus musculus	NA	NA	GO:0001942~hair follicle development,GO:0006400~tRNA modification,GO:0006412~translation,GO:0006419~alanyl-tRNA aminoacylation,GO:0006457~protein folding,GO:0021680~cerebellar Purkinje cell layer development,GO:0030968~endoplasmic reticulum unfolded protein response,GO:0034620~cellular response to unfolded protein,GO:0043039~tRNA aminoacylation,GO:0043200~response to amino acid,GO:0043524~negative regulation of neuron apoptotic process,GO:0043588~skin development,GO:0050885~neuromuscular process controlling balance,GO:0050905~neuromuscular process,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016020~membrane,GO:0070062~extracellular exosome,	GO:0000049~tRNA binding,GO:0000166~nucleotide binding,GO:0002161~aminoacyl-tRNA editing activity,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0004812~aminoacyl-tRNA ligase activity,GO:0004813~alanine-tRNA ligase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008270~zinc ion binding,GO:0016597~amino acid binding,GO:0016874~ligase activity,GO:0016876~ligase activity, forming aminoacyl-tRNA and related compounds,GO:0046872~metal ion binding,	IPR002318:Alanine-tRNA ligase, class IIc,IPR003156:Phosphoesterase, DHHA1,IPR009000:Translation elongation/initiation factor/Ribosomal, beta-barrel,IPR012947:Threonyl/alanyl tRNA synthetase, SAD,IPR018162:Alanine-tRNA ligase, class IIc, anti-codon-binding domain,IPR018163:Threonyl/alanyl tRNA synthetase, class II-like, putative editing domain,IPR018164:Alanyl-tRNA synthetase, class IIc, N-terminal,IPR018165:Alanyl-tRNA synthetase, class IIc, core domain,IPR023033:Alanine-tRNA ligase, eukaryota/bacteria,	mmu00970:Aminoacyl-tRNA biosynthesis,	NA	SM00863:SM00863,	Acetylation,Aminoacyl-tRNA synthetase,ATP-binding,Complete proteome,Cytoplasm,Ligase,Metal-binding,Nucleotide-binding,Phosphoprotein,Protein biosynthesis,Reference proteome,RNA-binding,tRNA-binding,Ubl conjugation,Zinc,	chain:Alanyl-tRNA synthetase, cytoplasmic,modified residue,region of interest:Catalytic,sequence conflict,
Aimp1	aminoacyl tRNA synthetase complex-interacting multifunctional protein 1(Aimp1)	Mus musculus	NA	NA	GO:0001525~angiogenesis,GO:0001937~negative regulation of endothelial cell proliferation,GO:0005975~carbohydrate metabolic process,GO:0006006~glucose metabolic process,GO:0006412~translation,GO:0006418~tRNA aminoacylation for protein translation,GO:0006915~apoptotic process,GO:0006954~inflammatory response,GO:0007155~cell adhesion,GO:0007267~cell-cell signaling,GO:0048514~blood vessel morphogenesis,GO:0050900~leukocyte migration,GO:0051607~defense response to virus,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0009986~cell surface,GO:0016020~membrane,GO:0017101~aminoacyl-tRNA synthetase multienzyme complex,GO:0017102~methionyl glutamyl tRNA synthetase complex,GO:0030133~transport vesicle,GO:0031410~cytoplasmic vesicle,	GO:0000049~tRNA binding,GO:0003723~RNA binding,GO:0005125~cytokine activity,GO:0042803~protein homodimerization activity,GO:0051020~GTPase binding,	IPR002547:tRNA-binding domain,IPR012340:Nucleic acid-binding, OB-fold,	NA	NA	NA	Acetylation,Angiogenesis,Apoptosis,Carbohydrate metabolism,Cell adhesion,Coiled coil,Complete proteome,Cytokine,Cytoplasm,Cytoplasmic vesicle,Direct protein sequencing,Endoplasmic reticulum,Glucose metabolism,Golgi apparatus,Inflammatory response,Nucleus,Phosphoprotein,Protein biosynthesis,Proteomics identification,Reference proteome,RNA-binding,Secreted,tRNA-binding,	chain:Aminoacyl tRNA synthetase complex- interacting multifunctional protein 1,chain:Endothelial monocyte-activating polypeptide 2,domain:tRNA-binding,modified residue,region of interest:Interaction with HSP90B1,region of interest:Required for endothelial cell death,region of interest:Required for endothelial cell migration,region of interest:Required for fibroblast proliferation,
Apex1	apurinic/apyrimidinic endonuclease 1(Apex1)	Mus musculus	m_setPathway:Granzyme A mediated Apoptosis Pathway,	NA	GO:0000723~telomere maintenance,GO:0006281~DNA repair,GO:0006284~base-excision repair,GO:0006310~DNA recombination,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006974~cellular response to DNA damage stimulus,GO:0007568~aging,GO:0014912~negative regulation of smooth muscle cell migration,GO:0042493~response to drug,GO:0043488~regulation of mRNA stability,GO:0045454~cell redox homeostasis,GO:0045739~positive regulation of DNA repair,GO:0070301~cellular response to hydrogen peroxide,GO:0071320~cellular response to cAMP,GO:0071375~cellular response to peptide hormone stimulus,GO:0080111~DNA demethylation,GO:1900087~positive regulation of G1/S transition of mitotic cell cycle,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005783~endoplasmic reticulum,GO:0005813~centrosome,GO:0016607~nuclear speck,GO:0048471~perinuclear region of cytoplasm,	GO:0003677~DNA binding,GO:0003684~damaged DNA binding,GO:0003691~double-stranded telomeric DNA binding,GO:0003713~transcription coactivator activity,GO:0003723~RNA binding,GO:0003906~DNA-(apurinic or apyrimidinic site) lyase activity,GO:0004518~nuclease activity,GO:0004519~endonuclease activity,GO:0004521~endoribonuclease activity,GO:0004527~exonuclease activity,GO:0008081~phosphoric diester hydrolase activity,GO:0008309~double-stranded DNA exodeoxyribonuclease activity,GO:0008311~double-stranded DNA 3'-5' exodeoxyribonuclease activity,GO:0008408~3'-5' exonuclease activity,GO:0016491~oxidoreductase activity,GO:0016787~hydrolase activity,GO:0016829~lyase activity,GO:0016890~site-specific endodeoxyribonuclease activity, specific for altered base,GO:0031490~chromatin DNA binding,GO:0032403~protein complex binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,GO:0051059~NF-kappaB binding,	IPR004808:Exodeoxyribonuclease III xth,IPR005135:Endonuclease/exonuclease/phosphatase,IPR020847:AP endonuclease, family 1, binding site,IPR020848:AP endonuclease, family 1, conserved site,	mmu03410:Base excision repair,	NA	NA	Acetylation,Activator,Cleavage on pair of basic residues,Complete proteome,Cytoplasm,Direct protein sequencing,Disulfide bond,DNA damage,DNA recombination,DNA repair,DNA-binding,Endonuclease,Endoplasmic reticulum,Exonuclease,Hydrolase,Lyase,Magnesium,Metal-binding,Mitochondrion,Nuclease,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repressor,RNA-binding,S-nitrosylation,Transcription,Transcription regulation,Ubl conjugation,	active site:Proton acceptor,chain:DNA-(apurinic or apyrimidinic site) lyase,metal ion-binding site:Magnesium or manganese,modified residue,site:Important for substrate recognition,
Carhsp1	calcium regulated heat stable protein 1(Carhsp1)	Mus musculus	NA	NA	GO:0006355~regulation of transcription, DNA-templated,GO:0043488~regulation of mRNA stability,	GO:0000177~cytoplasmic exosome (RNase complex),GO:0000932~cytoplasmic mRNA processing body,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0043186~P granule,GO:0070062~extracellular exosome,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0005515~protein binding,	IPR002059:Cold-shock protein, DNA-binding,IPR011129:Cold shock protein,IPR012340:Nucleic acid-binding, OB-fold,IPR019844:Cold-shock conserved site,	NA	NA	SM00357:CSP,	Acetylation,Complete proteome,Cytoplasm,Phosphoprotein,Reference proteome,RNA-binding,	chain:Calcium-regulated heat stable protein 1,domain:CSD,modified residue,
Caprin2	caprin family member 2(Caprin2)	Mus musculus	NA	NA	GO:0017148~negative regulation of translation,GO:0030154~cell differentiation,GO:0030308~negative regulation of cell growth,GO:0032092~positive regulation of protein binding,GO:0033138~positive regulation of peptidyl-serine phosphorylation,GO:0040008~regulation of growth,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0050775~positive regulation of dendrite morphogenesis,GO:0061003~positive regulation of dendritic spine morphogenesis,GO:0090263~positive regulation of canonical Wnt signaling pathway,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005813~centrosome,GO:0043235~receptor complex,	GO:0003723~RNA binding,GO:0005102~receptor binding,	IPR001073:Complement C1q protein,IPR008983:Tumour necrosis factor-like domain,IPR022070:Cytoplasmic activation/proliferation-associated protein-1 C term,	NA	NA	SM00110:C1Q,	Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Differentiation,Growth regulation,Phosphoprotein,Protein synthesis inhibitor,Reference proteome,RNA-binding,	chain:Caprin-2,domain:C1q,modified residue,sequence conflict,splice variant,
Caprin1	cell cycle associated protein 1(Caprin1)	Mus musculus	NA	NA	GO:0017148~negative regulation of translation,GO:0030154~cell differentiation,GO:0050775~positive regulation of dendrite morphogenesis,GO:0061003~positive regulation of dendritic spine morphogenesis,	GO:0000932~cytoplasmic mRNA processing body,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0010494~cytoplasmic stress granule,GO:0016020~membrane,GO:0030425~dendrite,GO:0042995~cell projection,	GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR022070:Cytoplasmic activation/proliferation-associated protein-1 C term,	NA	NA	NA	Acetylation,Cell projection,Coiled coil,Complete proteome,Cytoplasm,Differentiation,Glycoprotein,Methylation,Phosphoprotein,Protein synthesis inhibitor,Proteomics identification,Reference proteome,RNA-binding,	chain:Caprin-1,modified residue,region of interest:G3BP1-binding,sequence conflict,
Cdc5l	cell division cycle 5-like (S. pombe)(Cdc5l)	Mus musculus	NA	Transcription / RNA processing and modification / Cell division and chromosome partitioning,	GO:0000278~mitotic cell cycle,GO:0000398~mRNA splicing, via spliceosome,GO:0006281~DNA repair,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006397~mRNA processing,GO:0006974~cellular response to DNA damage stimulus,GO:0007049~cell cycle,GO:0008380~RNA splicing,GO:0030154~cell differentiation,GO:0044344~cellular response to fibroblast growth factor stimulus,GO:0071352~cellular response to interleukin-2,GO:0072422~signal transduction involved in DNA damage checkpoint,GO:1904568~cellular response to wortmannin,GO:1990090~cellular response to nerve growth factor stimulus,GO:1990646~cellular response to prolactin,	GO:0000974~Prp19 complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005662~DNA replication factor A complex,GO:0005681~spliceosomal complex,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0016607~nuclear speck,GO:0032993~protein-DNA complex,GO:0048471~perinuclear region of cytoplasm,GO:0071013~catalytic step 2 spliceosome,	GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001135~transcription factor activity, RNA polymerase II transcription factor recruiting,GO:0001222~transcription corepressor binding,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0008157~protein phosphatase 1 binding,GO:0019901~protein kinase binding,GO:0043522~leucine zipper domain binding,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,GO:0044822~poly(A) RNA binding,GO:0071987~WD40-repeat domain binding,	IPR001005:SANT/Myb domain,IPR009057:Homeodomain-like,IPR017930:Myb domain,IPR021786:Domain of unknown function DUF3351,	mmu03040:Spliceosome,	NA	SM00717:SANT,	Activator,Cell cycle,Coiled coil,Complete proteome,Cytoplasm,Direct protein sequencing,DNA damage,DNA repair,DNA-binding,Isopeptide bond,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Reference proteome,Repeat,RNA-binding,Spliceosome,Transcription,Transcription regulation,Ubl conjugation,	chain:Cell division cycle 5-related protein,DNA-binding region:H-T-H motif,domain:HTH myb-type 1,domain:HTH myb-type 2,modified residue,region of interest:Interaction with DAPK3,region of interest:Interaction with PLRG1,region of interest:Interaction with PPP1R8,
Cstf2t	cleavage stimulation factor, 3' pre-RNA subunit 2, tau(Cstf2t)	Mus musculus	NA	NA	GO:0006378~mRNA polyadenylation,GO:0006397~mRNA processing,GO:0031124~mRNA 3'-end processing,GO:0098789~pre-mRNA cleavage required for polyadenylation,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005847~mRNA cleavage and polyadenylation specificity factor complex,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,IPR025742:Cleavage stimulation factor subunit 2, hinge domain,IPR026896:Transcription termination and cleavage factor C-terminal domain,	mmu03015:mRNA surveillance pathway,	NA	SM00360:RRM,	Complete proteome,mRNA processing,Nucleus,Phosphoprotein,Reference proteome,Repeat,RNA-binding,	chain:Cleavage stimulation factor 64 kDa subunit, tau variant,compositionally biased region:Gly-rich,domain:RRM,modified residue,region of interest:12 X 5 AA tandem repeats of G-[AT]-G- [MI]-Q,region of interest:8 X 5 AA tandem repeats of M-E-T-R-[AG],repeat:1-1; approximate,repeat:1-2; approximate,repeat:1-3; approximate,repeat:1-4; approximate,repeat:1-5; approximate,repeat:1-6,repeat:1-7; approximate,repeat:1-8; approximate,repeat:2-10; approximate,repeat:2-11; approximate,repeat:2-12,repeat:2-1; approximate,repeat:2-2,repeat:2-3; approximate,repeat:2-4,repeat:2-5; approximate,repeat:2-6,repeat:2-7; approximate,repeat:2-8,repeat:2-9; approximate,sequence conflict,
Cirbp	cold inducible RNA binding protein(Cirbp)	Mus musculus	NA	NA	GO:0009411~response to UV,GO:0030308~negative regulation of cell growth,GO:0034063~stress granule assembly,GO:0045727~positive regulation of translation,GO:0048255~mRNA stabilization,GO:0070417~cellular response to cold,GO:1902806~regulation of cell cycle G1/S phase transition,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0010494~cytoplasmic stress granule,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0008266~poly(U) RNA binding,GO:0030371~translation repressor activity,GO:0044822~poly(A) RNA binding,GO:0070181~small ribosomal subunit rRNA binding,	IPR000504:RNA recognition motif domain,IPR003954:RNA recognition motif domain, eukaryote,IPR012677:Nucleotide-binding, alpha-beta plait,	NA	NA	SM00360:RRM,SM00361:RRM_1,	Activator,Complete proteome,Cytoplasm,Methylation,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repressor,RNA-binding,Stress response,	chain:Cold-inducible RNA-binding protein,compositionally biased region:Gly-rich,domain:RRM,mutagenesis site,
Csde1	cold shock domain containing E1, RNA binding(Csde1)	Mus musculus	NA	NA	GO:0006355~regulation of transcription, DNA-templated,GO:0070966~nuclear-transcribed mRNA catabolic process, no-go decay,	GO:0005737~cytoplasm,GO:0005743~mitochondrial inner membrane,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0070937~CRD-mediated mRNA stability complex,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR002059:Cold-shock protein, DNA-binding,IPR011129:Cold shock protein,IPR012340:Nucleic acid-binding, OB-fold,IPR019844:Cold-shock conserved site,IPR024642:SUZ-C domain,	NA	NA	SM00357:CSP,	Acetylation,Complete proteome,Cytoplasm,Isopeptide bond,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,RNA-binding,Transmembrane,Transmembrane helix,Ubl conjugation,	chain:Cold shock domain-containing protein E1,domain:CSD 1,domain:CSD 2; truncated,domain:CSD 3,domain:CSD 4; truncated,domain:CSD 5,domain:CSD 6,domain:CSD 7,domain:CSD 8,domain:CSD 9,modified residue,
Cryz	crystallin, zeta(Cryz)	Mus musculus	m_arenrf2Pathway:Oxidative Stress Induced Gene Expression Via Nrf2,	Energy production and conversion / General function prediction only,	GO:0042178~xenobiotic catabolic process,GO:0051289~protein homotetramerization,GO:0055114~oxidation-reduction process,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0003723~RNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0003960~NADPH:quinone reductase activity,GO:0008270~zinc ion binding,GO:0016491~oxidoreductase activity,GO:0050661~NADP binding,GO:0070402~NADPH binding,	IPR002085:Alcohol dehydrogenase superfamily, zinc-type,IPR002364:Quinone oxidoreductase/zeta-crystallin, conserved site,IPR011032:GroES-like,IPR013149:Alcohol dehydrogenase, C-terminal,IPR013154:Alcohol dehydrogenase GroES-like,IPR016040:NAD(P)-binding domain,IPR020843:Polyketide synthase, enoylreductase,	NA	NA	SM00829:SM00829,	Acetylation,Complete proteome,Cytoplasm,NADP,Oxidoreductase,Phosphoprotein,Proteomics identification,Reference proteome,RNA-binding,	chain:Quinone oxidoreductase,modified residue,sequence conflict,
Dkc1	dyskeratosis congenita 1, dyskerin(Dkc1)	Mus musculus	NA	NA	GO:0000154~rRNA modification,GO:0000454~snoRNA guided rRNA pseudouridine synthesis,GO:0000495~box H/ACA snoRNA 3'-end processing,GO:0001522~pseudouridine synthesis,GO:0006364~rRNA processing,GO:0006396~RNA processing,GO:0007004~telomere maintenance via telomerase,GO:0008283~cell proliferation,GO:0009451~RNA modification,GO:0031118~rRNA pseudouridine synthesis,GO:0031120~snRNA pseudouridine synthesis,GO:0032212~positive regulation of telomere maintenance via telomerase,GO:0033979~box H/ACA snoRNA metabolic process,GO:0042254~ribosome biogenesis,GO:0051973~positive regulation of telomerase activity,GO:0090669~telomerase RNA stabilization,GO:1904851~positive regulation of establishment of protein localization to telomere,GO:1904874~positive regulation of telomerase RNA localization to Cajal body,GO:1990481~mRNA pseudouridine synthesis,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005697~telomerase holoenzyme complex,GO:0005730~nucleolus,GO:0005732~small nucleolar ribonucleoprotein complex,GO:0015030~Cajal body,GO:0030529~intracellular ribonucleoprotein complex,GO:0031429~box H/ACA snoRNP complex,GO:0072588~box H/ACA RNP complex,GO:0090661~box H/ACA telomerase RNP complex,	GO:0003720~telomerase activity,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0009982~pseudouridine synthase activity,GO:0016853~isomerase activity,GO:0034513~box H/ACA snoRNA binding,GO:0044822~poly(A) RNA binding,GO:0070034~telomerase RNA binding,	IPR002478:Pseudouridine synthase/archaeosine transglycosylase,IPR002501:Pseudouridine synthase II,IPR004521:Uncharacterised domain CHP00451,IPR004802:tRNA pseudouridine synthase B family,IPR012960:Dyskerin-like,IPR015947:PUA-like domain,IPR020103:Pseudouridine synthase, catalytic domain,	mmu03008:Ribosome biogenesis in eukaryotes,	NA	SM00359:PUA,SM01136:SM01136,	Acetylation,Complete proteome,Isomerase,Isopeptide bond,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Ribonucleoprotein,Ribosome biogenesis,RNA-binding,rRNA processing,Ubl conjugation,	active site:Nucleophile,chain:H/ACA ribonucleoprotein complex subunit 4,compositionally biased region:Poly-Lys,domain:PUA,modified residue,mutagenesis site,region of interest:Nuclear and nucleolar localization,region of interest:Nucleolar localization,
Eif2s1	eukaryotic translation initiation factor 2, subunit 1 alpha(Eif2s1)	Mus musculus	m_chemicalPathway:Apoptotic Signaling in Response to DNA Damage,m_eif2Pathway:Regulation of eIF2,m_eifPathway:Eukaryotic protein translation,m_igf1mtorPathway:Skeletal muscle hypertrophy is regulated via AKT/mTOR pathway,m_rnaPathway:Double Stranded RNA Induced Gene Expression,	Translation, ribosomal structure and biogenesis,	GO:0002230~positive regulation of defense response to virus by host,GO:0006412~translation,GO:0006413~translational initiation,GO:0006417~regulation of translation,GO:0007568~aging,GO:0032057~negative regulation of translational initiation in response to stress,GO:0034198~cellular response to amino acid starvation,GO:0034605~cellular response to heat,GO:0034644~cellular response to UV,GO:0034976~response to endoplasmic reticulum stress,GO:0043558~regulation of translational initiation in response to stress,GO:0046777~protein autophosphorylation,GO:0098779~mitophagy in response to mitochondrial depolarization,GO:0098792~xenophagy,GO:1901216~positive regulation of neuron death,GO:1905098~negative regulation of guanyl-nucleotide exchange factor activity,GO:1990737~response to manganese-induced endoplasmic reticulum stress,GO:2000676~positive regulation of type B pancreatic cell apoptotic process,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005840~ribosome,GO:0005850~eukaryotic translation initiation factor 2 complex,GO:0005851~eukaryotic translation initiation factor 2B complex,GO:0010494~cytoplasmic stress granule,GO:0016020~membrane,GO:0033290~eukaryotic 48S preinitiation complex,GO:0043614~multi-eIF complex,GO:0044207~translation initiation ternary complex,GO:0070062~extracellular exosome,GO:0097451~glial limiting end-foot,	GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003743~translation initiation factor activity,GO:0005515~protein binding,GO:0043022~ribosome binding,GO:0044822~poly(A) RNA binding,	IPR003029:Ribosomal protein S1, RNA-binding domain,IPR011488:Translation initiation factor 2, alpha subunit,IPR012340:Nucleic acid-binding, OB-fold,IPR022967:RNA-binding domain, S1,IPR024054:Translation initiation factor 2, alpha subunit, middle domain,IPR024055:Translation initiation factor 2, alpha subunit, C-terminal,	mmu03013:RNA transport,mmu04141:Protein processing in endoplasmic reticulum,mmu04932:Non-alcoholic fatty liver disease (NAFLD),mmu05160:Hepatitis C,mmu05162:Measles,mmu05164:Influenza A,mmu05168:Herpes simplex infection,	NA	SM00316:SM00316,	Acetylation,Coiled coil,Complete proteome,Initiation factor,Phosphoprotein,Protein biosynthesis,Reference proteome,RNA-binding,Translation regulation,	chain:Eukaryotic translation initiation factor 2 subunit 1,domain:S1 motif,modified residue,
Eif3a	eukaryotic translation initiation factor 3, subunit A(Eif3a)	Mus musculus	m_eifPathway:Eukaryotic protein translation,m_iresPathway:Internal Ribosome entry pathway,m_mtorPathway:mTOR Signaling Pathway,	NA	GO:0001731~formation of translation preinitiation complex,GO:0001732~formation of cytoplasmic translation initiation complex,GO:0002188~translation reinitiation,GO:0006412~translation,GO:0006413~translational initiation,GO:0006446~regulation of translational initiation,GO:0070373~negative regulation of ERK1 and ERK2 cascade,GO:0075522~IRES-dependent viral translational initiation,GO:0075525~viral translational termination-reinitiation,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005815~microtubule organizing center,GO:0005852~eukaryotic translation initiation factor 3 complex,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0016020~membrane,GO:0016282~eukaryotic 43S preinitiation complex,GO:0033290~eukaryotic 48S preinitiation complex,GO:0043614~multi-eIF complex,GO:0071540~eukaryotic translation initiation factor 3 complex, eIF3e,GO:0071541~eukaryotic translation initiation factor 3 complex, eIF3m,	GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0003743~translation initiation factor activity,GO:0005515~protein binding,GO:0030971~receptor tyrosine kinase binding,GO:0044822~poly(A) RNA binding,	IPR000717:Proteasome component (PCI) domain,IPR027512:Eukaryotic translation initiation factor 3 subunit A,	mmu03013:RNA transport,	NA	SM00088:PINT,	Acetylation,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Initiation factor,Nucleus,Phosphoprotein,Protein biosynthesis,Reference proteome,Repeat,RNA editing,RNA-binding,	chain:Eukaryotic translation initiation factor 3 subunit A,compositionally biased region:Asp-rich,compositionally biased region:Glu-rich,domain:PCI,modified residue,region of interest:21 X 10 AA approximate tandem repeats of [DA]-[DE]-[ED]-R-[PLIGFSV]-[RPS]-[RW]- [RL]-[GNIHT]-[DGLPTAM],region of interest:Interaction with EIF3B,repeat:10,repeat:11,repeat:12,repeat:13,repeat:14,repeat:15,repeat:16,repeat:17,repeat:18,repeat:19,repeat:1; truncated,repeat:2,repeat:20,repeat:21; approximate,repeat:3; approximate,repeat:4,repeat:5,repeat:6,repeat:7,repeat:8,repeat:9,sequence conflict,
Eif3b	eukaryotic translation initiation factor 3, subunit B(Eif3b)	Mus musculus	NA	General function prediction only,	GO:0001731~formation of translation preinitiation complex,GO:0006412~translation,GO:0006413~translational initiation,GO:0006446~regulation of translational initiation,GO:0075522~IRES-dependent viral translational initiation,GO:0075525~viral translational termination-reinitiation,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005852~eukaryotic translation initiation factor 3 complex,GO:0016282~eukaryotic 43S preinitiation complex,GO:0033290~eukaryotic 48S preinitiation complex,GO:0070062~extracellular exosome,GO:0071541~eukaryotic translation initiation factor 3 complex, eIF3m,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003743~translation initiation factor activity,GO:0031369~translation initiation factor binding,	IPR000504:RNA recognition motif domain,IPR011042:Six-bladed beta-propeller, TolB-like,IPR011400:Eukaryotic translation initiation factor 3 subunit B,IPR012677:Nucleotide-binding, alpha-beta plait,IPR013979:Translation initiation factor, beta propellor-like domain,IPR015943:WD40/YVTN repeat-like-containing domain,	mmu03013:RNA transport,	PIRSF036424:translation initiation factor eIF-3b,	SM00360:RRM,	Acetylation,Complete proteome,Cytoplasm,Initiation factor,Phosphoprotein,Protein biosynthesis,Proteomics identification,Reference proteome,Repeat,RNA-binding,WD repeat,	chain:Eukaryotic translation initiation factor 3 subunit B,domain:RRM,modified residue,region of interest:Sufficient for interaction with EIF3E,region of interest:Sufficient for interaction with EIF3J,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,
Eif3d	eukaryotic translation initiation factor 3, subunit D(Eif3d)	Mus musculus	NA	NA	GO:0001731~formation of translation preinitiation complex,GO:0001732~formation of cytoplasmic translation initiation complex,GO:0002191~cap-dependent translational initiation,GO:0006412~translation,GO:0006413~translational initiation,GO:0006446~regulation of translational initiation,GO:0075522~IRES-dependent viral translational initiation,GO:0075525~viral translational termination-reinitiation,	GO:0005737~cytoplasm,GO:0005852~eukaryotic translation initiation factor 3 complex,GO:0016020~membrane,GO:0016282~eukaryotic 43S preinitiation complex,GO:0033290~eukaryotic 48S preinitiation complex,GO:0071541~eukaryotic translation initiation factor 3 complex, eIF3m,	GO:0003723~RNA binding,GO:0003743~translation initiation factor activity,GO:0044822~poly(A) RNA binding,GO:0098808~mRNA cap binding,	IPR007783:Eukaryotic translation initiation factor 3 subunit D,	mmu03013:RNA transport,	PIRSF016281:translation initiation factor eIF-3, subunit d,	NA	Acetylation,Complete proteome,Cytoplasm,Initiation factor,Phosphoprotein,Protein biosynthesis,Reference proteome,RNA-binding,	chain:Eukaryotic translation initiation factor 3 subunit D,compositionally biased region:Asp/Glu-rich,modified residue,sequence conflict,
Eif3g	eukaryotic translation initiation factor 3, subunit G(Eif3g)	Mus musculus	NA	NA	GO:0001731~formation of translation preinitiation complex,GO:0006412~translation,GO:0006413~translational initiation,GO:0006446~regulation of translational initiation,GO:0075525~viral translational termination-reinitiation,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005852~eukaryotic translation initiation factor 3 complex,GO:0016282~eukaryotic 43S preinitiation complex,GO:0033290~eukaryotic 48S preinitiation complex,GO:0048471~perinuclear region of cytoplasm,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003743~translation initiation factor activity,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,IPR017334:Eukaryotic translation initiation factor 3 subunit G,IPR024675:Eukaryotic translation initiation factor 3 subunit G, N-terminal,	mmu03013:RNA transport,	PIRSF037949:translation initiation factor 3, RNA-binding subunit,	SM00360:RRM,	Complete proteome,Cytoplasm,Initiation factor,Nucleus,Phosphoprotein,Protein biosynthesis,Reference proteome,RNA-binding,	chain:Eukaryotic translation initiation factor 3 subunit G,domain:RRM,modified residue,sequence conflict,
Eif4g3	eukaryotic translation initiation factor 4 gamma, 3(Eif4g3)	Mus musculus	m_iresPathway:Internal Ribosome entry pathway,m_mtorPathway:mTOR Signaling Pathway,	NA	GO:0001934~positive regulation of protein phosphorylation,GO:0006412~translation,GO:0006413~translational initiation,GO:0006417~regulation of translation,GO:0007283~spermatogenesis,GO:0045727~positive regulation of translation,GO:0060903~positive regulation of meiosis I,	NA	GO:0003723~RNA binding,GO:0003743~translation initiation factor activity,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR003307:W2 domain,IPR003890:MIF4G-like, type 3,IPR003891:Initiation factor eIF-4 gamma, MA3,IPR016021:MIF4-like, type 1/2/3,IPR016024:Armadillo-type fold,	mmu03013:RNA transport,mmu05416:Viral myocarditis,	NA	SM00515:eIF5C,SM00543:MIF4G,SM00544:MA3,	Alternative splicing,Coiled coil,Complete proteome,Initiation factor,Phosphoprotein,Protein biosynthesis,Proteomics identification,Reference proteome,Repeat,RNA-binding,Translation regulation,	chain:Eukaryotic translation initiation factor 4 gamma 3,domain:MI,domain:MIF4G,domain:W2,modified residue,region of interest:eIF3/EIF4A-binding,region of interest:EIF4A-binding,region of interest:EIF4E-binding,region of interest:Necessary but not sufficient for MKNK1- binding,region of interest:PABPC1-binding,repeat:HEAT 1,repeat:HEAT 2,repeat:HEAT 3,repeat:HEAT 4,repeat:HEAT 5,sequence conflict,splice variant,
Eif4g1	eukaryotic translation initiation factor 4, gamma 1(Eif4g1)	Mus musculus	NA	NA	GO:0001662~behavioral fear response,GO:0006412~translation,GO:0006413~translational initiation,GO:0006417~regulation of translation,GO:0006446~regulation of translational initiation,GO:0045666~positive regulation of neuron differentiation,GO:0098609~cell-cell adhesion,	GO:0005737~cytoplasm,GO:0005913~cell-cell adherens junction,GO:0016020~membrane,GO:0016281~eukaryotic translation initiation factor 4F complex,	GO:0003723~RNA binding,GO:0003743~translation initiation factor activity,GO:0005515~protein binding,GO:0008190~eukaryotic initiation factor 4E binding,GO:0044822~poly(A) RNA binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR003307:W2 domain,IPR003890:MIF4G-like, type 3,IPR003891:Initiation factor eIF-4 gamma, MA3,IPR016021:MIF4-like, type 1/2/3,IPR016024:Armadillo-type fold,	mmu03013:RNA transport,mmu05416:Viral myocarditis,	NA	SM00515:eIF5C,SM00543:MIF4G,SM00544:MA3,	Acetylation,Alternative splicing,Complete proteome,Initiation factor,Methylation,Phosphoprotein,Protein biosynthesis,Proteomics identification,Reference proteome,RNA-binding,Translation regulation,	chain:Eukaryotic translation initiation factor 4 gamma 1,compositionally biased region:Asp/Glu-rich,domain:MI,domain:MIF4G,domain:W2,modified residue,region of interest:eIF3/EIF4A-binding,region of interest:EIF4A-binding,region of interest:EIF4E-binding,region of interest:Necessary but not sufficient for MKNK1- binding,region of interest:PABPC1-binding,splice variant,
Eif4a1	eukaryotic translation initiation factor 4A1(Eif4a1)	Mus musculus	m_eif4Pathway:Regulation of eIF4e and p70 S6 Kinase,m_iresPathway:Internal Ribosome entry pathway,m_mtorPathway:mTOR Signaling Pathway,	NA	GO:0006412~translation,GO:0006413~translational initiation,GO:0006446~regulation of translational initiation,GO:0010468~regulation of gene expression,GO:0010501~RNA secondary structure unwinding,	GO:0005737~cytoplasm,GO:0016020~membrane,GO:0031012~extracellular matrix,GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003725~double-stranded RNA binding,GO:0003743~translation initiation factor activity,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0016887~ATPase activity,GO:0044822~poly(A) RNA binding,	IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site,IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	mmu03013:RNA transport,	NA	SM00487:DEXDc,SM00490:HELICc,	Acetylation,ATP-binding,Complete proteome,Helicase,Hydrolase,Initiation factor,Nucleotide-binding,Phosphoprotein,Protein biosynthesis,Reference proteome,RNA-binding,	chain:Eukaryotic initiation factor 4A-I,domain:Helicase ATP-binding,domain:Helicase C-terminal,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,short sequence motif:DEAD box,short sequence motif:Q motif,
Eif4a2	eukaryotic translation initiation factor 4A2(Eif4a2)	Mus musculus	m_eif4Pathway:Regulation of eIF4e and p70 S6 Kinase,m_iresPathway:Internal Ribosome entry pathway,m_mtorPathway:mTOR Signaling Pathway,	NA	GO:0006412~translation,GO:0006413~translational initiation,GO:0006446~regulation of translational initiation,GO:0010468~regulation of gene expression,GO:0010501~RNA secondary structure unwinding,GO:1900260~negative regulation of RNA-directed RNA polymerase activity,	GO:0048471~perinuclear region of cytoplasm,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003743~translation initiation factor activity,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0016887~ATPase activity,GO:0044822~poly(A) RNA binding,	IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site,IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	mmu03013:RNA transport,	NA	SM00487:DEXDc,SM00490:HELICc,	Alternative splicing,ATP-binding,Complete proteome,Helicase,Hydrolase,Initiation factor,Nucleotide-binding,Phosphoprotein,Protein biosynthesis,Proteomics identification,Reference proteome,RNA-binding,	chain:Eukaryotic initiation factor 4A-II,domain:Helicase ATP-binding,domain:Helicase C-terminal,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,short sequence motif:DEAD box,short sequence motif:Q motif,splice variant,
Eif4a3	eukaryotic translation initiation factor 4A3(Eif4a3)	Mus musculus	NA	NA	GO:0000184~nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,GO:0000381~regulation of alternative mRNA splicing, via spliceosome,GO:0006364~rRNA processing,GO:0006397~mRNA processing,GO:0008306~associative learning,GO:0008380~RNA splicing,GO:0010501~RNA secondary structure unwinding,GO:0010629~negative regulation of gene expression,GO:0014070~response to organic cyclic compound,GO:0016259~selenocysteine metabolic process,GO:0017148~negative regulation of translation,GO:0035640~exploration behavior,GO:0045727~positive regulation of translation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048026~positive regulation of mRNA splicing, via spliceosome,GO:0048701~embryonic cranial skeleton morphogenesis,GO:0051028~mRNA transport,GO:0072715~cellular response to selenite ion,GO:0090394~negative regulation of excitatory postsynaptic potential,GO:1902415~regulation of mRNA binding,GO:1904570~negative regulation of selenocysteine incorporation,GO:1904574~negative regulation of selenocysteine insertion sequence binding,GO:1990416~cellular response to brain-derived neurotrophic factor stimulus,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0016607~nuclear speck,GO:0030425~dendrite,GO:0030529~intracellular ribonucleoprotein complex,GO:0035145~exon-exon junction complex,GO:0043025~neuronal cell body,GO:0071013~catalytic step 2 spliceosome,	GO:0003676~nucleic acid binding,GO:0003729~mRNA binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0005524~ATP binding,GO:0008143~poly(A) binding,GO:0035368~selenocysteine insertion sequence binding,GO:0035613~RNA stem-loop binding,GO:0043021~ribonucleoprotein complex binding,GO:0044822~poly(A) RNA binding,	IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site,IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	mmu03013:RNA transport,mmu03015:mRNA surveillance pathway,mmu03040:Spliceosome,	NA	SM00487:DEXDc,SM00490:HELICc,	Acetylation,ATP-binding,Complete proteome,Cytoplasm,Helicase,Hydrolase,Isopeptide bond,mRNA processing,mRNA splicing,mRNA transport,Nonsense-mediated mRNA decay,Nucleotide-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,RNA-binding,rRNA processing,Spliceosome,Translation regulation,Transport,Ubl conjugation,	binding site:ATP,binding site:ATP; via carbonyl oxygen,chain:Eukaryotic initiation factor 4A-III,domain:Helicase ATP-binding,domain:Helicase C-terminal,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,short sequence motif:DEAD box,short sequence motif:Q motif,
Eif4b	eukaryotic translation initiation factor 4B(Eif4b)	Mus musculus	m_mtorPathway:mTOR Signaling Pathway,	NA	GO:0001731~formation of translation preinitiation complex,GO:0002181~cytoplasmic translation,GO:0006412~translation,GO:0006413~translational initiation,GO:0097010~eukaryotic translation initiation factor 4F complex assembly,	GO:0005844~polysome,GO:0016281~eukaryotic translation initiation factor 4F complex,GO:0030425~dendrite,GO:0043025~neuronal cell body,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003743~translation initiation factor activity,GO:0033592~RNA strand annealing activity,GO:0034057~RNA strand-exchange activity,GO:0043024~ribosomal small subunit binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,	mmu03013:RNA transport,mmu04150:mTOR signaling pathway,mmu04151:PI3K-Akt signaling pathway,mmu05205:Proteoglycans in cancer,	NA	SM00360:RRM,	Acetylation,Coiled coil,Complete proteome,Initiation factor,Phosphoprotein,Protein biosynthesis,Reference proteome,RNA-binding,	chain:Eukaryotic translation initiation factor 4B,compositionally biased region:Arg-rich,compositionally biased region:Asp-rich,domain:RRM,modified residue,
Eif4e	eukaryotic translation initiation factor 4E(Eif4e)	Mus musculus	m_eif4Pathway:Regulation of eIF4e and p70 S6 Kinase,m_igf1mtorPathway:Skeletal muscle hypertrophy is regulated via AKT/mTOR pathway,m_iresPathway:Internal Ribosome entry pathway,m_mtorPathway:mTOR Signaling Pathway,	NA	GO:0000082~G1/S transition of mitotic cell cycle,GO:0001662~behavioral fear response,GO:0006412~translation,GO:0006413~translational initiation,GO:0006417~regulation of translation,GO:0017148~negative regulation of translation,GO:0019827~stem cell population maintenance,GO:0030324~lung development,GO:0045665~negative regulation of neuron differentiation,GO:0045931~positive regulation of mitotic cell cycle,GO:0071549~cellular response to dexamethasone stimulus,	GO:0000932~cytoplasmic mRNA processing body,GO:0005737~cytoplasm,GO:0005845~mRNA cap binding complex,GO:0010494~cytoplasmic stress granule,GO:0016281~eukaryotic translation initiation factor 4F complex,GO:0016442~RISC complex,GO:0033391~chromatoid body,GO:0043234~protein complex,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,	GO:0003723~RNA binding,GO:0003743~translation initiation factor activity,GO:0005515~protein binding,GO:0019899~enzyme binding,GO:0031370~eukaryotic initiation factor 4G binding,GO:0044822~poly(A) RNA binding,GO:0070491~repressing transcription factor binding,	IPR001040:Translation Initiation factor eIF- 4e,IPR019770:Eukaryotic translation initiation factor 4E (eIF-4E), conserved site,IPR023398:Translation Initiation factor eIF- 4e-like  domain,	mmu03013:RNA transport,mmu04066:HIF-1 signaling pathway,mmu04150:mTOR signaling pathway,mmu04151:PI3K-Akt signaling pathway,mmu04910:Insulin signaling pathway,	NA	NA	3D-structure,Acetylation,Complete proteome,Cytoplasm,Initiation factor,Phosphoprotein,Protein biosynthesis,Proteomics identification,Reference proteome,RNA-binding,Translation regulation,	chain:Eukaryotic translation initiation factor 4E,helix,modified residue,sequence conflict,strand,turn,
Eif4h	eukaryotic translation initiation factor 4H(Eif4h)	Mus musculus	NA	NA	GO:0001731~formation of translation preinitiation complex,GO:0002181~cytoplasmic translation,GO:0006412~translation,GO:0006413~translational initiation,GO:0019953~sexual reproduction,GO:0048589~developmental growth,GO:0097010~eukaryotic translation initiation factor 4F complex assembly,GO:0098609~cell-cell adhesion,	GO:0005737~cytoplasm,GO:0005844~polysome,GO:0005913~cell-cell adherens junction,GO:0016020~membrane,GO:0016281~eukaryotic translation initiation factor 4F complex,GO:0048471~perinuclear region of cytoplasm,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003743~translation initiation factor activity,GO:0033592~RNA strand annealing activity,GO:0034057~RNA strand-exchange activity,GO:0043024~ribosomal small subunit binding,GO:0044822~poly(A) RNA binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,	NA	NA	SM00360:RRM,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Direct protein sequencing,Initiation factor,Methylation,Phosphoprotein,Protein biosynthesis,Reference proteome,RNA-binding,	chain:Eukaryotic translation initiation factor 4H,domain:RRM,helix,modified residue,splice variant,strand,turn,
Eif5a	eukaryotic translation initiation factor 5A(Eif5a)	Mus musculus	NA	NA	GO:0006406~mRNA export from nucleus,GO:0006412~translation,GO:0006414~translational elongation,GO:0006452~translational frameshifting,GO:0006611~protein export from nucleus,GO:0006810~transport,GO:0006915~apoptotic process,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0007568~aging,GO:0008284~positive regulation of cell proliferation,GO:0010666~positive regulation of cardiac muscle cell apoptotic process,GO:0015031~protein transport,GO:0043065~positive regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0045901~positive regulation of translational elongation,GO:0045905~positive regulation of translational termination,GO:0051028~mRNA transport,GO:0051149~positive regulation of muscle cell differentiation,GO:0097067~cellular response to thyroid hormone stimulus,GO:2000379~positive regulation of reactive oxygen species metabolic process,	GO:0005634~nucleus,GO:0005642~annulate lamellae,GO:0005643~nuclear pore,GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0030425~dendrite,GO:0043025~neuronal cell body,GO:0070062~extracellular exosome,	GO:0003723~RNA binding,GO:0003746~translation elongation factor activity,GO:0017070~U6 snRNA binding,GO:0043022~ribosome binding,GO:0044822~poly(A) RNA binding,GO:0047485~protein N-terminus binding,	IPR001884:Translation elongation factor IF5A,IPR008991:Translation protein SH3-like domain,IPR012340:Nucleic acid-binding, OB-fold,IPR014722:Ribosomal protein L2 domain 2,IPR019769:Translation elongation factor, IF5A, hypusine site,IPR020189:Translation elongation factor, IF5A C-terminal,	NA	PIRSF003025:translation initiation factor eIF-5A,	SM01376:SM01376,	Acetylation,Complete proteome,Cytoplasm,Direct protein sequencing,Elongation factor,Endoplasmic reticulum,Hypusine,Membrane,mRNA transport,Nuclear pore complex,Nucleus,Protein biosynthesis,Protein transport,Proteomics identification,Reference proteome,RNA-binding,Translocation,Transport,	chain:Eukaryotic translation initiation factor 5A-1,modified residue,region of interest:Nuclear localization regulation,sequence conflict,
Exosc3	exosome component 3(Exosc3)	Mus musculus	NA	Translation, ribosomal structure and biogenesis,	GO:0000467~exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0006364~rRNA processing,GO:0034427~nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5',GO:0034475~U4 snRNA 3'-end processing,GO:0043928~exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay,GO:0045006~DNA deamination,GO:0045190~isotype switching,GO:0045830~positive regulation of isotype switching,GO:0071034~CUT catabolic process,GO:0071035~nuclear polyadenylation-dependent rRNA catabolic process,GO:0071038~nuclear polyadenylation-dependent tRNA catabolic process,GO:0071049~nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription,GO:0071051~polyadenylation-dependent snoRNA 3'-end processing,	GO:0000176~nuclear exosome (RNase complex),GO:0000177~cytoplasmic exosome (RNase complex),GO:0000178~exosome (RNase complex),GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0035327~transcriptionally active chromatin,	GO:0003723~RNA binding,GO:0004518~nuclease activity,GO:0004527~exonuclease activity,GO:0016787~hydrolase activity,	IPR004088:K Homology domain, type 1,IPR012340:Nucleic acid-binding, OB-fold,IPR026699:Exosome complex RNA-binding protein 1/RRP40/RRP4,	mmu03018:RNA degradation,	NA	NA	Acetylation,Complete proteome,Cytoplasm,Exonuclease,Exosome,Hydrolase,Nuclease,Nucleus,Proteomics identification,Reference proteome,RNA-binding,rRNA processing,	chain:Exosome complex exonuclease RRP40,modified residue,sequence conflict,
Exosc4	exosome component 4(Exosc4)	Mus musculus	NA	NA	GO:0000460~maturation of 5.8S rRNA,GO:0000956~nuclear-transcribed mRNA catabolic process,GO:0006364~rRNA processing,GO:0016075~rRNA catabolic process,GO:0030307~positive regulation of cell growth,GO:0031125~rRNA 3'-end processing,GO:0034427~nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5',GO:0034475~U4 snRNA 3'-end processing,GO:0045006~DNA deamination,GO:0051607~defense response to virus,GO:0071028~nuclear mRNA surveillance,GO:0071044~histone mRNA catabolic process,GO:0071051~polyadenylation-dependent snoRNA 3'-end processing,	GO:0000176~nuclear exosome (RNase complex),GO:0000177~cytoplasmic exosome (RNase complex),GO:0000178~exosome (RNase complex),GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0035327~transcriptionally active chromatin,	GO:0003723~RNA binding,GO:0005515~protein binding,GO:0017091~AU-rich element binding,	IPR001247:Exoribonuclease, phosphorolytic domain 1,IPR015847:Exoribonuclease, phosphorolytic domain 2,IPR020568:Ribosomal protein S5 domain 2-type fold,IPR027408:PNPase/RNase PH domain,	mmu03018:RNA degradation,	NA	NA	Acetylation,Complete proteome,Cytoplasm,Exosome,Nucleus,Reference proteome,RNA-binding,rRNA processing,	chain:Exosome complex exonuclease RRP41,modified residue,
Exosc6	exosome component 6(Exosc6)	Mus musculus	NA	NA	GO:0006364~rRNA processing,GO:0016075~rRNA catabolic process,GO:0031125~rRNA 3'-end processing,GO:0034427~nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5',GO:0034475~U4 snRNA 3'-end processing,GO:0045006~DNA deamination,GO:0045190~isotype switching,GO:0045830~positive regulation of isotype switching,GO:0071028~nuclear mRNA surveillance,GO:0071051~polyadenylation-dependent snoRNA 3'-end processing,	GO:0000176~nuclear exosome (RNase complex),GO:0000177~cytoplasmic exosome (RNase complex),GO:0000178~exosome (RNase complex),GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,	GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR001247:Exoribonuclease, phosphorolytic domain 1,IPR015847:Exoribonuclease, phosphorolytic domain 2,IPR020568:Ribosomal protein S5 domain 2-type fold,IPR027408:PNPase/RNase PH domain,	mmu03018:RNA degradation,	NA	NA	Complete proteome,Cytoplasm,Exosome,Nucleus,Reference proteome,RNA-binding,rRNA processing,	chain:Exosome complex exonuclease MTR3,
Xpo1	exportin 1(Xpo1)	Mus musculus	m_cremPathway:Regulation of Spermatogenesis by CREM,m_ptc1Pathway:Sonic Hedgehog (SHH) Receptor Ptc1 Regulates cell cycle,	Nuclear structure / Intracellular trafficking and secretion,	GO:0000055~ribosomal large subunit export from nucleus,GO:0000056~ribosomal small subunit export from nucleus,GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006611~protein export from nucleus,GO:0006810~transport,GO:0006886~intracellular protein transport,GO:0010824~regulation of centrosome duplication,GO:0015031~protein transport,GO:0034504~protein localization to nucleus,GO:0042176~regulation of protein catabolic process,GO:0042493~response to drug,GO:0046825~regulation of protein export from nucleus,GO:0051028~mRNA transport,	GO:0000776~kinetochore,GO:0005634~nucleus,GO:0005642~annulate lamellae,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0015030~Cajal body,GO:0016020~membrane,GO:0030529~intracellular ribonucleoprotein complex,GO:0031965~nuclear membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0003723~RNA binding,GO:0005049~nuclear export signal receptor activity,GO:0005487~nucleocytoplasmic transporter activity,GO:0005515~protein binding,GO:0008536~Ran GTPase binding,GO:0008565~protein transporter activity,GO:0019904~protein domain specific binding,	IPR001494:Importin-beta, N-terminal,IPR011989:Armadillo-like helical,IPR013598:Exportin-1/Importin-beta-like,IPR014877:CRM1 C-terminal domain,IPR016024:Armadillo-type fold,	mmu03008:Ribosome biogenesis in eukaryotes,mmu03013:RNA transport,mmu05164:Influenza A,mmu05166:HTLV-I infection,	NA	SM00913:SM00913,SM01102:SM01102,	3D-structure,Acetylation,Complete proteome,Cytoplasm,mRNA transport,Nucleus,Phosphoprotein,Protein transport,Proteomics identification,Reference proteome,Repeat,RNA-binding,Transport,	chain:Exportin-1,domain:Importin N-terminal,helix,modified residue,region of interest:Necessary for interaction with Ran and nuclear export complex formation,region of interest:Necessary for interaction with RANBP3,repeat:HEAT 1,repeat:HEAT 10,repeat:HEAT 2,repeat:HEAT 3,repeat:HEAT 4,repeat:HEAT 5,repeat:HEAT 6,repeat:HEAT 7,repeat:HEAT 8,repeat:HEAT 9,strand,turn,
Xpo5	exportin 5(Xpo5)	Mus musculus	NA	NA	GO:0006405~RNA export from nucleus,GO:0006611~protein export from nucleus,GO:0006810~transport,GO:0006886~intracellular protein transport,GO:0015031~protein transport,GO:0031047~gene silencing by RNA,GO:0035281~pre-miRNA export from nucleus,GO:0046825~regulation of protein export from nucleus,GO:1900370~positive regulation of RNA interference,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0042565~RNA nuclear export complex,	GO:0000049~tRNA binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0005049~nuclear export signal receptor activity,GO:0008536~Ran GTPase binding,GO:0008565~protein transporter activity,GO:0044822~poly(A) RNA binding,GO:0070883~pre-miRNA binding,GO:0090631~pre-miRNA transporter activity,	IPR001494:Importin-beta, N-terminal,IPR011989:Armadillo-like helical,IPR013598:Exportin-1/Importin-beta-like,IPR016024:Armadillo-type fold,	mmu03013:RNA transport,	NA	SM00913:SM00913,	Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Nucleus,Protein transport,Reference proteome,RNA-binding,RNA-mediated gene silencing,Transport,tRNA-binding,	chain:Exportin-5,modified residue,region of interest:Necessary for interaction with ILF3,region of interest:Necessary for interaction with Ran,sequence conflict,splice variant,
Xpot	exportin, tRNA (nuclear export receptor for tRNAs)(Xpot)	Mus musculus	NA	NA	GO:0006409~tRNA export from nucleus,GO:0006810~transport,GO:0006886~intracellular protein transport,GO:0071528~tRNA re-export from nucleus,	GO:0005622~intracellular,GO:0005623~cell,GO:0005634~nucleus,GO:0005643~nuclear pore,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016363~nuclear matrix,	GO:0000049~tRNA binding,GO:0003723~RNA binding,GO:0008536~Ran GTPase binding,GO:0015932~nucleobase-containing compound transmembrane transporter activity,	IPR001494:Importin-beta, N-terminal,IPR011989:Armadillo-like helical,IPR013598:Exportin-1/Importin-beta-like,IPR016024:Armadillo-type fold,	mmu03013:RNA transport,	NA	SM00913:SM00913,	Acetylation,Complete proteome,Cytoplasm,Nucleus,Reference proteome,RNA-binding,Transport,tRNA-binding,	chain:Exportin-T,modified residue,sequence conflict,
Fam120a	family with sequence similarity 120, member A(Fam120a)	Mus musculus	NA	NA	NA	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR026783:Constitutive coactivator of PPAR-gamma-like protein 1,IPR026784:Constitutive coactivator of PPAR-gamma,	NA	NA	NA	Acetylation,Cell membrane,Complete proteome,Cytoplasm,Membrane,Methylation,Phosphoprotein,Reference proteome,RNA-binding,	chain:Constitutive coactivator of PPAR-gamma- like protein 1,modified residue,region of interest:Interaction with YES1, SRC and FYN,region of interest:RNA binding,
Fbl	fibrillarin(Fbl)	Mus musculus	NA	NA	GO:0000494~box C/D snoRNA 3'-end processing,GO:0001649~osteoblast differentiation,GO:0006364~rRNA processing,GO:0006396~RNA processing,GO:0008033~tRNA processing,GO:0016074~snoRNA metabolic process,GO:0016571~histone methylation,GO:0031167~rRNA methylation,GO:0032259~methylation,GO:0048254~snoRNA localization,GO:1990258~histone glutamine methylation,	GO:0001651~dense fibrillar component,GO:0001652~granular component,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0015030~Cajal body,GO:0016020~membrane,GO:0030529~intracellular ribonucleoprotein complex,GO:0031428~box C/D snoRNP complex,GO:0032040~small-subunit processome,GO:0070062~extracellular exosome,	GO:0001094~TFIID-class transcription factor binding,GO:0003723~RNA binding,GO:0008168~methyltransferase activity,GO:0008649~rRNA methyltransferase activity,GO:0016740~transferase activity,GO:0044822~poly(A) RNA binding,GO:0051117~ATPase binding,GO:1990259~histone-glutamine methyltransferase activity,	IPR000692:Fibrillarin,IPR020813:Fibrillarin, conserved site,	mmu03008:Ribosome biogenesis in eukaryotes,	NA	SM01206:SM01206,	Complete proteome,Methylation,Methyltransferase,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Ribonucleoprotein,RNA-binding,rRNA processing,S-adenosyl-L-methionine,Transferase,	binding site:S-adenosyl-L-methionine,chain:rRNA 2'-O-methyltransferase fibrillarin,compositionally biased region:DMA/Gly-rich,modified residue,region of interest:S-adenosyl-L-methionine binding,sequence conflict,
Fbll1	fibrillarin-like 1(Fbll1)	Mus musculus	NA	NA	GO:0000494~box C/D snoRNA 3'-end processing,GO:0006364~rRNA processing,GO:0008033~tRNA processing,GO:0016571~histone methylation,GO:0031167~rRNA methylation,GO:0032259~methylation,GO:1990258~histone glutamine methylation,	GO:0005634~nucleus,GO:0015030~Cajal body,GO:0030529~intracellular ribonucleoprotein complex,GO:0031428~box C/D snoRNP complex,GO:0032040~small-subunit processome,	GO:0003723~RNA binding,GO:0008168~methyltransferase activity,GO:0008649~rRNA methyltransferase activity,GO:0016740~transferase activity,GO:1990259~histone-glutamine methyltransferase activity,	IPR000692:Fibrillarin,IPR020813:Fibrillarin, conserved site,	mmu03008:Ribosome biogenesis in eukaryotes,	PIRSF006540:fibrillarin,	SM01206:SM01206,	Complete proteome,Methylation,Methyltransferase,Nucleus,Phosphoprotein,Reference proteome,Ribonucleoprotein,RNA-binding,rRNA processing,S-adenosyl-L-methionine,Transferase,	binding site:S-adenosyl-L-methionine,chain:rRNA/tRNA 2'-O-methyltransferase fibrillarin-like protein 1,compositionally biased region:DMA/Gly-rich,modified residue,region of interest:S-adenosyl-L-methionine binding,
Fxr1	fragile X mental retardation gene 1, autosomal homolog(Fxr1)	Mus musculus	NA	NA	GO:0007275~multicellular organism development,GO:0007517~muscle organ development,GO:0017148~negative regulation of translation,GO:0030154~cell differentiation,GO:2000637~positive regulation of gene silencing by miRNA,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005844~polysome,GO:0016020~membrane,GO:0030424~axon,GO:0030425~dendrite,GO:0035770~ribonucleoprotein granule,GO:0043034~costamere,GO:0043197~dendritic spine,GO:0048471~perinuclear region of cytoplasm,	GO:0002151~G-quadruplex RNA binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0005515~protein binding,GO:0033592~RNA strand annealing activity,GO:0042803~protein homodimerization activity,GO:0044822~poly(A) RNA binding,GO:0046982~protein heterodimerization activity,	IPR004087:K Homology domain,IPR004088:K Homology domain, type 1,IPR008395:Agenet-like domain,IPR022034:Fragile X mental retardation protein family,	mmu03013:RNA transport,	NA	SM00322:KH,	Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Developmental protein,Differentiation,Methylation,Myogenesis,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,RNA-binding,	chain:Fragile X mental retardation syndrome- related protein 1,compositionally biased region:Poly-Arg,compositionally biased region:Poly-Pro,domain:KH 1,domain:KH 2,modified residue,region of interest:RNA-binding RGG-box,sequence conflict,splice variant,
Fmr1	fragile X mental retardation syndrome 1(Fmr1)	Mus musculus	NA	NA	GO:0000381~regulation of alternative mRNA splicing, via spliceosome,GO:0002092~positive regulation of receptor internalization,GO:0006397~mRNA processing,GO:0006417~regulation of translation,GO:0006810~transport,GO:0006974~cellular response to DNA damage stimulus,GO:0007215~glutamate receptor signaling pathway,GO:0007399~nervous system development,GO:0007417~central nervous system development,GO:0008380~RNA splicing,GO:0010629~negative regulation of gene expression,GO:0017148~negative regulation of translation,GO:0031047~gene silencing by RNA,GO:0033129~positive regulation of histone phosphorylation,GO:0034644~cellular response to UV,GO:0043488~regulation of mRNA stability,GO:0044830~modulation by host of viral RNA genome replication,GO:0045727~positive regulation of translation,GO:0045947~negative regulation of translational initiation,GO:0046928~regulation of neurotransmitter secretion,GO:0051028~mRNA transport,GO:0051489~regulation of filopodium assembly,GO:0051491~positive regulation of filopodium assembly,GO:0060964~regulation of gene silencing by miRNA,GO:0060996~dendritic spine development,GO:0060998~regulation of dendritic spine development,GO:0060999~positive regulation of dendritic spine development,GO:0072711~cellular response to hydroxyurea,GO:0098586~cellular response to virus,GO:0098908~regulation of neuronal action potential,GO:1900453~negative regulation of long term synaptic depression,GO:1901254~positive regulation of intracellular transport of viral material,GO:1901386~negative regulation of voltage-gated calcium channel activity,GO:1901800~positive regulation of proteasomal protein catabolic process,GO:1902416~positive regulation of mRNA binding,GO:2000301~negative regulation of synaptic vesicle exocytosis,GO:2000637~positive regulation of gene silencing by miRNA,GO:2000766~negative regulation of cytoplasmic translation,GO:2001022~positive regulation of response to DNA damage stimulus,	GO:0000775~chromosome, centromeric region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005844~polysome,GO:0005845~mRNA cap binding complex,GO:0005874~microtubule,GO:0005886~plasma membrane,GO:0010369~chromocenter,GO:0010494~cytoplasmic stress granule,GO:0014069~postsynaptic density,GO:0016020~membrane,GO:0019034~viral replication complex,GO:0019897~extrinsic component of plasma membrane,GO:0030054~cell junction,GO:0030424~axon,GO:0030425~dendrite,GO:0030426~growth cone,GO:0030529~intracellular ribonucleoprotein complex,GO:0032433~filopodium tip,GO:0032797~SMN complex,GO:0036464~cytoplasmic ribonucleoprotein granule,GO:0042734~presynaptic membrane,GO:0042995~cell projection,GO:0043005~neuron projection,GO:0043197~dendritic spine,GO:0043198~dendritic shaft,GO:0043204~perikaryon,GO:0043679~axon terminus,GO:0044297~cell body,GO:0045202~synapse,GO:0045211~postsynaptic membrane,GO:0048471~perinuclear region of cytoplasm,GO:0071598~neuronal ribonucleoprotein granule,GO:0097386~glial cell projection,GO:0098793~presynapse,GO:0098794~postsynapse,GO:1902737~dendritic filopodium,GO:1990812~growth cone filopodium,GO:1990904~ribonucleoprotein complex,	GO:0002151~G-quadruplex RNA binding,GO:0003676~nucleic acid binding,GO:0003682~chromatin binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0005515~protein binding,GO:0008017~microtubule binding,GO:0008266~poly(U) RNA binding,GO:0030371~translation repressor activity,GO:0031369~translation initiation factor binding,GO:0033592~RNA strand annealing activity,GO:0034046~poly(G) binding,GO:0035064~methylated histone binding,GO:0035197~siRNA binding,GO:0035198~miRNA binding,GO:0035613~RNA stem-loop binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0043022~ribosome binding,GO:0044325~ion channel binding,GO:0044822~poly(A) RNA binding,GO:0045502~dynein binding,GO:0046982~protein heterodimerization activity,GO:0048027~mRNA 5'-UTR binding,GO:1990825~sequence-specific mRNA binding,	IPR004087:K Homology domain,IPR004088:K Homology domain, type 1,IPR008395:Agenet-like domain,IPR022034:Fragile X mental retardation protein family,	mmu03013:RNA transport,	NA	SM00322:KH,	Acetylation,Activator,Alternative splicing,Cell junction,Cell membrane,Cell projection,Centromere,Chromosome,Complete proteome,Cytoplasm,DNA damage,Membrane,Methylation,mRNA processing,mRNA splicing,mRNA transport,Neurogenesis,Nucleus,Phosphoprotein,Postsynaptic cell membrane,Proteomics identification,Reference proteome,Repeat,Repressor,Ribonucleoprotein,RNA-binding,RNA-mediated gene silencing,Synapse,Synaptosome,Translation regulation,Transport,Ubl conjugation,	chain:Fragile X mental retardation protein 1 homolog,domain:KH 1,domain:KH 2,modified residue,mutagenesis site,region of interest:Interaction with RANBP9,region of interest:RNA-binding RGG-box,splice variant,
Fus	fused in sarcoma(Fus)	Mus musculus	NA	NA	GO:0071277~cellular response to calcium ion,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005844~polysome,GO:0030425~dendrite,GO:0043025~neuronal cell body,GO:0043197~dendritic spine,GO:0043204~perikaryon,GO:0044327~dendritic spine head,GO:0048471~perinuclear region of cytoplasm,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003713~transcription coactivator activity,GO:0008270~zinc ion binding,GO:0030331~estrogen receptor binding,GO:0031489~myosin V binding,GO:0035255~ionotropic glutamate receptor binding,GO:0044822~poly(A) RNA binding,GO:0046965~retinoid X receptor binding,GO:0046966~thyroid hormone receptor binding,	IPR000504:RNA recognition motif domain,IPR001876:Zinc finger, RanBP2-type,IPR012677:Nucleotide-binding, alpha-beta plait,	mmu05202:Transcriptional misregulation in cancer,	NA	SM00360:RRM,SM00547:ZnF_RBZ,	Complete proteome,DNA-binding,Metal-binding,Methylation,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,RNA-binding,Zinc,Zinc-finger,	chain:RNA-binding protein FUS,compositionally biased region:Arg/Gly-rich,compositionally biased region:Gln/Gly/Ser/Tyr-rich,compositionally biased region:Gly-rich,domain:RRM,modified residue,zinc finger region:RanBP2-type,
Eprs	glutamyl-prolyl-tRNA synthetase(Eprs)	Mus musculus	NA	NA	GO:0006412~translation,GO:0006417~regulation of translation,GO:0006418~tRNA aminoacylation for protein translation,GO:0006424~glutamyl-tRNA aminoacylation,GO:0006433~prolyl-tRNA aminoacylation,GO:0008152~metabolic process,GO:0017148~negative regulation of translation,GO:0043039~tRNA aminoacylation,GO:0071346~cellular response to interferon-gamma,	GO:0005737~cytoplasm,GO:0016020~membrane,GO:0017101~aminoacyl-tRNA synthetase multienzyme complex,GO:0030529~intracellular ribonucleoprotein complex,GO:0097452~GAIT complex,	GO:0000166~nucleotide binding,GO:0003723~RNA binding,GO:0003824~catalytic activity,GO:0004812~aminoacyl-tRNA ligase activity,GO:0004818~glutamate-tRNA ligase activity,GO:0004827~proline-tRNA ligase activity,GO:0005524~ATP binding,GO:0016874~ligase activity,GO:0016876~ligase activity, forming aminoacyl-tRNA and related compounds,GO:0035613~RNA stem-loop binding,GO:0051020~GTPase binding,	IPR000738:WHEP-TRS,IPR000924:Glutamyl/glutaminyl-tRNA synthetase, class Ib,IPR001412:Aminoacyl-tRNA synthetase, class I, conserved site,IPR002314:Aminoacyl-tRNA synthetase, class II (G/ H/ P/ S), conserved domain,IPR004046:Glutathione S-transferase, C-terminal,IPR004154:Anticodon-binding,IPR004499:Proline-tRNA ligase, class IIa, archaeal-type,IPR004526:Glutamyl-tRNA synthetase, class Ib, archaeal/eukaryotic cytosolic,IPR006195:Aminoacyl-tRNA synthetase, class II,IPR009068:S15/NS1, RNA-binding,IPR010987:Glutathione S-transferase, C-terminal-like,IPR011035:Ribosomal protein L25/Gln-tRNA synthetase, anti-codon-binding domain,IPR012336:Thioredoxin-like fold,IPR014729:Rossmann-like alpha/beta/alpha sandwich fold,IPR016061:Proline-tRNA ligase, class II, C-terminal,IPR017449:Prolyl-tRNA synthetase, class II,IPR020056:Ribosomal protein L25/Gln-tRNA synthetase, beta-barrel domain,IPR020058:Glutamyl/glutaminyl-tRNA synthetase, class Ib, catalytic domain,IPR020059:Glutamyl/glutaminyl-tRNA synthetase, class Ib, anti-codon binding domain,IPR020061:Glutamyl/glutaminyl-tRNA synthetase, class Ib, alpha-bundle domain,	mmu00860:Porphyrin and chlorophyll metabolism,mmu00970:Aminoacyl-tRNA biosynthesis,mmu01100:Metabolic pathways,	NA	SM00946:SM00946,SM00991:SM00991,	Acetylation,Aminoacyl-tRNA synthetase,ATP-binding,Complete proteome,Ligase,Methylation,Multifunctional enzyme,Nucleotide-binding,Phosphoprotein,Polymorphism,Protein biosynthesis,Proteomics identification,Reference proteome,Repeat,RNA-binding,Translation regulation,	"binding site:ATP,chain:Bifunctional aminoacyl-tRNA synthetase,compositionally biased region:Asp/Glu/Lys-rich,domain:WHEP-TRS 1,domain:WHEP-TRS 2,domain:WHEP-TRS 3,modified residue,nucleotide phosphate-binding region:ATP,region of interest:3 X 57 AA approximate repeats,region of interest:Glutamyl-tRNA synthetase,region of interest:Prolyl-tRNA synthetase,sequence conflict,sequence variant,short sequence motif:""HIGH"" region,short sequence motif:""KMSKS"" region,"
Hnrnpab	heterogeneous nuclear ribonucleoprotein A/B(Hnrnpab)	Mus musculus	NA	NA	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001837~epithelial to mesenchymal transition,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0019013~viral nucleocapsid,GO:0030529~intracellular ribonucleoprotein complex,GO:0090575~RNA polymerase II transcription factor complex,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0043565~sequence-specific DNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,IPR012956:CARG-binding factor, N-terminal,	NA	NA	SM00360:RRM,	Acetylation,Complete proteome,Cytoplasm,Direct protein sequencing,DNA-binding,Methylation,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Repressor,Ribonucleoprotein,RNA-binding,Transcription,Transcription regulation,Viral nucleoprotein,Virion,	chain:Heterogeneous nuclear ribonucleoprotein A/B,compositionally biased region:Gly-rich,compositionally biased region:Poly-Ala,domain:RRM 1,domain:RRM 2,modified residue,sequence conflict,
Hnrnpa0	heterogeneous nuclear ribonucleoprotein A0(Hnrnpa0)	Mus musculus	NA	NA	GO:0006954~inflammatory response,GO:0032496~response to lipopolysaccharide,GO:0070935~3'-UTR-mediated mRNA stabilization,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0030529~intracellular ribonucleoprotein complex,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0017091~AU-rich element binding,GO:0019901~protein kinase binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,	NA	NA	SM00360:RRM,	Acetylation,Complete proteome,Isopeptide bond,Methylation,Nucleus,Phosphoprotein,Reference proteome,Repeat,Ribonucleoprotein,RNA-binding,Ubl conjugation,	NA
Hnrnpa1	heterogeneous nuclear ribonucleoprotein A1(Hnrnpa1)	Mus musculus	NA	NA	GO:0000380~alternative mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0006810~transport,GO:0008380~RNA splicing,GO:0032211~negative regulation of telomere maintenance via telomerase,GO:0032212~positive regulation of telomere maintenance via telomerase,GO:0051028~mRNA transport,GO:0051168~nuclear export,GO:0051170~nuclear import,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0019013~viral nucleocapsid,GO:0030529~intracellular ribonucleoprotein complex,GO:0070062~extracellular exosome,GO:0071013~catalytic step 2 spliceosome,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003697~single-stranded DNA binding,GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,GO:0061752~telomeric repeat-containing RNA binding,GO:0098505~G-rich strand telomeric DNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,IPR021662:Nuclear factor hnRNPA1,	mmu03040:Spliceosome,	NA	SM00360:RRM,	Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Direct protein sequencing,Isopeptide bond,Methylation,mRNA processing,mRNA splicing,mRNA transport,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Ribonucleoprotein,RNA-binding,Spliceosome,Transport,Ubl conjugation,Viral nucleoprotein,Virion,	chain:Heterogeneous nuclear ribonucleoprotein A1,compositionally biased region:Gly-rich,compositionally biased region:Poly-Ser,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),domain:RRM 1,domain:RRM 2,modified residue,region of interest:Globular A domain,region of interest:Globular B domain,region of interest:Nuclear targeting sequence,region of interest:RNA-binding RGG-box,splice variant,
Hnrnpa2b1	heterogeneous nuclear ribonucleoprotein A2/B1(Hnrnpa2b1)	Mus musculus	NA	NA	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000398~mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0006406~mRNA export from nucleus,GO:0006810~transport,GO:0008380~RNA splicing,GO:0016233~telomere capping,GO:0031053~primary miRNA processing,GO:0048025~negative regulation of mRNA splicing, via spliceosome,GO:0050658~RNA transport,GO:0051028~mRNA transport,GO:1990428~miRNA transport,	GO:0000785~chromatin,GO:0005576~extracellular region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0019013~viral nucleocapsid,GO:0030529~intracellular ribonucleoprotein complex,GO:0043005~neuron projection,GO:0043025~neuronal cell body,GO:0043204~perikaryon,GO:0070062~extracellular exosome,GO:0071013~catalytic step 2 spliceosome,GO:0071598~neuronal ribonucleoprotein granule,	GO:0000166~nucleotide binding,GO:0001069~regulatory region RNA binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0035198~miRNA binding,GO:0043047~single-stranded telomeric DNA binding,GO:0044822~poly(A) RNA binding,GO:0097157~pre-mRNA intronic binding,GO:1990247~N6-methyladenosine-containing RNA binding,GO:1990715~mRNA CDS binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,IPR021662:Nuclear factor hnRNPA1,	NA	NA	SM00360:RRM,	Acetylation,Alternative splicing,Complete proteome,Direct protein sequencing,Isopeptide bond,Methylation,mRNA processing,mRNA splicing,mRNA transport,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Ribonucleoprotein,RNA-binding,Secreted,Spliceosome,Transport,Ubl conjugation,Viral nucleoprotein,Virion,	chain:Heterogeneous nuclear ribonucleoproteins A2/B1,compositionally biased region:Gly-rich,domain:RRM 1,domain:RRM 2,modified residue,region of interest:Nuclear targeting sequence,sequence conflict,short sequence motif:Nuclear localization signal,splice variant,
Hnrnpc	heterogeneous nuclear ribonucleoprotein C(Hnrnpc)	Mus musculus	NA	NA	GO:0000398~mRNA splicing, via spliceosome,GO:0001649~osteoblast differentiation,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0032211~negative regulation of telomere maintenance via telomerase,GO:0043044~ATP-dependent chromatin remodeling,GO:0070935~3'-UTR-mediated mRNA stabilization,GO:0090367~negative regulation of mRNA modification,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005697~telomerase holoenzyme complex,GO:0005829~cytosol,GO:0016020~membrane,GO:0030529~intracellular ribonucleoprotein complex,GO:0043234~protein complex,GO:0045120~pronucleus,GO:0070062~extracellular exosome,GO:0071013~catalytic step 2 spliceosome,GO:1990826~nucleoplasmic periphery of the nuclear pore complex,	GO:0000166~nucleotide binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000980~RNA polymerase II distal enhancer sequence-specific DNA binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0004857~enzyme inhibitor activity,GO:0008266~poly(U) RNA binding,GO:0019904~protein domain specific binding,GO:0031492~nucleosomal DNA binding,GO:0042802~identical protein binding,GO:0043021~ribonucleoprotein complex binding,GO:0044822~poly(A) RNA binding,GO:0070034~telomerase RNA binding,GO:1990247~N6-methyladenosine-containing RNA binding,GO:1990827~deaminase binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,IPR017347:Heterogeneous nuclear ribonucleoprotein C, Raly,	mmu03040:Spliceosome,	PIRSF037992:heterogeneous nuclear ribonucleoprotein C, Raly type,	SM00360:RRM,	Acetylation,Alternative splicing,Coiled coil,Complete proteome,Direct protein sequencing,Isopeptide bond,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Reference proteome,Ribonucleoprotein,RNA-binding,Spliceosome,Ubl conjugation,	chain:Heterogeneous nuclear ribonucleoproteins C1/C2,compositionally biased region:Asp/Glu-rich (acidic),cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),domain:RRM,modified residue,sequence conflict,short sequence motif:Nuclear localization signal,splice variant,
Hnrnpd	heterogeneous nuclear ribonucleoprotein D(Hnrnpd)	Mus musculus	NA	NA	GO:0001889~liver development,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0021549~cerebellum development,GO:0042752~regulation of circadian rhythm,GO:0043488~regulation of mRNA stability,GO:0045727~positive regulation of translation,GO:0048255~mRNA stabilization,GO:0048511~rhythmic process,GO:0051592~response to calcium ion,GO:0051602~response to electrical stimulus,GO:0061158~3'-UTR-mediated mRNA destabilization,GO:0071230~cellular response to amino acid stimulus,GO:0071392~cellular response to estradiol stimulus,GO:0071732~cellular response to nitric oxide,GO:0097167~circadian regulation of translation,GO:1901355~response to rapamycin,GO:1904383~response to sodium phosphate,GO:1904586~cellular response to putrescine,GO:1990828~hepatocyte dedifferentiation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0019013~viral nucleocapsid,GO:0030529~intracellular ribonucleoprotein complex,GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003680~AT DNA binding,GO:0003682~chromatin binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0008134~transcription factor binding,GO:0035925~mRNA 3'-UTR AU-rich region binding,GO:0042162~telomeric DNA binding,GO:0042826~histone deacetylase binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,IPR012956:CARG-binding factor, N-terminal,	NA	NA	SM00360:RRM,	Acetylation,Alternative splicing,Biological rhythms,Complete proteome,Cytoplasm,Direct protein sequencing,DNA-binding,Isopeptide bond,Methylation,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Ribonucleoprotein,RNA-binding,Transcription,Transcription regulation,Ubl conjugation,Viral nucleoprotein,Virion,	chain:Heterogeneous nuclear ribonucleoprotein D0,domain:RRM 1,domain:RRM 2,modified residue,sequence conflict,splice variant,
Hnrnpdl	heterogeneous nuclear ribonucleoprotein D-like(Hnrnpdl)	Mus musculus	NA	NA	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0016071~mRNA metabolic process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,	NA	NA	SM00360:RRM,	Acetylation,Activator,Complete proteome,Cytoplasm,Direct protein sequencing,DNA-binding,Methylation,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Repressor,RNA-binding,Transcription,Transcription regulation,	chain:Heterogeneous nuclear ribonucleoprotein D-like,compositionally biased region:Gly-rich,compositionally biased region:Poly-Gln,compositionally biased region:Tyr-rich,domain:RRM 1,domain:RRM 2,modified residue,region of interest:Necessary for interaction with TNPO1,
Hnrnpf	heterogeneous nuclear ribonucleoprotein F(Hnrnpf)	Mus musculus	NA	NA	GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0043484~regulation of RNA splicing,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0030529~intracellular ribonucleoprotein complex,GO:0071013~catalytic step 2 spliceosome,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003727~single-stranded RNA binding,GO:0008134~transcription factor binding,GO:0017025~TBP-class protein binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,IPR012996:Zinc finger, CHHC-type,	NA	NA	SM00360:RRM,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Isopeptide bond,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Ribonucleoprotein,RNA-binding,Spliceosome,Ubl conjugation,	chain:Heterogeneous nuclear ribonucleoprotein F,chain:Heterogeneous nuclear ribonucleoprotein F, N-terminally processed,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),domain:RRM 1,domain:RRM 2,domain:RRM 3,helix,modified residue,sequence conflict,site:Required for RNA recognition,splice variant,strand,turn,
Hnrnph1	heterogeneous nuclear ribonucleoprotein H1(Hnrnph1)	Mus musculus	NA	NA	GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0043484~regulation of RNA splicing,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0019013~viral nucleocapsid,GO:0030529~intracellular ribonucleoprotein complex,GO:0071013~catalytic step 2 spliceosome,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,IPR012996:Zinc finger, CHHC-type,	NA	NA	SM00360:RRM,	Acetylation,Complete proteome,Direct protein sequencing,Methylation,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Ribonucleoprotein,RNA-binding,Spliceosome,Viral nucleoprotein,Virion,	chain:Heterogeneous nuclear ribonucleoprotein H,chain:Heterogeneous nuclear ribonucleoprotein H, N-terminally processed,domain:RRM 1,domain:RRM 2,domain:RRM 3,modified residue,region of interest:2 X 16 AA Gly-rich approximate repeats,region of interest:2 X 19 AA perfect repeats,repeat:1-1,repeat:1-2,repeat:2-1,repeat:2-2,
Hnrnph2	heterogeneous nuclear ribonucleoprotein H2(Hnrnph2)	Mus musculus	NA	NA	NA	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0030529~intracellular ribonucleoprotein complex,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,IPR012996:Zinc finger, CHHC-type,	NA	NA	SM00360:RRM,	Acetylation,Complete proteome,Methylation,Nucleus,Phosphoprotein,Reference proteome,Repeat,Ribonucleoprotein,RNA-binding,	chain:Heterogeneous nuclear ribonucleoprotein H2,domain:RRM 1,domain:RRM 2,domain:RRM 3,modified residue,region of interest:2 X 16 AA Gly-rich approximate repeats,region of interest:2 X 19 AA perfect repeats,repeat:1-1,repeat:1-2,repeat:2-1,repeat:2-2,
Hnrnpk	heterogeneous nuclear ribonucleoprotein K(Hnrnpk)	Mus musculus	NA	NA	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001541~ovarian follicle development,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0010629~negative regulation of gene expression,GO:0010976~positive regulation of neuron projection development,GO:0010988~regulation of low-density lipoprotein particle clearance,GO:0021987~cerebral cortex development,GO:0032091~negative regulation of protein binding,GO:0032869~cellular response to insulin stimulus,GO:0033120~positive regulation of RNA splicing,GO:0043066~negative regulation of apoptotic process,GO:0045716~positive regulation of low-density lipoprotein particle receptor biosynthetic process,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048025~negative regulation of mRNA splicing, via spliceosome,GO:0048260~positive regulation of receptor-mediated endocytosis,GO:0050806~positive regulation of synaptic transmission,GO:0060999~positive regulation of dendritic spine development,GO:0072369~regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter,GO:0090129~positive regulation of synapse maturation,GO:1900273~positive regulation of long-term synaptic potentiation,GO:1902165~regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,GO:1903861~positive regulation of dendrite extension,GO:1904322~cellular response to forskolin,GO:2000010~positive regulation of protein localization to cell surface,GO:2000173~negative regulation of branching morphogenesis of a nerve,	GO:0000790~nuclear chromatin,GO:0002102~podosome,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0005913~cell-cell adherens junction,GO:0005925~focal adhesion,GO:0005938~cell cortex,GO:0014069~postsynaptic density,GO:0016020~membrane,GO:0019013~viral nucleocapsid,GO:0030054~cell junction,GO:0030529~intracellular ribonucleoprotein complex,GO:0031012~extracellular matrix,GO:0032993~protein-DNA complex,GO:0042995~cell projection,GO:0043197~dendritic spine,GO:0043679~axon terminus,GO:0070062~extracellular exosome,GO:0071013~catalytic step 2 spliceosome,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001159~core promoter proximal region DNA binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003690~double-stranded DNA binding,GO:0003697~single-stranded DNA binding,GO:0003723~RNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0005515~protein binding,GO:0005521~lamin binding,GO:0008134~transcription factor binding,GO:0019904~protein domain specific binding,GO:0030628~pre-mRNA 3'-splice site binding,GO:0031072~heat shock protein binding,GO:0042805~actinin binding,GO:0043021~ribonucleoprotein complex binding,GO:0044822~poly(A) RNA binding,GO:0051117~ATPase binding,GO:0098641~cadherin binding involved in cell-cell adhesion,GO:1990715~mRNA CDS binding,GO:1990829~C-rich single-stranded DNA binding,	IPR004087:K Homology domain,IPR004088:K Homology domain, type 1,IPR009019:K homology domain, prokaryotic type,IPR012987:ROK, N-terminal,	mmu03040:Spliceosome,mmu05168:Herpes simplex infection,mmu05203:Viral carcinogenesis,mmu05206:MicroRNAs in cancer,	NA	SM00322:KH,	Acetylation,Activator,Alternative splicing,Cell junction,Cell projection,Complete proteome,Cytoplasm,Direct protein sequencing,DNA-binding,Glycoprotein,Isopeptide bond,Methylation,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Repressor,Ribonucleoprotein,RNA-binding,Spliceosome,Transcription,Transcription regulation,Ubl conjugation,Viral nucleoprotein,Virion,	chain:Heterogeneous nuclear ribonucleoprotein K,compositionally biased region:Poly-Pro,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),domain:KH 1,domain:KH 2,domain:KH 3,modified residue,region of interest:2 X 22 AA approximate repeats,region of interest:2 X 6 AA approximate repeats,region of interest:5 X 4 AA repeats of G-X-G-G,region of interest:Interaction with ZIK1,region of interest:RNA-binding RGG-box,repeat:1-1,repeat:1-2,repeat:2-1,repeat:2-2,repeat:3-1,repeat:3-2,repeat:3-3,repeat:3-4,repeat:3-5,sequence conflict,splice variant,
Hnrnpl	heterogeneous nuclear ribonucleoprotein L(Hnrnpl)	Mus musculus	NA	NA	GO:0000381~regulation of alternative mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0034198~cellular response to amino acid starvation,GO:0045727~positive regulation of translation,GO:0048025~negative regulation of mRNA splicing, via spliceosome,GO:1902416~positive regulation of mRNA binding,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016020~membrane,GO:0030529~intracellular ribonucleoprotein complex,GO:0035770~ribonucleoprotein granule,GO:0045120~pronucleus,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0005515~protein binding,GO:0044212~transcription regulatory region DNA binding,GO:0044822~poly(A) RNA binding,GO:0097157~pre-mRNA intronic binding,GO:1990715~mRNA CDS binding,	IPR000504:RNA recognition motif domain,IPR006536:HnRNP-L/PTB/hephaestus splicing factor,IPR012677:Nucleotide-binding, alpha-beta plait,	NA	NA	SM00360:RRM,	3D-structure,Acetylation,Complete proteome,Cytoplasm,Direct protein sequencing,Isopeptide bond,Methylation,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Ribonucleoprotein,RNA-binding,Ubl conjugation,	chain:Heterogeneous nuclear ribonucleoprotein L,compositionally biased region:Gly-rich,compositionally biased region:Pro-rich,domain:RRM 1,domain:RRM 2,domain:RRM 3,modified residue,sequence conflict,
Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like(Hnrnpll)	Mus musculus	NA	NA	GO:0006397~mRNA processing,GO:0033120~positive regulation of RNA splicing,	GO:0005634~nucleus,GO:0016020~membrane,GO:0030529~intracellular ribonucleoprotein complex,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR006536:HnRNP-L/PTB/hephaestus splicing factor,IPR012677:Nucleotide-binding, alpha-beta plait,	NA	NA	SM00360:RRM,	3D-structure,Alternative splicing,Complete proteome,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Ribonucleoprotein,RNA-binding,	chain:Heterogeneous nuclear ribonucleoprotein L-like,chain:Phospholipid hydroperoxide glutathione peroxidase, mitochondrial,chain:Phospholipid hydroperoxide glutathione peroxidase, nuclear,compositionally biased region:Gly-rich,compositionally biased region:Poly-Ser,domain:RRM 1,domain:RRM 2,domain:RRM 3,helix,mutagenesis site,sequence conflict,splice variant,strand,transit peptide:Mitochondrion,turn,
Hnrnpm	heterogeneous nuclear ribonucleoprotein M(Hnrnpm)	Mus musculus	NA	NA	GO:0000380~alternative mRNA splicing, via spliceosome,GO:0000398~mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:1900182~positive regulation of protein localization to nucleus,GO:1904591~positive regulation of protein import,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0009986~cell surface,GO:0016020~membrane,GO:0016363~nuclear matrix,GO:0030529~intracellular ribonucleoprotein complex,GO:0031012~extracellular matrix,GO:0042382~paraspeckles,GO:0070062~extracellular exosome,GO:0071013~catalytic step 2 spliceosome,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0019904~protein domain specific binding,GO:0044822~poly(A) RNA binding,GO:0048306~calcium-dependent protein binding,GO:1990405~protein antigen binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,IPR024666:Heterogeneous nuclear ribonucleoprotein M, PY nuclear localisation signal,IPR024667:Heterogeneous nuclear ribonucleoprotein M,	mmu03040:Spliceosome,	NA	SM00360:RRM,	Acetylation,Alternative splicing,Complete proteome,Direct protein sequencing,Isopeptide bond,Methylation,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Ribonucleoprotein,RNA-binding,Spliceosome,Ubl conjugation,	chain:Heterogeneous nuclear ribonucleoprotein M,compositionally biased region:Poly-Gly,domain:RRM 1,domain:RRM 2,domain:RRM 3,modified residue,region of interest:27 X 6 AA repeats of [GEVSTPAN]-[ILMV]- [DE]-[RH]-[MLVI]-[GAV],repeat:1,repeat:10,repeat:11,repeat:12,repeat:13,repeat:14,repeat:15,repeat:16,repeat:17,repeat:18,repeat:19,repeat:2,repeat:20,repeat:21,repeat:22,repeat:23,repeat:24,repeat:25,repeat:26,repeat:27,repeat:3,repeat:4,repeat:5,repeat:6,repeat:7,repeat:8,repeat:9,sequence conflict,splice variant,
Hnrnpu	heterogeneous nuclear ribonucleoprotein U(Hnrnpu)	Mus musculus	NA	NA	GO:0001649~osteoblast differentiation,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0010628~positive regulation of gene expression,GO:0032211~negative regulation of telomere maintenance via telomerase,GO:0032922~circadian regulation of gene expression,GO:0048511~rhythmic process,GO:0055013~cardiac muscle cell development,GO:0070934~CRD-mediated mRNA stabilization,GO:0071549~cellular response to dexamethasone stimulus,GO:2000373~positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005697~telomerase holoenzyme complex,GO:0005737~cytoplasm,GO:0009986~cell surface,GO:0016020~membrane,GO:0019013~viral nucleocapsid,GO:0030529~intracellular ribonucleoprotein complex,GO:0031012~extracellular matrix,GO:0036464~cytoplasmic ribonucleoprotein granule,GO:0070937~CRD-mediated mRNA stability complex,GO:0071013~catalytic step 2 spliceosome,	GO:0000166~nucleotide binding,GO:0001047~core promoter binding,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0034046~poly(G) binding,GO:0035326~enhancer binding,GO:0043021~ribonucleoprotein complex binding,GO:0044822~poly(A) RNA binding,GO:0070034~telomerase RNA binding,	IPR001870:B30.2/SPRY domain,IPR003034:SAP domain,IPR003877:SPla/RYanodine receptor SPRY,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,IPR026745:Heterogeneous nuclear ribonucleoprotein U,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	mmu03040:Spliceosome,	NA	SM00449:SPRY,SM00513:SAP,	Acetylation,ATP-binding,Biological rhythms,Citrullination,Coiled coil,Complete proteome,Cytoplasm,DNA-binding,Isopeptide bond,Methylation,mRNA processing,mRNA splicing,Nucleotide-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Ribonucleoprotein,RNA-binding,Spliceosome,Ubl conjugation,Viral nucleoprotein,Virion,	chain:Heterogeneous nuclear ribonucleoprotein U,compositionally biased region:Asp/Glu-rich (acidic),compositionally biased region:Gly-rich,domain:B30.2/SPRY,domain:SAP,modified residue,nucleotide phosphate-binding region:ATP,region of interest:RNA-binding RGG-box,
Hnrnpul1	heterogeneous nuclear ribonucleoprotein U-like 1(Hnrnpul1)	Mus musculus	NA	NA	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006396~RNA processing,GO:0009615~response to virus,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0030529~intracellular ribonucleoprotein complex,	GO:0003723~RNA binding,GO:0019899~enzyme binding,GO:0044822~poly(A) RNA binding,	IPR001870:B30.2/SPRY domain,IPR003034:SAP domain,IPR003877:SPla/RYanodine receptor SPRY,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,IPR027025:Heterogeneous nuclear ribonucleoprotein U-like protein 1,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	mmu05164:Influenza A,	NA	SM00449:SPRY,SM00513:SAP,	Activator,Alternative splicing,Complete proteome,Isopeptide bond,Methylation,Nucleus,Phosphoprotein,Reference proteome,Repeat,Repressor,Ribonucleoprotein,RNA-binding,Transcription,Transcription regulation,Ubl conjugation,	chain:Heterogeneous nuclear ribonucleoprotein U-like protein 1,compositionally biased region:Asn-rich,compositionally biased region:Gln-rich,compositionally biased region:Gly-rich,compositionally biased region:Pro-rich,compositionally biased region:Tyr-rich,domain:B30.2/SPRY,domain:SAP,modified residue,region of interest:5 X 3 AA repeats of R-G-G,region of interest:Necessary for interaction with BRD7 and transcriptional activation,region of interest:Necessary for interaction with HRMT1L1,region of interest:Necessary for interaction with TP53,region of interest:Necessary for transcription repression,repeat:1-1,repeat:1-2,repeat:1-3,repeat:1-4,repeat:1-5,sequence conflict,splice variant,
Hdlbp	high density lipoprotein (HDL) binding protein(Hdlbp)	Mus musculus	NA	NA	GO:0006629~lipid metabolic process,GO:0006810~transport,GO:0006869~lipid transport,GO:0008202~steroid metabolic process,GO:0008203~cholesterol metabolic process,GO:0098609~cell-cell adhesion,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005913~cell-cell adherens junction,GO:0034364~high-density lipoprotein particle,	GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR004087:K Homology domain,IPR004088:K Homology domain, type 1,	NA	NA	SM00322:KH,	Acetylation,Cholesterol metabolism,Coiled coil,Complete proteome,Cytoplasm,HDL,Lipid metabolism,Lipid transport,Lipoprotein,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,RNA-binding,Steroid metabolism,Sterol metabolism,Transport,	chain:Vigilin,domain:KH 1,domain:KH 10,domain:KH 11,domain:KH 12,domain:KH 13,domain:KH 14,domain:KH 2,domain:KH 3,domain:KH 4,domain:KH 5,domain:KH 6,domain:KH 7,domain:KH 8,domain:KH 9,modified residue,
Raly	hnRNP-associated with lethal yellow(Raly)	Mus musculus	NA	NA	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:1903506~regulation of nucleic acid-templated transcription,GO:2000188~regulation of cholesterol homeostasis,	GO:0005634~nucleus,GO:0005681~spliceosomal complex,GO:0030529~intracellular ribonucleoprotein complex,GO:0071013~catalytic step 2 spliceosome,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003712~transcription cofactor activity,GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,IPR017347:Heterogeneous nuclear ribonucleoprotein C, Raly,	NA	PIRSF037992:heterogeneous nuclear ribonucleoprotein C, Raly type,	SM00360:RRM,	Acetylation,Alternative splicing,Coiled coil,Complete proteome,Isopeptide bond,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Ribonucleoprotein,RNA-binding,Spliceosome,Transcription,Transcription regulation,Ubl conjugation,	chain:RNA-binding protein Raly,domain:RRM,modified residue,sequence conflict,splice variant,
Impdh2	inosine 5'-phosphate dehydrogenase 2(Impdh2)	Mus musculus	NA	NA	GO:0006164~purine nucleotide biosynthetic process,GO:0006177~GMP biosynthetic process,GO:0006183~GTP biosynthetic process,GO:0046651~lymphocyte proliferation,GO:0051289~protein homotetramerization,GO:0055114~oxidation-reduction process,GO:0060041~retina development in camera-type eye,GO:0071353~cellular response to interleukin-4,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005778~peroxisomal membrane,GO:0016020~membrane,GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0003824~catalytic activity,GO:0003938~IMP dehydrogenase activity,GO:0016491~oxidoreductase activity,GO:0046872~metal ion binding,	IPR000644:Cystathionine beta-synthase, core,IPR001093:IMP dehydrogenase/GMP reductase,IPR005990:Inosine-5'-monophosphate dehydrogenase,IPR013785:Aldolase-type TIM barrel,IPR015875:IMP dehydrogenase / GMP reductase, conserved site,	mmu00230:Purine metabolism,mmu00983:Drug metabolism - other enzymes,mmu01100:Metabolic pathways,	PIRSF000130:inosine-5'-monophosphate dehydrogenase,	SM00116:CBS,	Acetylation,CBS domain,Complete proteome,Cytoplasm,Direct protein sequencing,DNA-binding,GMP biosynthesis,Metal-binding,NAD,Nucleus,Oxidoreductase,Phosphoprotein,Potassium,Proteomics identification,Purine biosynthesis,Reference proteome,Repeat,RNA-binding,	active site:Thioimidate intermediate,binding site:IMP,binding site:Inhibitor,chain:Inosine-5'-monophosphate dehydrogenase 2,domain:CBS 1,domain:CBS 2,metal ion-binding site:Potassium; via carbonyl oxygen,modified residue,nucleotide phosphate-binding region:NAD,region of interest:IMP binding,sequence conflict,sequence variant,
Igf2bp1	insulin-like growth factor 2 mRNA binding protein 1(Igf2bp1)	Mus musculus	NA	NA	GO:0006403~RNA localization,GO:0006417~regulation of translation,GO:0006810~transport,GO:0010610~regulation of mRNA stability involved in response to stress,GO:0017148~negative regulation of translation,GO:0022013~pallium cell proliferation in forebrain,GO:0051028~mRNA transport,GO:0070934~CRD-mediated mRNA stabilization,GO:0097150~neuronal stem cell population maintenance,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0010494~cytoplasmic stress granule,GO:0030027~lamellipodium,GO:0030175~filopodium,GO:0030424~axon,GO:0030425~dendrite,GO:0030426~growth cone,GO:0030529~intracellular ribonucleoprotein complex,GO:0042995~cell projection,GO:0043197~dendritic spine,GO:0048471~perinuclear region of cytoplasm,GO:0070937~CRD-mediated mRNA stability complex,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0044822~poly(A) RNA binding,GO:0045182~translation regulator activity,GO:0048027~mRNA 5'-UTR binding,	IPR000504:RNA recognition motif domain,IPR004087:K Homology domain,IPR004088:K Homology domain, type 1,IPR012677:Nucleotide-binding, alpha-beta plait,	mmu05206:MicroRNAs in cancer,	NA	SM00322:KH,SM00360:RRM,	Cell projection,Complete proteome,Cytoplasm,Direct protein sequencing,Isopeptide bond,mRNA transport,Nucleus,Phosphoprotein,Reference proteome,Repeat,RNA-binding,Translation regulation,Transport,Ubl conjugation,	chain:Insulin-like growth factor 2 mRNA-binding protein 1,domain:KH 1,domain:KH 2,domain:KH 3,domain:KH 4,domain:RRM 1,domain:RRM 2,modified residue,region of interest:Necessary for interaction with IGF2BP1 and binding to TAU mRNA,region of interest:Sufficient for nuclear export,sequence conflict,
Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2(Igf2bp2)	Mus musculus	NA	NA	GO:0006417~regulation of translation,GO:0006810~transport,GO:0051028~mRNA transport,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005856~cytoskeleton,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0044822~poly(A) RNA binding,GO:0048027~mRNA 5'-UTR binding,	IPR000504:RNA recognition motif domain,IPR004087:K Homology domain,IPR004088:K Homology domain, type 1,IPR012677:Nucleotide-binding, alpha-beta plait,	NA	NA	SM00322:KH,SM00360:RRM,	Alternative splicing,Complete proteome,Cytoplasm,mRNA transport,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,RNA-binding,Translation regulation,Transport,	chain:Insulin-like growth factor 2 mRNA-binding protein 2,domain:KH 1,domain:KH 2,domain:KH 3,domain:KH 4,domain:RRM 1,domain:RRM 2,modified residue,sequence conflict,splice variant,
Igf2bp3	insulin-like growth factor 2 mRNA binding protein 3(Igf2bp3)	Mus musculus	NA	NA	GO:0006355~regulation of transcription, DNA-templated,GO:0006417~regulation of translation,GO:0006810~transport,GO:0051028~mRNA transport,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,GO:0048027~mRNA 5'-UTR binding,	IPR000504:RNA recognition motif domain,IPR002059:Cold-shock protein, DNA-binding,IPR004087:K Homology domain,IPR004088:K Homology domain, type 1,IPR011129:Cold shock protein,IPR012340:Nucleic acid-binding, OB-fold,IPR012677:Nucleotide-binding, alpha-beta plait,IPR019844:Cold-shock conserved site,	NA	NA	SM00322:KH,SM00357:CSP,SM00360:RRM,	Complete proteome,Cytoplasm,Isopeptide bond,mRNA transport,Nucleus,Phosphoprotein,Reference proteome,Repeat,RNA-binding,Translation regulation,Transport,Ubl conjugation,	chain:Insulin-like growth factor 2 mRNA-binding protein 3,domain:KH 1,domain:KH 2,domain:KH 3,domain:KH 4,domain:RRM 1,domain:RRM 2,modified residue,sequence conflict,
Ilf3	interleukin enhancer binding factor 3(Ilf3)	Mus musculus	NA	NA	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006468~protein phosphorylation,GO:0006479~protein methylation,GO:0017148~negative regulation of translation,GO:0045071~negative regulation of viral genome replication,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0051607~defense response to virus,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0016020~membrane,GO:0030529~intracellular ribonucleoprotein complex,	GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0003725~double-stranded RNA binding,GO:0019899~enzyme binding,GO:0044822~poly(A) RNA binding,	IPR006561:DZF,IPR014720:Double-stranded RNA-binding-like domain,	NA	NA	SM00358:DSRM,SM00572:DZF,	3D-structure,Acetylation,Alternative splicing,Antiviral defense,Complete proteome,Cytoplasm,Direct protein sequencing,DNA-binding,Isopeptide bond,Methylation,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,RNA-binding,Transcription,Transcription regulation,Ubl conjugation,	chain:Interleukin enhancer-binding factor 3,compositionally biased region:Arg/Gly-rich,compositionally biased region:Poly-Gly,compositionally biased region:Poly-Lys,compositionally biased region:Poly-Pro,domain:DRBM 1,domain:DRBM 2,domain:DZF,modified residue,region of interest:Interaction with PRMT1,sequence conflict,short sequence motif:Bipartite nuclear localization signal,splice variant,
Jmjd6	jumonji domain containing 6(Jmjd6)	Mus musculus	NA	NA	GO:0001568~blood vessel development,GO:0001822~kidney development,GO:0002040~sprouting angiogenesis,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006397~mRNA processing,GO:0007166~cell surface receptor signaling pathway,GO:0007275~multicellular organism development,GO:0007507~heart development,GO:0008380~RNA splicing,GO:0016569~covalent chromatin modification,GO:0018395~peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine,GO:0030154~cell differentiation,GO:0030324~lung development,GO:0033077~T cell differentiation in thymus,GO:0042116~macrophage activation,GO:0043277~apoptotic cell clearance,GO:0043654~recognition of apoptotic cell,GO:0048024~regulation of mRNA splicing, via spliceosome,GO:0048821~erythrocyte development,GO:0055114~oxidation-reduction process,GO:0060041~retina development in camera-type eye,GO:0070078~histone H3-R2 demethylation,GO:0070079~histone H4-R3 demethylation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0030529~intracellular ribonucleoprotein complex,GO:0044452~nucleolar part,	GO:0003723~RNA binding,GO:0003727~single-stranded RNA binding,GO:0004872~receptor activity,GO:0005506~iron ion binding,GO:0005515~protein binding,GO:0016491~oxidoreductase activity,GO:0033746~histone demethylase activity (H3-R2 specific),GO:0033749~histone demethylase activity (H4-R3 specific),GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0046872~metal ion binding,GO:0051213~dioxygenase activity,GO:0070815~peptidyl-lysine 5-dioxygenase activity,	IPR003347:JmjC domain,	NA	NA	SM00558:JmjC,	Alternative splicing,Chromatin regulator,Complete proteome,Developmental protein,Differentiation,Dioxygenase,Iron,Metal-binding,mRNA processing,mRNA splicing,Nucleus,Oxidoreductase,Proteomics identification,Receptor,Reference proteome,RNA-binding,Transcription,Transcription regulation,	binding site:Substrate,chain:Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6,compositionally biased region:Ser-rich,domain:JmjC,metal ion-binding site:Iron; catalytic,sequence conflict,short sequence motif:Nuclear localization signal 1,short sequence motif:Nuclear localization signal 2,short sequence motif:Nuclear localization signal 3,short sequence motif:Nuclear localization signal 4,short sequence motif:Nuclear localization signal 5,splice variant,
Lrpprc	leucine-rich PPR-motif containing(Lrpprc)	Mus musculus	NA	NA	GO:0000961~negative regulation of mitochondrial RNA catabolic process,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006810~transport,GO:0051028~mRNA transport,GO:0070129~regulation of mitochondrial translation,	GO:0000794~condensed nuclear chromosome,GO:0005634~nucleus,GO:0005637~nuclear inner membrane,GO:0005640~nuclear outer membrane,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0016020~membrane,GO:0030529~intracellular ribonucleoprotein complex,GO:0042645~mitochondrial nucleoid,GO:0048471~perinuclear region of cytoplasm,	GO:0003677~DNA binding,GO:0003697~single-stranded DNA binding,GO:0003723~RNA binding,GO:0031625~ubiquitin protein ligase binding,GO:0044822~poly(A) RNA binding,GO:0048487~beta-tubulin binding,	IPR002885:Pentatricopeptide repeat,	NA	NA	NA	Acetylation,Complete proteome,DNA-binding,Membrane,Mitochondrion,mRNA transport,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,RNA-binding,Transcription,Transcription regulation,Transit peptide,Transport,	chain:Leucine-rich PPR motif-containing protein, mitochondrial,modified residue,region of interest:RNA-binding,repeat:PPR 1,repeat:PPR 10,repeat:PPR 11,repeat:PPR 12,repeat:PPR 13,repeat:PPR 14,repeat:PPR 15,repeat:PPR 16,repeat:PPR 17,repeat:PPR 18,repeat:PPR 19,repeat:PPR 2,repeat:PPR 20,repeat:PPR 3,repeat:PPR 4,repeat:PPR 5,repeat:PPR 6,repeat:PPR 7,repeat:PPR 8,repeat:PPR 9,sequence conflict,transit peptide:Mitochondrion,
Magohb	mago homolog B, exon junction complex core component(Magohb)	Mus musculus	NA	NA	GO:0000184~nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,GO:0006397~mRNA processing,GO:0006810~transport,GO:0008380~RNA splicing,GO:0051028~mRNA transport,	GO:0005634~nucleus,GO:0035145~exon-exon junction complex,GO:0043025~neuronal cell body,GO:0071013~catalytic step 2 spliceosome,	GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR004023:Mago nashi protein,	mmu03013:RNA transport,mmu03015:mRNA surveillance pathway,mmu03040:Spliceosome,	NA	NA	Complete proteome,mRNA processing,mRNA splicing,mRNA transport,Nucleus,Proteomics identification,Reference proteome,RNA-binding,Transport,	chain:Protein mago nashi homolog 1-related,
Matr3	matrin 3(Matr3)	Mus musculus	m_antisensePathway:RNA polymerase III transcription,	NA	GO:0003170~heart valve development,GO:0003281~ventricular septum development,GO:0010608~posttranscriptional regulation of gene expression,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0016363~nuclear matrix,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0008270~zinc ion binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR000504:RNA recognition motif domain,IPR000690:Zinc finger, C2H2-type matrin,IPR003604:Zinc finger, U1-type,IPR012677:Nucleotide-binding, alpha-beta plait,	NA	NA	SM00360:RRM,SM00451:ZnF_U1,	3D-structure,Acetylation,Coiled coil,Complete proteome,Direct protein sequencing,Isopeptide bond,Metal-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,RNA-binding,Ubl conjugation,Zinc,Zinc-finger,	chain:Matrin-3,domain:RRM 1,domain:RRM 2,helix,modified residue,short sequence motif:Nuclear localization signal,strand,turn,zinc finger region:Matrin-type,
Mars	methionine-tRNA synthetase(Mars)	Mus musculus	NA	Posttranslational modification, protein turnover, chaperones,	GO:0006412~translation,GO:0006418~tRNA aminoacylation for protein translation,GO:0006431~methionyl-tRNA aminoacylation,GO:0009303~rRNA transcription,	GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0000049~tRNA binding,GO:0000166~nucleotide binding,GO:0003723~RNA binding,GO:0004812~aminoacyl-tRNA ligase activity,GO:0004825~methionine-tRNA ligase activity,GO:0005524~ATP binding,GO:0016874~ligase activity,	IPR000738:WHEP-TRS,IPR001412:Aminoacyl-tRNA synthetase, class I, conserved site,IPR004046:Glutathione S-transferase, C-terminal,IPR009068:S15/NS1, RNA-binding,IPR009080:Aminoacyl-tRNA synthetase, class 1a, anticodon-binding,IPR010987:Glutathione S-transferase, C-terminal-like,IPR014729:Rossmann-like alpha/beta/alpha sandwich fold,IPR014758:Methionyl-tRNA synthetase,IPR015413:Methionyl/Leucyl tRNA synthetase,IPR023458:Methionine-tRNA ligase, type 1,	mmu00450:Selenocompound metabolism,mmu00970:Aminoacyl-tRNA biosynthesis,	NA	SM00991:SM00991,	Aminoacyl-tRNA synthetase,ATP-binding,Complete proteome,Cytoplasm,Ligase,Membrane,Nucleotide-binding,Phosphoprotein,Protein biosynthesis,Proteomics identification,Reference proteome,RNA-binding,Transmembrane,Transmembrane helix,tRNA-binding,	"binding site:ATP,chain:Methionyl-tRNA synthetase, cytoplasmic,domain:GST C-terminal,domain:WHEP-TRS,modified residue,short sequence motif:""HIGH"" region,short sequence motif:""KMSKS"" region,"
Msi1	musashi RNA-binding protein 1(Msi1)	Mus musculus	NA	NA	GO:0009725~response to hormone,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005844~polysome,GO:0016021~integral component of membrane,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003727~single-stranded RNA binding,GO:0008266~poly(U) RNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,	mmu03015:mRNA surveillance pathway,	NA	SM00360:RRM,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Membrane,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,RNA-binding,Transmembrane,Transmembrane helix,	chain:RNA-binding protein Musashi homolog 1,compositionally biased region:Poly-Ala,domain:RRM 1,domain:RRM 2,helix,modified residue,mutagenesis site,splice variant,strand,turn,
Myef2	myelin basic protein expression factor 2, repressor(Myef2)	Mus musculus	NA	NA	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0000166~nucleotide binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001078~transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003676~nucleic acid binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,	NA	NA	SM00360:RRM,	Alternative splicing,Complete proteome,DNA-binding,Methylation,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Repressor,RNA-binding,Transcription,	chain:Myelin expression factor 2,compositionally biased region:Gly-rich,domain:RRM 1,domain:RRM 2,domain:RRM 3,modified residue,sequence conflict,splice variant,
Nelfb	negative elongation factor complex member B(Nelfb)	Mus musculus	NA	NA	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0034244~negative regulation of transcription elongation from RNA polymerase II promoter,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0032021~NELF complex,	NA	IPR010405:Cofactor of BRCA1,	NA	NA	NA	Acetylation,Complete proteome,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,	chain:Negative elongation factor B,modified residue,sequence conflict,
Nono	non-POU-domain-containing, octamer binding protein(Nono)	Mus musculus	m_antisensePathway:RNA polymerase III transcription,	NA	GO:0000398~mRNA splicing, via spliceosome,GO:0006281~DNA repair,GO:0006310~DNA recombination,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006397~mRNA processing,GO:0006974~cellular response to DNA damage stimulus,GO:0007623~circadian rhythm,GO:0008380~RNA splicing,GO:0042752~regulation of circadian rhythm,GO:0045892~negative regulation of transcription, DNA-templated,GO:0048511~rhythmic process,GO:1903377~negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0016020~membrane,GO:0016363~nuclear matrix,GO:0016607~nuclear speck,GO:0042382~paraspeckles,GO:0090575~RNA polymerase II transcription factor complex,	GO:0000166~nucleotide binding,GO:0000980~RNA polymerase II distal enhancer sequence-specific DNA binding,GO:0001047~core promoter binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0042802~identical protein binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,IPR012975:NOPS,	NA	NA	SM00360:RRM,	3D-structure,Acetylation,Activator,Alternative splicing,Biological rhythms,Coiled coil,Complete proteome,Direct protein sequencing,DNA damage,DNA recombination,DNA repair,DNA-binding,Isopeptide bond,Methylation,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Repressor,RNA-binding,Transcription,Transcription regulation,Ubl conjugation,	chain:Non-POU domain-containing octamer-binding protein,compositionally biased region:Poly-Arg,compositionally biased region:Poly-Gln,compositionally biased region:Poly-Pro,domain:RRM 1,domain:RRM 2,helix,modified residue,region of interest:DBHS,sequence conflict,splice variant,strand,turn,
Nxf1	nuclear RNA export factor 1(Nxf1)	Mus musculus	NA	NA	GO:0006405~RNA export from nucleus,GO:0006406~mRNA export from nucleus,GO:0016973~poly(A)+ mRNA export from nucleus,GO:0051028~mRNA transport,	GO:0000346~transcription export complex,GO:0005634~nucleus,GO:0005643~nuclear pore,GO:0005737~cytoplasm,GO:0016607~nuclear speck,GO:0042405~nuclear inclusion body,	GO:0000166~nucleotide binding,GO:0003723~RNA binding,GO:0003727~single-stranded RNA binding,GO:0003729~mRNA binding,GO:0005487~nucleocytoplasmic transporter activity,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR001611:Leucine-rich repeat,IPR002075:Nuclear transport factor 2,IPR005637:TAP C-terminal (TAP-C) domain,IPR009060:UBA-like,IPR012677:Nucleotide-binding, alpha-beta plait,IPR015245:Nuclear RNA export factor Tap, RNA-binding domain,IPR018222:Nuclear transport factor 2, Eukaryote,	mmu03008:Ribosome biogenesis in eukaryotes,mmu03013:RNA transport,mmu03015:mRNA surveillance pathway,mmu05164:Influenza A,mmu05168:Herpes simplex infection,	NA	SM00804:TAP_C,	Acetylation,Complete proteome,Cytoplasm,Leucine-rich repeat,Methylation,mRNA transport,Nitration,Nucleus,Proteomics identification,Reference proteome,Repeat,RNA-binding,Transport,	chain:Nuclear RNA export factor 1,compositionally biased region:Pro-rich,domain:NTF2,domain:RRM,domain:TAP-C,modified residue,region of interest:Interaction with THOC4,repeat:LRR 1,repeat:LRR 2,repeat:LRR 3,repeat:LRR 4,sequence conflict,short sequence motif:Nuclear export signal,short sequence motif:Nuclear localization signal,
Ncbp2	nuclear cap binding protein subunit 2(Ncbp2)	Mus musculus	NA	NA	GO:0000184~nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,GO:0000398~mRNA splicing, via spliceosome,GO:0006370~7-methylguanosine mRNA capping,GO:0006397~mRNA processing,GO:0006408~snRNA export from nucleus,GO:0006417~regulation of translation,GO:0006446~regulation of translational initiation,GO:0006810~transport,GO:0008380~RNA splicing,GO:0031047~gene silencing by RNA,GO:0031442~positive regulation of mRNA 3'-end processing,GO:0045292~mRNA cis splicing, via spliceosome,GO:0046833~positive regulation of RNA export from nucleus,GO:0051028~mRNA transport,GO:0098789~pre-mRNA cleavage required for polyadenylation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005845~mRNA cap binding complex,GO:0005846~nuclear cap binding complex,	GO:0000166~nucleotide binding,GO:0000339~RNA cap binding,GO:0000340~RNA 7-methylguanosine cap binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0017069~snRNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,IPR027157:Nuclear cap-binding protein subunit 2,	mmu03013:RNA transport,mmu03015:mRNA surveillance pathway,mmu03040:Spliceosome,	NA	SM00360:RRM,	Acetylation,Complete proteome,Cytoplasm,Methylation,mRNA capping,mRNA processing,mRNA splicing,mRNA transport,Nonsense-mediated mRNA decay,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,RNA-binding,RNA-mediated gene silencing,Translation regulation,Transport,	binding site:mRNA cap,chain:Nuclear cap-binding protein subunit 2,domain:RRM,modified residue,region of interest:mRNA cap-binding,
Nifk	nucleolar protein interacting with the FHA domain of MKI67(Nifk)	Mus musculus	NA	NA	GO:0010923~negative regulation of phosphatase activity,	GO:0000794~condensed nuclear chromosome,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0005737~cytoplasm,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,IPR021043:MKI67 FHA domain-interacting nucleolar phosphoprotein, FHA Ki67 binding,	NA	NA	SM00360:RRM,	Acetylation,Alternative splicing,Chromosome,Citrullination,Complete proteome,Isopeptide bond,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,RNA-binding,Ubl conjugation,	chain:MKI67 FHA domain-interacting nucleolar phosphoprotein,domain:RRM,modified residue,sequence conflict,splice variant,
Ncl	nucleolin(Ncl)	Mus musculus	NA	NA	GO:0001525~angiogenesis,GO:0006897~endocytosis,GO:0032760~positive regulation of tumor necrosis factor production,GO:0043066~negative regulation of apoptotic process,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0071222~cellular response to lipopolysaccharide,GO:0071364~cellular response to epidermal growth factor stimulus,GO:1901838~positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter,GO:2000232~regulation of rRNA processing,GO:2000778~positive regulation of interleukin-6 secretion,	GO:0001650~fibrillar center,GO:0001651~dense fibrillar component,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005938~cell cortex,GO:0009986~cell surface,GO:0016020~membrane,GO:0030529~intracellular ribonucleoprotein complex,GO:0036464~cytoplasmic ribonucleoprotein granule,GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003697~single-stranded DNA binding,GO:0003723~RNA binding,GO:0005102~receptor binding,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0008022~protein C-terminus binding,GO:0035368~selenocysteine insertion sequence binding,GO:0042134~rRNA primary transcript binding,GO:0042162~telomeric DNA binding,GO:0042393~histone binding,GO:0042802~identical protein binding,GO:0043236~laminin binding,GO:0043565~sequence-specific DNA binding,GO:0044822~poly(A) RNA binding,GO:1990631~ErbB-4 class receptor binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,	NA	NA	SM00360:RRM,	Acetylation,Complete proteome,Cytoplasm,Direct protein sequencing,DNA-binding,Isopeptide bond,Methylation,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,RNA-binding,Ubl conjugation,	chain:Nucleolin,compositionally biased region:Arg/Gly/Phe-rich,compositionally biased region:Asp/Glu-rich (acidic),domain:RRM 1,domain:RRM 2,domain:RRM 3,domain:RRM 4,modified residue,region of interest:8 X 8 AA tandem repeats of X-T-P-X-K-K-X- X,repeat:1,repeat:2,repeat:3,repeat:4,repeat:5; truncated,repeat:6,repeat:7,repeat:8,sequence conflict,
Npm1	nucleophosmin 1(Npm1)	Mus musculus	NA	NA	GO:0000055~ribosomal large subunit export from nucleus,GO:0000056~ribosomal small subunit export from nucleus,GO:0000448~cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0006281~DNA repair,GO:0006334~nucleosome assembly,GO:0006407~rRNA export from nucleus,GO:0006884~cell volume homeostasis,GO:0006913~nucleocytoplasmic transport,GO:0006950~response to stress,GO:0007098~centrosome cycle,GO:0007569~cell aging,GO:0008104~protein localization,GO:0008284~positive regulation of cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0009303~rRNA transcription,GO:0010608~posttranscriptional regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0010667~negative regulation of cardiac muscle cell apoptotic process,GO:0010824~regulation of centrosome duplication,GO:0010825~positive regulation of centrosome duplication,GO:0010826~negative regulation of centrosome duplication,GO:0016049~cell growth,GO:0019827~stem cell population maintenance,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031398~positive regulation of protein ubiquitination,GO:0031647~regulation of protein stability,GO:0031648~protein destabilization,GO:0032071~regulation of endodeoxyribonuclease activity,GO:0042273~ribosomal large subunit biogenesis,GO:0042274~ribosomal small subunit biogenesis,GO:0043066~negative regulation of apoptotic process,GO:0043085~positive regulation of catalytic activity,GO:0043516~regulation of DNA damage response, signal transduction by p53 class mediator,GO:0043523~regulation of neuron apoptotic process,GO:0043524~negative regulation of neuron apoptotic process,GO:0044387~negative regulation of protein kinase activity by regulation of protein phosphorylation,GO:0045727~positive regulation of translation,GO:0045740~positive regulation of DNA replication,GO:0045860~positive regulation of protein kinase activity,GO:0045893~positive regulation of transcription, DNA-templated,GO:0046599~regulation of centriole replication,GO:0048025~negative regulation of mRNA splicing, via spliceosome,GO:0050680~negative regulation of epithelial cell proliferation,GO:0050821~protein stabilization,GO:0051054~positive regulation of DNA metabolic process,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0051259~protein oligomerization,GO:0051260~protein homooligomerization,GO:0051726~regulation of cell cycle,GO:0060699~regulation of endoribonuclease activity,GO:0060735~regulation of eIF2 alpha phosphorylation by dsRNA,GO:1900264~positive regulation of DNA-directed DNA polymerase activity,GO:1902751~positive regulation of cell cycle G2/M phase transition,GO:1904751~positive regulation of protein localization to nucleolus,GO:2000381~negative regulation of mesoderm development,	GO:0001652~granular component,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005925~focal adhesion,GO:0015934~large ribosomal subunit,GO:0015935~small ribosomal subunit,GO:0016020~membrane,GO:0016363~nuclear matrix,GO:0016607~nuclear speck,GO:0030529~intracellular ribonucleoprotein complex,GO:0031616~spindle pole centrosome,	GO:0002039~p53 binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003713~transcription coactivator activity,GO:0003723~RNA binding,GO:0004860~protein kinase inhibitor activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0005547~phosphatidylinositol-3,4,5-trisphosphate binding,GO:0008134~transcription factor binding,GO:0019843~rRNA binding,GO:0019899~enzyme binding,GO:0019901~protein kinase binding,GO:0030957~Tat protein binding,GO:0042393~histone binding,GO:0042803~protein homodimerization activity,GO:0043023~ribosomal large subunit binding,GO:0043024~ribosomal small subunit binding,GO:0043422~protein kinase B binding,GO:0044822~poly(A) RNA binding,GO:0046982~protein heterodimerization activity,GO:0047485~protein N-terminus binding,GO:0051059~NF-kappaB binding,GO:0051082~unfolded protein binding,	IPR004301:Nucleoplasmin,IPR024057:Nucleoplasmin core domain,	NA	NA	NA	3D-structure,Acetylation,ADP-ribosylation,Chaperone,Complete proteome,Cytoplasm,Cytoskeleton,Direct protein sequencing,Disulfide bond,DNA-binding,Isopeptide bond,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,RNA-binding,Ubl conjugation,	chain:Nucleophosmin,compositionally biased region:Asp/Glu-rich (acidic),compositionally biased region:Asp/Glu-rich (highly acidic),compositionally biased region:Met-rich,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),modified residue,region of interest:Required for interaction with SENP3,region of interest:Required for nucleolar localization,short sequence motif:Nuclear localization signal,
Nudt16l1	nudix (nucleoside diphosphate linked moiety X)-type motif 16-like 1(Nudt16l1)	Mus musculus	NA	NA	NA	GO:0005737~cytoplasm,	GO:0003723~RNA binding,GO:0016787~hydrolase activity,GO:0030515~snoRNA binding,GO:0044822~poly(A) RNA binding,GO:0050072~m7G(5')pppN diphosphatase activity,	IPR015797:NUDIX hydrolase domain-like,	mmu05205:Proteoglycans in cancer,	NA	NA	3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Reference proteome,RNA-binding,	chain:Protein syndesmos,region of interest:Interaction with PXN,sequence conflict,splice variant,
Nudt21	nudix (nucleoside diphosphate linked moiety X)-type motif 21(Nudt21)	Mus musculus	NA	NA	GO:0006378~mRNA polyadenylation,GO:0006379~mRNA cleavage,GO:0006397~mRNA processing,GO:0051262~protein tetramerization,	GO:0005634~nucleus,GO:0005813~centrosome,GO:0005815~microtubule organizing center,GO:0005849~mRNA cleavage factor complex,GO:0042382~paraspeckles,	GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0016787~hydrolase activity,GO:0017091~AU-rich element binding,GO:0042803~protein homodimerization activity,GO:0042826~histone deacetylase binding,GO:0044822~poly(A) RNA binding,	IPR000086:NUDIX hydrolase domain,IPR015797:NUDIX hydrolase domain-like,IPR016706:Cleavage/polyadenylation specificity factor subunit 5,	mmu03015:mRNA surveillance pathway,	PIRSF017888:cleavage and polyadenylation specificity factor subunit 5,	NA	Acetylation,Complete proteome,Methylation,mRNA processing,Nucleus,Phosphoprotein,Reference proteome,RNA-binding,	chain:Cleavage and polyadenylation specificity factor subunit 5,domain:Nudix hydrolase,modified residue,region of interest:Necessary for interactions with PAPOLA and PABPN1,region of interest:Necessary for RNA-binding,sequence conflict,short sequence motif:Nudix box,site:Stabilizes the adenine base,
Nudt5	nudix (nucleoside diphosphate linked moiety X)-type motif 5(Nudt5)	Mus musculus	NA	NA	GO:0006139~nucleobase-containing compound metabolic process,GO:0006338~chromatin remodeling,GO:0009191~ribonucleoside diphosphate catabolic process,GO:0019303~D-ribose catabolic process,GO:1990966~ATP generation from poly-ADP-D-ribose,	GO:0005634~nucleus,GO:0070062~extracellular exosome,	GO:0000287~magnesium ion binding,GO:0003723~RNA binding,GO:0016740~transferase activity,GO:0016779~nucleotidyltransferase activity,GO:0016787~hydrolase activity,GO:0017110~nucleoside-diphosphatase activity,GO:0019144~ADP-sugar diphosphatase activity,GO:0030515~snoRNA binding,GO:0042803~protein homodimerization activity,GO:0044715~8-oxo-dGDP phosphatase activity,GO:0046872~metal ion binding,GO:0047631~ADP-ribose diphosphatase activity,GO:0050072~m7G(5')pppN diphosphatase activity,	IPR000086:NUDIX hydrolase domain,IPR015797:NUDIX hydrolase domain-like,IPR020084:NUDIX hydrolase, conserved site,IPR020476:NUDIX hydrolase,	mmu00230:Purine metabolism,	NA	NA	Acetylation,Complete proteome,Direct protein sequencing,Hydrolase,Magnesium,Metal-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,RNA-binding,Transferase,	chain:ADP-sugar pyrophosphatase,domain:Nudix hydrolase,modified residue,sequence conflict,short sequence motif:Nudix box,
Pspc1	paraspeckle protein 1(Pspc1)	Mus musculus	NA	NA	GO:0000398~mRNA splicing, via spliceosome,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007155~cell adhesion,GO:0042752~regulation of circadian rhythm,GO:0045892~negative regulation of transcription, DNA-templated,GO:0048511~rhythmic process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0016363~nuclear matrix,GO:0016607~nuclear speck,GO:0042382~paraspeckles,	GO:0000166~nucleotide binding,GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0001047~core promoter binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR006077:Vinculin/alpha-catenin,IPR012677:Nucleotide-binding, alpha-beta plait,IPR012975:NOPS,	NA	NA	SM00360:RRM,	Acetylation,Activator,Alternative splicing,Biological rhythms,Coiled coil,Complete proteome,Cytoplasm,Methylation,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Repressor,RNA-binding,Transcription,Transcription regulation,	chain:Paraspeckle component 1,compositionally biased region:Gly-rich,domain:RRM 1,domain:RRM 2,modified residue,mutagenesis site,region of interest:Sufficient for paraspeckles localization,region of interest:Sufficient for perinucleolar caps localization and interaction with NONO,sequence conflict,splice variant,
Ppie	peptidylprolyl isomerase E (cyclophilin E)(Ppie)	Mus musculus	NA	NA	GO:0000413~protein peptidyl-prolyl isomerization,GO:0006355~regulation of transcription, DNA-templated,GO:0006397~mRNA processing,GO:0006457~protein folding,GO:0008380~RNA splicing,GO:0045070~positive regulation of viral genome replication,	GO:0005634~nucleus,GO:0005681~spliceosomal complex,GO:0071013~catalytic step 2 spliceosome,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003755~peptidyl-prolyl cis-trans isomerase activity,GO:0016853~isomerase activity,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR002130:Cyclophilin-like peptidyl-prolyl cis-trans isomerase domain,IPR012677:Nucleotide-binding, alpha-beta plait,IPR016304:Cyclophilin-type peptidyl-prolyl cis-trans isomerase E,IPR020892:Cyclophilin-type peptidyl-prolyl cis-trans isomerase, conserved site,IPR024936:Cyclophilin-type peptidyl-prolyl cis-trans isomerase,	mmu03040:Spliceosome,	PIRSF001475:peptidyl-prolyl cis-trans isomerase E,	SM00360:RRM,	Complete proteome,Isomerase,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Reference proteome,RNA-binding,Rotamase,Spliceosome,	chain:Peptidyl-prolyl cis-trans isomerase E,domain:PPIase cyclophilin-type,domain:RRM,sequence conflict,
Pabpc1	poly(A) binding protein, cytoplasmic 1(Pabpc1)	Mus musculus	m_eif4Pathway:Regulation of eIF4e and p70 S6 Kinase,	NA	GO:0000184~nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0031047~gene silencing by RNA,GO:0045070~positive regulation of viral genome replication,GO:0060213~positive regulation of nuclear-transcribed mRNA poly(A) tail shortening,GO:1900153~positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,GO:2000623~negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,	GO:0005634~nucleus,GO:0005681~spliceosomal complex,GO:0005737~cytoplasm,GO:0005925~focal adhesion,GO:0010494~cytoplasmic stress granule,GO:0016020~membrane,GO:0030425~dendrite,GO:0030529~intracellular ribonucleoprotein complex,GO:0036464~cytoplasmic ribonucleoprotein granule,GO:0070062~extracellular exosome,GO:0071013~catalytic step 2 spliceosome,GO:1990124~messenger ribonucleoprotein complex,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0005515~protein binding,GO:0008022~protein C-terminus binding,GO:0008143~poly(A) binding,GO:0008266~poly(U) RNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR002004:Polyadenylate-binding protein/Hyperplastic disc protein,IPR003954:RNA recognition motif domain, eukaryote,IPR006515:Polyadenylate binding protein, human types 1, 2, 3, 4,IPR012677:Nucleotide-binding, alpha-beta plait,	mmu03013:RNA transport,mmu03015:mRNA surveillance pathway,mmu03018:RNA degradation,	NA	SM00360:RRM,SM00361:RRM_1,SM00517:PolyA,	Acetylation,Complete proteome,Cytoplasm,Methylation,mRNA processing,mRNA splicing,Nonsense-mediated mRNA decay,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,RNA-binding,Spliceosome,	chain:Polyadenylate-binding protein 1,compositionally biased region:Poly-Ala,domain:PABC,domain:RRM 1,domain:RRM 2,domain:RRM 3,domain:RRM 4,modified residue,region of interest:CSDE1-binding,
Pabpn1	poly(A) binding protein, nuclear 1(Pabpn1)	Mus musculus	m_cpsfPathway:Polyadenylation of mRNA,	NA	GO:0000165~MAPK cascade,GO:0006378~mRNA polyadenylation,GO:0006397~mRNA processing,GO:0016973~poly(A)+ mRNA export from nucleus,GO:0071222~cellular response to lipopolysaccharide,GO:1904247~positive regulation of polynucleotide adenylyltransferase activity,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0016607~nuclear speck,GO:0030529~intracellular ribonucleoprotein complex,GO:0042405~nuclear inclusion body,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0008143~poly(A) binding,GO:0043621~protein self-association,GO:0044822~poly(A) RNA binding,GO:0070063~RNA polymerase binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,	mmu03015:mRNA surveillance pathway,mmu05164:Influenza A,	NA	SM00360:RRM,	Acetylation,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Methylation,mRNA processing,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,RNA-binding,	chain:Polyadenylate-binding protein 2,compositionally biased region:Ala-rich,domain:RRM,modified residue,region of interest:Interacts with PAPOLA,region of interest:Interacts with SKIP,region of interest:Stimulates PAPOLA,region of interest:Strong poly(A) affinity and self- association,splice variant,
Pcbp1	poly(rC) binding protein 1(Pcbp1)	Mus musculus	NA	NA	GO:0006397~mRNA processing,GO:0039694~viral RNA genome replication,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005913~cell-cell adherens junction,GO:0016020~membrane,GO:0030529~intracellular ribonucleoprotein complex,GO:0043231~intracellular membrane-bounded organelle,GO:0070062~extracellular exosome,	GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003697~single-stranded DNA binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0005515~protein binding,GO:0008494~translation activator activity,GO:0044822~poly(A) RNA binding,GO:0098641~cadherin binding involved in cell-cell adhesion,GO:0098847~sequence-specific single stranded DNA binding,	IPR004087:K Homology domain,IPR004088:K Homology domain, type 1,	mmu03040:Spliceosome,	NA	SM00322:KH,	Acetylation,Complete proteome,Direct protein sequencing,DNA-binding,Nucleus,Phosphoprotein,Reference proteome,Repeat,Ribonucleoprotein,RNA-binding,	chain:Poly(rC)-binding protein 1,domain:KH 1,domain:KH 2,domain:KH 3,modified residue,
Pcbp2	poly(rC) binding protein 2(Pcbp2)	Mus musculus	NA	NA	GO:0002376~immune system process,GO:0039694~viral RNA genome replication,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0045087~innate immune response,GO:0050687~negative regulation of defense response to virus,GO:0051607~defense response to virus,GO:0075522~IRES-dependent viral translational initiation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0030529~intracellular ribonucleoprotein complex,GO:0070062~extracellular exosome,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0019899~enzyme binding,GO:0031625~ubiquitin protein ligase binding,GO:0044822~poly(A) RNA binding,GO:1990829~C-rich single-stranded DNA binding,	IPR004087:K Homology domain,IPR004088:K Homology domain, type 1,	NA	NA	SM00322:KH,	Alternative splicing,Antiviral defense,Complete proteome,Cytoplasm,Direct protein sequencing,DNA-binding,Immunity,Innate immunity,Nucleus,Phosphoprotein,Reference proteome,Repeat,Ribonucleoprotein,RNA-binding,	chain:Poly(rC)-binding protein 2,domain:KH 1,domain:KH 2,domain:KH 3,modified residue,splice variant,
Pcbp4	poly(rC) binding protein 4(Pcbp4)	Mus musculus	NA	NA	GO:0043488~regulation of mRNA stability,GO:0048025~negative regulation of mRNA splicing, via spliceosome,GO:1902163~negative regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,	GO:0005737~cytoplasm,GO:0030529~intracellular ribonucleoprotein complex,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0044822~poly(A) RNA binding,	IPR004087:K Homology domain,IPR004088:K Homology domain, type 1,	NA	NA	SM00322:KH,	Complete proteome,Cytoplasm,DNA-binding,Proteomics identification,Reference proteome,Repeat,Ribonucleoprotein,RNA-binding,	chain:Poly(rC)-binding protein 4,domain:KH 1,domain:KH 2,domain:KH 3,sequence conflict,
Puf60	poly-U binding splicing factor 60(Puf60)	Mus musculus	NA	NA	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006397~mRNA processing,GO:0006915~apoptotic process,GO:0008380~RNA splicing,GO:0098609~cell-cell adhesion,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005913~cell-cell adherens junction,GO:0019907~cyclin-dependent protein kinase activating kinase holoenzyme complex,GO:0030054~cell junction,GO:0030529~intracellular ribonucleoprotein complex,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0042802~identical protein binding,GO:0044822~poly(A) RNA binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000504:RNA recognition motif domain,IPR003954:RNA recognition motif domain, eukaryote,IPR006532:Poly-U binding splicing factor, half-pint,IPR012677:Nucleotide-binding, alpha-beta plait,	mmu03040:Spliceosome,	NA	SM00360:RRM,SM00361:RRM_1,	Acetylation,Alternative splicing,Apoptosis,Complete proteome,DNA-binding,Isopeptide bond,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Reference proteome,Repeat,Repressor,Ribonucleoprotein,RNA-binding,Transcription,Transcription regulation,Ubl conjugation,	chain:Poly(U)-binding-splicing factor PUF60,compositionally biased region:Ala-rich,domain:RRM 1,domain:RRM 2,domain:RRM 3; atypical,modified residue,region of interest:Inhibits homodimerization,region of interest:Inhibits transcriptional repression, interaction with ERCC3 and apoptosis induction,sequence conflict,splice variant,
Ptbp1	polypyrimidine tract binding protein 1(Ptbp1)	Mus musculus	m_iresPathway:Internal Ribosome entry pathway,	NA	GO:0000381~regulation of alternative mRNA splicing, via spliceosome,GO:0000956~nuclear-transcribed mRNA catabolic process,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0010976~positive regulation of neuron projection development,GO:0032024~positive regulation of insulin secretion,GO:0033119~negative regulation of RNA splicing,GO:0045727~positive regulation of translation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048025~negative regulation of mRNA splicing, via spliceosome,GO:0051148~negative regulation of muscle cell differentiation,GO:0070935~3'-UTR-mediated mRNA stabilization,GO:0075522~IRES-dependent viral translational initiation,GO:1904411~positive regulation of secretory granule organization,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0044306~neuron projection terminus,GO:0070062~extracellular exosome,	GO:0000014~single-stranded DNA endodeoxyribonuclease activity,GO:0000166~nucleotide binding,GO:0001069~regulatory region RNA binding,GO:0003676~nucleic acid binding,GO:0003697~single-stranded DNA binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0005515~protein binding,GO:0036002~pre-mRNA binding,GO:0043565~sequence-specific DNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR006536:HnRNP-L/PTB/hephaestus splicing factor,IPR012677:Nucleotide-binding, alpha-beta plait,	NA	NA	SM00360:RRM,	Acetylation,Activator,Complete proteome,Direct protein sequencing,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Repressor,RNA-binding,	chain:Polypyrimidine tract-binding protein 1,compositionally biased region:Poly-Ala,domain:RRM 1,domain:RRM 2,domain:RRM 3,domain:RRM 4,modified residue,
Ptbp3	polypyrimidine tract binding protein 3(Ptbp3)	Mus musculus	NA	NA	GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0016070~RNA metabolic process,GO:0030154~cell differentiation,GO:0033119~negative regulation of RNA splicing,GO:0043249~erythrocyte maturation,GO:0045595~regulation of cell differentiation,GO:0048025~negative regulation of mRNA splicing, via spliceosome,	GO:0005634~nucleus,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR006536:HnRNP-L/PTB/hephaestus splicing factor,IPR012677:Nucleotide-binding, alpha-beta plait,	NA	NA	SM00360:RRM,	Acetylation,Alternative splicing,Complete proteome,Differentiation,Erythrocyte maturation,mRNA processing,mRNA splicing,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Repressor,RNA-binding,	chain:Regulator of differentiation 1,domain:RRM 1,domain:RRM 2,domain:RRM 3,domain:RRM 4,modified residue,splice variant,
Prpf31	pre-mRNA processing factor 31(Prpf31)	Mus musculus	NA	NA	GO:0000244~spliceosomal tri-snRNP complex assembly,GO:0000398~mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0071166~ribonucleoprotein complex localization,	GO:0005634~nucleus,GO:0005681~spliceosomal complex,GO:0005687~U4 snRNP,GO:0005690~U4atac snRNP,GO:0015030~Cajal body,GO:0016607~nuclear speck,GO:0030529~intracellular ribonucleoprotein complex,GO:0046540~U4/U6 x U5 tri-snRNP complex,GO:0071011~precatalytic spliceosome,GO:0071339~MLL1 complex,GO:0097526~spliceosomal tri-snRNP complex,	GO:0003723~RNA binding,GO:0030621~U4 snRNA binding,GO:0030622~U4atac snRNA binding,GO:0043021~ribonucleoprotein complex binding,GO:0044822~poly(A) RNA binding,GO:0070990~snRNP binding,	IPR002687:Nop domain,IPR012976:NOSIC,IPR019175:Prp31 C-terminal,IPR027105:U4/U6 small nuclear ribonucleoprotein Prp31,	mmu03040:Spliceosome,	NA	SM00931:SM00931,	Acetylation,Alternative splicing,Coiled coil,Complete proteome,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Reference proteome,Ribonucleoprotein,RNA-binding,Spliceosome,	chain:U4/U6 small nuclear ribonucleoprotein Prp31,compositionally biased region:Poly-Glu,domain:Nop,modified residue,sequence conflict,site:Interaction with U4 snRNA,splice variant,
Prpf8	pre-mRNA processing factor 8(Prpf8)	Mus musculus	NA	RNA processing and modification,	GO:0000244~spliceosomal tri-snRNP complex assembly,GO:0000398~mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0071222~cellular response to lipopolysaccharide,GO:0071356~cellular response to tumor necrosis factor,	GO:0005634~nucleus,GO:0005681~spliceosomal complex,GO:0005682~U5 snRNP,GO:0016020~membrane,GO:0016607~nuclear speck,GO:0030529~intracellular ribonucleoprotein complex,GO:0030532~small nuclear ribonucleoprotein complex,GO:0071013~catalytic step 2 spliceosome,	GO:0000386~second spliceosomal transesterification activity,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0017070~U6 snRNA binding,GO:0030619~U1 snRNA binding,GO:0030620~U2 snRNA binding,GO:0030623~U5 snRNA binding,GO:0044822~poly(A) RNA binding,GO:0070530~K63-linked polyubiquitin binding,GO:0097157~pre-mRNA intronic binding,	IPR000555:JAB1/Mov34/MPN/PAD-1,IPR012337:Ribonuclease H-like domain,IPR012591:Pre-mRNA-processing-splicing factor 8,IPR012592:PROCN,IPR012984:PRO, C-terminal,IPR019580:Pre-mRNA-processing-splicing factor 8, U6-snRNA-binding,IPR019581:Pre-mRNA-processing-splicing factor 8, U5-snRNA-binding,IPR019582:RNA recognition motif, spliceosomal PrP8,IPR021983:PRP8 domain IV core,	mmu03040:Spliceosome,	NA	SM00232:JAB_MPN,	Acetylation,Complete proteome,Methylation,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Ribonucleoprotein,RNA-binding,Spliceosome,	chain:Pre-mRNA-processing-splicing factor 8,domain:MPN,modified residue,region of interest:Involved in interaction with pre-mRNA 5' splice site,region of interest:Required for interaction with EFTUD2 and SNRNP200,sequence conflict,
Pdcd4	programmed cell death 4(Pdcd4)	Mus musculus	NA	NA	GO:0006915~apoptotic process,GO:0007569~cell aging,GO:0034393~positive regulation of smooth muscle cell apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0043508~negative regulation of JUN kinase activity,GO:0045892~negative regulation of transcription, DNA-templated,GO:0051246~regulation of protein metabolic process,GO:1904761~negative regulation of myofibroblast differentiation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0003723~RNA binding,GO:0005515~protein binding,	IPR003891:Initiation factor eIF-4 gamma, MA3,IPR016021:MIF4-like, type 1/2/3,IPR016024:Armadillo-type fold,	mmu05205:Proteoglycans in cancer,mmu05206:MicroRNAs in cancer,	NA	SM00544:MA3,	3D-structure,Acetylation,Apoptosis,Complete proteome,Cytoplasm,Nucleus,Phosphoprotein,Reference proteome,Repeat,RNA-binding,Tumor suppressor,Ubl conjugation,	chain:Programmed cell death protein 4,domain:MI 1,domain:MI 2,helix,modified residue,sequence conflict,short sequence motif:Nuclear localization signal,
Pa2g4	proliferation-associated 2G4(Pa2g4)	Mus musculus	NA	NA	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006364~rRNA processing,GO:0006417~regulation of translation,GO:0043066~negative regulation of apoptotic process,GO:0045597~positive regulation of cell differentiation,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0030529~intracellular ribonucleoprotein complex,GO:0070062~extracellular exosome,	GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003723~RNA binding,GO:0031625~ubiquitin protein ligase binding,GO:0044822~poly(A) RNA binding,	IPR000994:Peptidase M24, structural domain,IPR004545:Proliferation-associated protein 1,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR018349:Peptidase M24A, methionine aminopeptidase, subfamily 2, binding site,	NA	NA	NA	3D-structure,Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repressor,Ribonucleoprotein,RNA-binding,rRNA processing,Transcription,Transcription regulation,Translation regulation,Ubl conjugation,	chain:Proliferation-associated protein 2G4,helix,modified residue,mutagenesis site,region of interest:Interaction with RNA,region of interest:Necessary for nucleolar localization,region of interest:RNA-binding,sequence conflict,strand,turn,
Prkra	protein kinase, interferon inducible double stranded RNA dependent activator(Prkra)	Mus musculus	NA	NA	GO:0006468~protein phosphorylation,GO:0008284~positive regulation of cell proliferation,GO:0030422~production of siRNA involved in RNA interference,GO:0031047~gene silencing by RNA,GO:0031054~pre-miRNA processing,GO:0034599~cellular response to oxidative stress,GO:0035196~production of miRNAs involved in gene silencing by miRNA,GO:0042473~outer ear morphogenesis,GO:0042474~middle ear morphogenesis,GO:0048705~skeletal system morphogenesis,GO:2001244~positive regulation of intrinsic apoptotic signaling pathway,	GO:0005622~intracellular,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0048471~perinuclear region of cytoplasm,	GO:0003723~RNA binding,GO:0003725~double-stranded RNA binding,GO:0005515~protein binding,GO:0008047~enzyme activator activity,GO:0019899~enzyme binding,GO:0019901~protein kinase binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0044822~poly(A) RNA binding,	IPR014720:Double-stranded RNA-binding-like domain,	NA	NA	SM00358:DSRM,	Complete proteome,Cytoplasm,Phosphoprotein,Reference proteome,Repeat,RNA-binding,RNA-mediated gene silencing,	chain:Interferon-inducible double stranded RNA- dependent protein kinase activator A,domain:DRBM 1,domain:DRBM 2,domain:DRBM 3,modified residue,region of interest:Sufficient for self-association and interaction with TARBP2,sequence conflict,
Ppp1r8	protein phosphatase 1, regulatory (inhibitor) subunit 8(Ppp1r8)	Mus musculus	NA	NA	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006397~mRNA processing,GO:0007275~multicellular organism development,GO:0008283~cell proliferation,GO:0008380~RNA splicing,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0016607~nuclear speck,	GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0004864~protein phosphatase inhibitor activity,GO:0005515~protein binding,GO:0008599~protein phosphatase type 1 regulator activity,GO:0019888~protein phosphatase regulator activity,	IPR000253:Forkhead-associated (FHA) domain,IPR008984:SMAD/FHA domain,	NA	NA	SM00240:FHA,	3D-structure,Complete proteome,Developmental protein,DNA-binding,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Protein phosphatase inhibitor,Proteomics identification,Reference proteome,Repressor,RNA-binding,Spliceosome,Transcription,Transcription regulation,	chain:Nuclear inhibitor of protein phosphatase 1,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Lys,domain:FHA,modified residue,region of interest:Interaction with CDC5L, SF3B1 and MELK,region of interest:Interaction with EED,region of interest:Involved in PP-1 binding,region of interest:Involved in PP-1 inhibition,region of interest:RNA-binding,short sequence motif:Nuclear localization signal 1,short sequence motif:Nuclear localization signal 2,strand,turn,
Qk	quaking(Qk)	Mus musculus	NA	NA	GO:0001570~vasculogenesis,GO:0006397~mRNA processing,GO:0006417~regulation of translation,GO:0006810~transport,GO:0007275~multicellular organism development,GO:0007286~spermatid development,GO:0008366~axon ensheathment,GO:0008380~RNA splicing,GO:0010628~positive regulation of gene expression,GO:0010667~negative regulation of cardiac muscle cell apoptotic process,GO:0010976~positive regulation of neuron projection development,GO:0030154~cell differentiation,GO:0042552~myelination,GO:0042692~muscle cell differentiation,GO:0042759~long-chain fatty acid biosynthetic process,GO:0048255~mRNA stabilization,GO:0048714~positive regulation of oligodendrocyte differentiation,GO:0051028~mRNA transport,GO:0061158~3'-UTR-mediated mRNA destabilization,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0017124~SH3 domain binding,GO:0044822~poly(A) RNA binding,	IPR004087:K Homology domain,IPR004088:K Homology domain, type 1,	NA	NA	SM00322:KH,	3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Developmental protein,Differentiation,Methylation,mRNA processing,mRNA splicing,mRNA transport,Nucleus,Phosphoprotein,Reference proteome,RNA-binding,SH3-binding,Translation regulation,Transport,	chain:Protein quaking,domain:KH,mutagenesis site,sequence conflict,short sequence motif:Nuclear localization signal,short sequence motif:SH3-binding,splice variant,
Rnps1	ribonucleic acid binding protein S1(Rnps1)	Mus musculus	NA	NA	GO:0000184~nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,GO:0000381~regulation of alternative mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0043065~positive regulation of apoptotic process,GO:0048025~negative regulation of mRNA splicing, via spliceosome,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016607~nuclear speck,GO:0061574~ASAP complex,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,	mmu03013:RNA transport,mmu03015:mRNA surveillance pathway,	NA	SM00360:RRM,	Acetylation,Alternative splicing,Complete proteome,Cytoplasm,DNA-binding,mRNA processing,mRNA splicing,Nonsense-mediated mRNA decay,Nucleus,Phosphoprotein,Reference proteome,RNA-binding,	chain:RNA-binding protein with serine-rich domain 1,compositionally biased region:Arg-rich,compositionally biased region:Arg/Pro-rich,compositionally biased region:Lys-rich,compositionally biased region:Ser-rich,domain:RRM,modified residue,region of interest:Necessary for interaction with PNN and exon-skipping,region of interest:Necessary for interaction with SRP54, nuclear localization and exon-skipping,region of interest:Necessary for interaction with the cleaved p110 isoform of CDC2L1,region of interest:Necessary for interaction with TRA2B, nuclear localization and exon-skipping,region of interest:Necessary for interactions with RENT2 and REN3B and RENT2-dependent NMD,splice variant,
Rpl12	ribosomal protein L12(Rpl12)	Mus musculus	NA	NA	GO:0000027~ribosomal large subunit assembly,GO:0006412~translation,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005840~ribosome,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0022625~cytosolic large ribosomal subunit,GO:0030529~intracellular ribonucleoprotein complex,GO:0031012~extracellular matrix,GO:0070062~extracellular exosome,	GO:0003723~RNA binding,GO:0003735~structural constituent of ribosome,GO:0005515~protein binding,GO:0019843~rRNA binding,GO:0044822~poly(A) RNA binding,GO:0070180~large ribosomal subunit rRNA binding,	IPR000911:Ribosomal protein L11,IPR020783:Ribosomal protein L11, C-terminal,IPR020784:Ribosomal protein L11, N-terminal,IPR020785:Ribosomal protein L11, conserved site,	mmu03010:Ribosome,	NA	SM00649:RL11,	3D-structure,Acetylation,Complete proteome,Phosphoprotein,Proteomics identification,Reference proteome,Ribonucleoprotein,Ribosomal protein,RNA-binding,	chain:60S ribosomal protein L12,helix,modified residue,sequence conflict,strand,turn,
Rpl22	ribosomal protein L22(Rpl22)	Mus musculus	NA	NA	GO:0002181~cytoplasmic translation,GO:0006412~translation,GO:0046632~alpha-beta T cell differentiation,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005840~ribosome,GO:0005925~focal adhesion,GO:0022625~cytosolic large ribosomal subunit,GO:0030529~intracellular ribonucleoprotein complex,GO:0031012~extracellular matrix,GO:0070062~extracellular exosome,	GO:0003723~RNA binding,GO:0003735~structural constituent of ribosome,GO:0008201~heparin binding,GO:0044822~poly(A) RNA binding,	IPR002671:Ribosomal protein L22e,	mmu03010:Ribosome,	NA	NA	Complete proteome,Heparin-binding,Phosphoprotein,Reference proteome,Ribonucleoprotein,Ribosomal protein,RNA-binding,	chain:60S ribosomal protein L22,compositionally biased region:Asp/Glu-rich (highly acidic),
Rpl5	ribosomal protein L5(Rpl5)	Mus musculus	NA	NA	GO:0000027~ribosomal large subunit assembly,GO:0006364~rRNA processing,GO:0006412~translation,GO:0010922~positive regulation of phosphatase activity,GO:0042273~ribosomal large subunit biogenesis,GO:0071241~cellular response to inorganic substance,GO:1905017~positive regulation of isoleucine-tRNA ligase activity,GO:1905020~positive regulation of methionine-tRNA ligase activity,GO:1905023~positive regulation of threonine-tRNA ligase activity,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005840~ribosome,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0017101~aminoacyl-tRNA synthetase multienzyme complex,GO:0022625~cytosolic large ribosomal subunit,GO:0022626~cytosolic ribosome,GO:0030529~intracellular ribonucleoprotein complex,GO:0070062~extracellular exosome,	GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0003735~structural constituent of ribosome,GO:0005515~protein binding,GO:0008097~5S rRNA binding,GO:0019843~rRNA binding,GO:0044822~poly(A) RNA binding,	IPR005485:Ribosomal protein L5 eukaryotic/L18 archaeal,IPR025607:Ribosomal protein L5 eukaryotic/L18 archaeal, C-terminal,	mmu03010:Ribosome,	NA	NA	Acetylation,Complete proteome,Cytoplasm,Isopeptide bond,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Ribonucleoprotein,Ribosomal protein,RNA-binding,rRNA-binding,Ubl conjugation,	NA
Rpl7	ribosomal protein L7(Rpl7)	Mus musculus	NA	NA	GO:0000463~maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0002181~cytoplasmic translation,GO:0006364~rRNA processing,GO:0006412~translation,GO:0042273~ribosomal large subunit biogenesis,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005840~ribosome,GO:0005844~polysome,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0022625~cytosolic large ribosomal subunit,GO:0030529~intracellular ribonucleoprotein complex,GO:0031672~A band,GO:0070062~extracellular exosome,	GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0003735~structural constituent of ribosome,GO:0008097~5S rRNA binding,GO:0042803~protein homodimerization activity,GO:0044822~poly(A) RNA binding,	IPR005998:Ribosomal protein L7, eukaryotic,IPR012988:Ribosomal protein L30, N-terminal,IPR016082:Ribosomal protein L30, ferredoxin-like fold domain,IPR018038:Ribosomal protein L30, conserved site,	mmu03010:Ribosome,	NA	NA	Acetylation,Complete proteome,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Ribonucleoprotein,Ribosomal protein,RNA-binding,	chain:60S ribosomal protein L7,modified residue,region of interest:6 X 12 AA tandem repeats,repeat:1,repeat:2,repeat:3,repeat:4,repeat:5,repeat:6,sequence conflict,
Rpl8	ribosomal protein L8(Rpl8)	Mus musculus	NA	NA	GO:0002181~cytoplasmic translation,GO:0006412~translation,	GO:0005622~intracellular,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005840~ribosome,GO:0005925~focal adhesion,GO:0015934~large ribosomal subunit,GO:0016020~membrane,GO:0022625~cytosolic large ribosomal subunit,GO:0030529~intracellular ribonucleoprotein complex,	GO:0003723~RNA binding,GO:0003735~structural constituent of ribosome,GO:0005515~protein binding,GO:0019843~rRNA binding,GO:0044822~poly(A) RNA binding,	IPR002171:Ribosomal protein L2,IPR008991:Translation protein SH3-like domain,IPR012340:Nucleic acid-binding, OB-fold,IPR014722:Ribosomal protein L2 domain 2,IPR014726:Ribosomal protein L2, domain 3,IPR022666:Ribosomal Proteins L2, RNA binding domain,IPR022669:Ribosomal protein L2, C-terminal,IPR022671:Ribosomal protein L2, conserved site,IPR023672:Ribosomal protein L2, archaeal-type,	mmu03010:Ribosome,	PIRSF002158:ribosomal protein, L2p/L2a/L8e/organellar L2 types,	SM01382:SM01382,SM01383:SM01383,	Complete proteome,Cytoplasm,Hydroxylation,Reference proteome,Ribonucleoprotein,Ribosomal protein,RNA-binding,rRNA-binding,	chain:60S ribosomal protein L8,modified residue,
Rps11	ribosomal protein S11(Rps11)	Mus musculus	NA	NA	GO:0001649~osteoblast differentiation,GO:0006412~translation,	GO:0005622~intracellular,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005840~ribosome,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0022627~cytosolic small ribosomal subunit,GO:0030529~intracellular ribonucleoprotein complex,GO:0031012~extracellular matrix,GO:0070062~extracellular exosome,	GO:0003723~RNA binding,GO:0003735~structural constituent of ribosome,GO:0019843~rRNA binding,GO:0044822~poly(A) RNA binding,	IPR000266:Ribosomal protein S17,IPR012340:Nucleic acid-binding, OB-fold,IPR019979:Ribosomal protein S17, conserved site,	mmu03010:Ribosome,	NA	NA	Acetylation,Citrullination,Complete proteome,Lipoprotein,Methylation,Palmitate,Phosphoprotein,Proteomics identification,Reference proteome,Ribonucleoprotein,Ribosomal protein,RNA-binding,rRNA-binding,	chain:40S ribosomal protein S11,modified residue,
Rps3	ribosomal protein S3(Rps3)	Mus musculus	NA	NA	GO:0006281~DNA repair,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006412~translation,GO:0006417~regulation of translation,GO:0006915~apoptotic process,GO:0006974~cellular response to DNA damage stimulus,GO:0006979~response to oxidative stress,GO:0007049~cell cycle,GO:0007059~chromosome segregation,GO:0007067~mitotic nuclear division,GO:0010628~positive regulation of gene expression,GO:0017148~negative regulation of translation,GO:0031116~positive regulation of microtubule polymerization,GO:0031397~negative regulation of protein ubiquitination,GO:0032079~positive regulation of endodeoxyribonuclease activity,GO:0042769~DNA damage response, detection of DNA damage,GO:0042981~regulation of apoptotic process,GO:0043507~positive regulation of JUN kinase activity,GO:0045738~negative regulation of DNA repair,GO:0045739~positive regulation of DNA repair,GO:0051225~spindle assembly,GO:0051301~cell division,GO:0061481~response to TNF agonist,GO:0070301~cellular response to hydrogen peroxide,GO:1901224~positive regulation of NIK/NF-kappaB signaling,GO:1902231~positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage,GO:1902546~positive regulation of DNA N-glycosylase activity,GO:1905053~positive regulation of base-excision repair,GO:1990090~cellular response to nerve growth factor stimulus,GO:2001235~positive regulation of apoptotic signaling pathway,GO:2001272~positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005759~mitochondrial matrix,GO:0005829~cytosol,GO:0005840~ribosome,GO:0005844~polysome,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0012505~endomembrane system,GO:0015935~small ribosomal subunit,GO:0016020~membrane,GO:0022627~cytosolic small ribosomal subunit,GO:0030425~dendrite,GO:0030529~intracellular ribonucleoprotein complex,GO:0031012~extracellular matrix,GO:0032587~ruffle membrane,GO:0070062~extracellular exosome,GO:0071159~NF-kappaB complex,GO:0072686~mitotic spindle,	GO:0003677~DNA binding,GO:0003684~damaged DNA binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0003735~structural constituent of ribosome,GO:0003906~DNA-(apurinic or apyrimidinic site) lyase activity,GO:0004520~endodeoxyribonuclease activity,GO:0005515~protein binding,GO:0008017~microtubule binding,GO:0008134~transcription factor binding,GO:0008534~oxidized purine nucleobase lesion DNA N-glycosylase activity,GO:0015631~tubulin binding,GO:0016829~lyase activity,GO:0019899~enzyme binding,GO:0019900~kinase binding,GO:0019901~protein kinase binding,GO:0030544~Hsp70 protein binding,GO:0032183~SUMO binding,GO:0032357~oxidized purine DNA binding,GO:0032358~oxidized pyrimidine DNA binding,GO:0044390~ubiquitin-like protein conjugating enzyme binding,GO:0044822~poly(A) RNA binding,GO:0051018~protein kinase A binding,GO:0051879~Hsp90 protein binding,GO:0070181~small ribosomal subunit rRNA binding,GO:0097100~supercoiled DNA binding,	IPR001351:Ribosomal protein S3, C-terminal,IPR004044:K Homology domain, type 2,IPR005703:Ribosomal protein S3, eukaryotic/archaeal,IPR009019:K homology domain, prokaryotic type,IPR015946:K homology domain-like, alpha/beta,IPR018280:Ribosomal protein S3, conserved site,	mmu03010:Ribosome,	NA	NA	Acetylation,Apoptosis,Cell cycle,Cell division,Complete proteome,Cytoplasm,Cytoskeleton,Direct protein sequencing,DNA damage,DNA repair,DNA-binding,Isopeptide bond,Lyase,Membrane,Methylation,Mitochondrion,Mitochondrion inner membrane,Mitosis,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Ribonucleoprotein,Ribosomal protein,RNA-binding,Transcription,Transcription regulation,Translation regulation,Ubl conjugation,	chain:40S ribosomal protein S3,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),domain:KH type-2,modified residue,
Rps4x	ribosomal protein S4, X-linked(Rps4x)	Mus musculus	NA	NA	GO:0006412~translation,GO:0007275~multicellular organism development,GO:0008284~positive regulation of cell proliferation,GO:0045727~positive regulation of translation,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005840~ribosome,GO:0005844~polysome,GO:0005925~focal adhesion,GO:0015935~small ribosomal subunit,GO:0016020~membrane,GO:0022627~cytosolic small ribosomal subunit,GO:0030529~intracellular ribonucleoprotein complex,GO:0036464~cytoplasmic ribonucleoprotein granule,GO:0070062~extracellular exosome,	GO:0003723~RNA binding,GO:0003735~structural constituent of ribosome,GO:0019843~rRNA binding,GO:0044822~poly(A) RNA binding,	IPR000876:Ribosomal protein S4e,IPR002942:RNA-binding S4 domain,IPR005824:KOW,IPR013843:Ribosomal protein S4e, N-terminal,IPR013845:Ribosomal protein S4e, central region,IPR018199:Ribosomal protein S4e, N-terminal, conserved site,	mmu03010:Ribosome,	PIRSF002116:ribosomal protein S4a/S4e,	SM00363:S4,	Acetylation,Complete proteome,Cytoplasm,Reference proteome,Ribonucleoprotein,Ribosomal protein,RNA-binding,rRNA-binding,	chain:40S ribosomal protein S4, X isoform,domain:S4 RNA-binding,modified residue,sequence conflict,
Rps9	ribosomal protein S9(Rps9)	Mus musculus	NA	NA	GO:0006412~translation,GO:0008284~positive regulation of cell proliferation,GO:0045903~positive regulation of translational fidelity,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005840~ribosome,GO:0005925~focal adhesion,GO:0015935~small ribosomal subunit,GO:0016020~membrane,GO:0022627~cytosolic small ribosomal subunit,GO:0030529~intracellular ribonucleoprotein complex,GO:0070062~extracellular exosome,	GO:0003723~RNA binding,GO:0003735~structural constituent of ribosome,GO:0019843~rRNA binding,GO:0044822~poly(A) RNA binding,GO:0045182~translation regulator activity,GO:1990932~5.8S rRNA binding,	IPR001912:Ribosomal protein S4/S9, N-terminal,IPR002942:RNA-binding S4 domain,IPR005710:Ribosomal protein S4/S9, eukaryotic/archaeal,IPR018079:Ribosomal protein S4, conserved site,IPR022801:Ribosomal protein S4/S9,	mmu03010:Ribosome,	NA	SM00363:S4,SM01390:SM01390,	Acetylation,Complete proteome,Cytoplasm,Phosphoprotein,Proteomics identification,Reference proteome,Ribonucleoprotein,Ribosomal protein,RNA-binding,rRNA-binding,	chain:40S ribosomal protein S9,domain:S4 RNA-binding,modified residue,sequence conflict,
Safb	scaffold attachment factor B(Safb)	Mus musculus	NA	NA	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0030520~intracellular estrogen receptor signaling pathway,GO:0040007~growth,GO:0042445~hormone metabolic process,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0050684~regulation of mRNA processing,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0000166~nucleotide binding,GO:0001047~core promoter binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003690~double-stranded DNA binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0043565~sequence-specific DNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR003034:SAP domain,IPR012677:Nucleotide-binding, alpha-beta plait,	NA	NA	SM00360:RRM,SM00513:SAP,	Acetylation,Coiled coil,Complete proteome,DNA-binding,Isopeptide bond,Methylation,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repressor,RNA-binding,Transcription,Transcription regulation,Ubl conjugation,	NA
Srrm1	serine/arginine repetitive matrix 1(Srrm1)	Mus musculus	NA	NA	GO:0000375~RNA splicing, via transesterification reactions,GO:0000398~mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0008380~RNA splicing,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0016363~nuclear matrix,GO:0016607~nuclear speck,GO:0071013~catalytic step 2 spliceosome,	GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR002483:PWI domain,	mmu03013:RNA transport,mmu03015:mRNA surveillance pathway,	NA	SM00311:PWI,	Acetylation,Alternative splicing,Citrullination,Complete proteome,DNA-binding,Isopeptide bond,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,RNA-binding,Spliceosome,Ubl conjugation,	chain:Serine/arginine repetitive matrix protein 1,compositionally biased region:Arg-rich,compositionally biased region:Lys-rich,compositionally biased region:Pro-rich,compositionally biased region:Ser-rich,domain:PWI,modified residue,region of interest:Necessary for DNA and RNA-binding,region of interest:Necessary for mRNA 3'-end cleavage and cytoplasmic accumulation,region of interest:Necessary for speckles and matrix localization,sequence conflict,splice variant,
Srsf1	serine/arginine-rich splicing factor 1(Srsf1)	Mus musculus	NA	NA	GO:0000380~alternative mRNA splicing, via spliceosome,GO:0000395~mRNA 5'-splice site recognition,GO:0001701~in utero embryonic development,GO:0006397~mRNA processing,GO:0006810~transport,GO:0008380~RNA splicing,GO:0033120~positive regulation of RNA splicing,GO:0048709~oligodendrocyte differentiation,GO:0051028~mRNA transport,GO:0060048~cardiac muscle contraction,GO:0097421~liver regeneration,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005737~cytoplasm,GO:0016607~nuclear speck,GO:0035145~exon-exon junction complex,GO:0070062~extracellular exosome,GO:0071013~catalytic step 2 spliceosome,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0043422~protein kinase B binding,GO:0044822~poly(A) RNA binding,GO:0050733~RS domain binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,	mmu03040:Spliceosome,mmu05168:Herpes simplex infection,	NA	SM00360:RRM,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Direct protein sequencing,Isopeptide bond,Methylation,mRNA processing,mRNA splicing,mRNA transport,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,RNA-binding,Spliceosome,Transport,Ubl conjugation,	chain:Splicing factor, arginine/serine-rich 1,compositionally biased region:Arg/Ser-rich (RS domain),compositionally biased region:Gly-rich (hinge region),domain:RRM 1,domain:RRM 2,helix,modified residue,region of interest:Interacts with SAFB1,sequence conflict,splice variant,strand,
Srsf10	serine/arginine-rich splicing factor 10(Srsf10)	Mus musculus	NA	NA	GO:0000375~RNA splicing, via transesterification reactions,GO:0000398~mRNA splicing, via spliceosome,GO:0006355~regulation of transcription, DNA-templated,GO:0006376~mRNA splice site selection,GO:0006397~mRNA processing,GO:0006406~mRNA export from nucleus,GO:0008380~RNA splicing,GO:0016482~cytosolic transport,GO:0048024~regulation of mRNA splicing, via spliceosome,GO:0048025~negative regulation of mRNA splicing, via spliceosome,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0016607~nuclear speck,GO:0030425~dendrite,GO:0043025~neuronal cell body,GO:0043679~axon terminus,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,GO:0051082~unfolded protein binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,	mmu03040:Spliceosome,	NA	SM00360:RRM,	Alternative splicing,Complete proteome,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,RNA-binding,	chain:Splicing factor, arginine/serine-rich 13A,compositionally biased region:Arg/Ser-rich (RS domain),domain:RRM,modified residue,sequence conflict,splice variant,
Srsf2	serine/arginine-rich splicing factor 2(Srsf2)	Mus musculus	NA	NA	GO:0000381~regulation of alternative mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0007067~mitotic nuclear division,GO:0008380~RNA splicing,GO:0033197~response to vitamin E,	GO:0005634~nucleus,GO:0005681~spliceosomal complex,GO:0016607~nuclear speck,GO:0035061~interchromatin granule,GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0005080~protein kinase C binding,GO:0005515~protein binding,GO:0036002~pre-mRNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR003954:RNA recognition motif domain, eukaryote,IPR012677:Nucleotide-binding, alpha-beta plait,	mmu03040:Spliceosome,mmu05168:Herpes simplex infection,	NA	SM00360:RRM,SM00361:RRM_1,	Acetylation,Complete proteome,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Reference proteome,RNA-binding,	chain:Splicing factor, arginine/serine-rich 2,compositionally biased region:Arg/Ser-rich (RS domain),compositionally biased region:Gly-rich (hinge region),domain:RRM,modified residue,sequence conflict,
Srsf3	serine/arginine-rich splicing factor 3(Srsf3)	Mus musculus	NA	NA	GO:0006397~mRNA processing,GO:0006810~transport,GO:0008286~insulin receptor signaling pathway,GO:0008380~RNA splicing,GO:0048024~regulation of mRNA splicing, via spliceosome,GO:0051028~mRNA transport,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0016607~nuclear speck,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0043274~phospholipase binding,GO:0044822~poly(A) RNA binding,GO:1990825~sequence-specific mRNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,	mmu03040:Spliceosome,mmu05168:Herpes simplex infection,	NA	SM00360:RRM,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Cytoplasm,mRNA processing,mRNA splicing,mRNA transport,Nucleus,Phosphoprotein,Reference proteome,Repeat,RNA-binding,Transport,	chain:Splicing factor, arginine/serine-rich 3,compositionally biased region:Arg/Ser-rich (RS domain),domain:RRM,modified residue,region of interest:2 X approximate repeats, basic,repeat:B-1,repeat:B-2,splice variant,
Srsf5	serine/arginine-rich splicing factor 5(Srsf5)	Mus musculus	NA	NA	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0009611~response to wounding,GO:0032868~response to insulin,GO:0032869~cellular response to insulin stimulus,GO:0033120~positive regulation of RNA splicing,GO:0051726~regulation of cell cycle,GO:0097421~liver regeneration,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0016607~nuclear speck,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0043422~protein kinase B binding,GO:0044822~poly(A) RNA binding,GO:0050733~RS domain binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,	mmu03040:Spliceosome,mmu05168:Herpes simplex infection,	NA	SM00360:RRM,	Acetylation,Complete proteome,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,RNA-binding,Transcription,Transcription regulation,	chain:Splicing factor, arginine/serine-rich 5,compositionally biased region:Arg/Ser-rich (RS domain),compositionally biased region:Gly-rich (hinge region),domain:RRM 1,domain:RRM 2,modified residue,
Srsf6	serine/arginine-rich splicing factor 6(Srsf6)	Mus musculus	NA	NA	GO:0000380~alternative mRNA splicing, via spliceosome,GO:0000381~regulation of alternative mRNA splicing, via spliceosome,GO:0006376~mRNA splice site selection,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0010629~negative regulation of gene expression,GO:0010837~regulation of keratinocyte proliferation,GO:0032868~response to insulin,GO:0045617~negative regulation of keratinocyte differentiation,GO:0048025~negative regulation of mRNA splicing, via spliceosome,GO:0060501~positive regulation of epithelial cell proliferation involved in lung morphogenesis,GO:0060548~negative regulation of cell death,GO:0061041~regulation of wound healing,GO:2000675~negative regulation of type B pancreatic cell apoptotic process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0016607~nuclear speck,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0036002~pre-mRNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,	mmu03040:Spliceosome,mmu05168:Herpes simplex infection,	NA	SM00360:RRM,	Acetylation,Complete proteome,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Repressor,RNA-binding,	NA
Srsf7	serine/arginine-rich splicing factor 7(Srsf7)	Mus musculus	NA	NA	GO:0006397~mRNA processing,GO:0006810~transport,GO:0008380~RNA splicing,GO:0048025~negative regulation of mRNA splicing, via spliceosome,GO:0051028~mRNA transport,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR000504:RNA recognition motif domain,IPR001878:Zinc finger, CCHC-type,IPR012677:Nucleotide-binding, alpha-beta plait,	mmu03040:Spliceosome,mmu05168:Herpes simplex infection,	NA	SM00360:RRM,	Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Metal-binding,mRNA processing,mRNA splicing,mRNA transport,Nucleus,Phosphoprotein,Reference proteome,Repeat,Repressor,RNA-binding,Transport,Zinc,Zinc-finger,	chain:Splicing factor, arginine/serine-rich 7,compositionally biased region:Arg/Ser-rich (RS domain),domain:RRM,modified residue,region of interest:6 X 8 AA repeats of R-R-S-R-S-X-S-X,repeat:1,repeat:2,repeat:3,repeat:4,repeat:5; approximate,repeat:6; approximate,sequence conflict,splice variant,zinc finger region:CCHC-type,
Srsf9	serine/arginine-rich splicing factor 9(Srsf9)	Mus musculus	NA	NA	GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0009636~response to toxic substance,GO:0043279~response to alkaloid,GO:0048025~negative regulation of mRNA splicing, via spliceosome,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,	mmu03040:Spliceosome,mmu05168:Herpes simplex infection,	NA	SM00360:RRM,	3D-structure,Complete proteome,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Repressor,RNA-binding,	chain:Splicing factor, arginine/serine-rich 9,compositionally biased region:Arg/Ser-rich (RS domain),compositionally biased region:Gly-rich (hinge region),domain:RRM 1,domain:RRM 2,helix,modified residue,region of interest:Interacts with SAFB1,sequence conflict,strand,turn,
Serbp1	serpine1 mRNA binding protein 1(Serbp1)	Mus musculus	NA	NA	GO:0042981~regulation of apoptotic process,GO:0098609~cell-cell adhesion,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005913~cell-cell adherens junction,GO:0016020~membrane,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,	GO:0003723~RNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0044822~poly(A) RNA binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR006861:Hyaluronan/mRNA-binding protein,IPR027205:Plasminogen activator inhibitor 1 RNA-binding protein,	NA	NA	SM01233:SM01233,	Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Isopeptide bond,Methylation,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,RNA-binding,Ubl conjugation,	chain:Plasminogen activator inhibitor 1 RNA- binding protein,modified residue,sequence conflict,splice variant,
Srp14	signal recognition particle 14(Srp14)	Mus musculus	NA	NA	GO:0006614~SRP-dependent cotranslational protein targeting to membrane,GO:0042493~response to drug,GO:0045047~protein targeting to ER,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005786~signal recognition particle, endoplasmic reticulum targeting,GO:0030529~intracellular ribonucleoprotein complex,GO:0048500~signal recognition particle,GO:0070062~extracellular exosome,	GO:0003723~RNA binding,GO:0008312~7S RNA binding,GO:0030942~endoplasmic reticulum signal peptide binding,GO:0044822~poly(A) RNA binding,	IPR003210:Signal recognition particle, SRP14 subunit,IPR009018:Signal recognition particle, SRP9/SRP14 subunit,	mmu03060:Protein export,	NA	NA	3D-structure,Complete proteome,Cytoplasm,Direct protein sequencing,Phosphoprotein,Proteomics identification,Reference proteome,Ribonucleoprotein,RNA-binding,Signal recognition particle,	chain:Signal recognition particle 14 kDa protein,helix,modified residue,strand,turn,
Srp19	signal recognition particle 19(Srp19)	Mus musculus	NA	NA	GO:0006614~SRP-dependent cotranslational protein targeting to membrane,GO:0006616~SRP-dependent cotranslational protein targeting to membrane, translocation,GO:0006617~SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition,GO:0042493~response to drug,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005786~signal recognition particle, endoplasmic reticulum targeting,GO:0030529~intracellular ribonucleoprotein complex,GO:0048500~signal recognition particle,	GO:0003723~RNA binding,GO:0008312~7S RNA binding,GO:0044822~poly(A) RNA binding,	IPR002778:Signal recognition particle, SRP19 subunit,	mmu03060:Protein export,	NA	NA	Complete proteome,Cytoplasm,Proteomics identification,Reference proteome,Ribonucleoprotein,RNA-binding,Signal recognition particle,	chain:Signal recognition particle 19 kDa protein,modified residue,region of interest:Basic region, potentially involved in RNA-binding,
Snrnp70	small nuclear ribonucleoprotein 70 (U1)(Snrnp70)	Mus musculus	NA	NA	GO:0000398~mRNA splicing, via spliceosome,GO:0043484~regulation of RNA splicing,GO:0048026~positive regulation of mRNA splicing, via spliceosome,GO:0071300~cellular response to retinoic acid,GO:0071356~cellular response to tumor necrosis factor,GO:0071560~cellular response to transforming growth factor beta stimulus,	GO:0000243~commitment complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005685~U1 snRNP,GO:0005737~cytoplasm,GO:0016607~nuclear speck,GO:0019013~viral nucleocapsid,GO:0030529~intracellular ribonucleoprotein complex,GO:0071004~U2-type prespliceosome,GO:0071011~precatalytic spliceosome,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0030619~U1 snRNA binding,GO:0044822~poly(A) RNA binding,GO:1990446~U1 snRNP binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,IPR022023:U1 small nuclear ribonucleoprotein of 70kDa N-terminal,	mmu03040:Spliceosome,	NA	SM00360:RRM,	Acetylation,Alternative splicing,Complete proteome,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Ribonucleoprotein,RNA-binding,Viral nucleoprotein,Virion,	chain:U1 small nuclear ribonucleoprotein 70 kDa,compositionally biased region:Arg/Asp/Glu-rich (mixed charge),compositionally biased region:Arg/Glu-rich (mixed charge),compositionally biased region:Poly-Gly,domain:RRM,modified residue,sequence conflict,splice variant,
Snrpd3	small nuclear ribonucleoprotein D3(Snrpd3)	Mus musculus	NA	NA	GO:0000245~spliceosomal complex assembly,GO:0000387~spliceosomal snRNP assembly,GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0006479~protein methylation,GO:0008380~RNA splicing,	GO:0000243~commitment complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005682~U5 snRNP,GO:0005683~U7 snRNP,GO:0005685~U1 snRNP,GO:0005686~U2 snRNP,GO:0005687~U4 snRNP,GO:0005689~U12-type spliceosomal complex,GO:0005697~telomerase holoenzyme complex,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0019013~viral nucleocapsid,GO:0030529~intracellular ribonucleoprotein complex,GO:0034709~methylosome,GO:0034715~pICln-Sm protein complex,GO:0034719~SMN-Sm protein complex,GO:0070062~extracellular exosome,GO:0071010~prespliceosome,GO:0071011~precatalytic spliceosome,GO:0071013~catalytic step 2 spliceosome,GO:0097526~spliceosomal tri-snRNP complex,	GO:0003723~RNA binding,GO:0019899~enzyme binding,GO:0030620~U2 snRNA binding,GO:0044822~poly(A) RNA binding,GO:0070034~telomerase RNA binding,GO:0071208~histone pre-mRNA DCP binding,GO:0071209~U7 snRNA binding,GO:1990446~U1 snRNP binding,	IPR001163:Ribonucleoprotein LSM domain,IPR010920:Like-Sm (LSM) domain,IPR027141:U6 snRNA-associated Sm-like protein LSm4/Small nuclear ribonucleoprotein Sm D1/D3,	mmu03040:Spliceosome,mmu05322:Systemic lupus erythematosus,	NA	SM00651:Sm,	Acetylation,Complete proteome,Cytoplasm,Methylation,mRNA processing,mRNA splicing,Nucleus,Reference proteome,Repeat,Ribonucleoprotein,RNA-binding,Spliceosome,Viral nucleoprotein,Virion,	chain:Small nuclear ribonucleoprotein Sm D3,compositionally biased region:Arg/Lys-rich (basic),modified residue,region of interest:5 X 2 AA tandem repeats of [RM]-G,repeat:1,repeat:2,repeat:3,repeat:4,repeat:5,
Snrpe	small nuclear ribonucleoprotein E(Snrpe)	Mus musculus	NA	NA	GO:0000387~spliceosomal snRNP assembly,GO:0000398~mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0042633~hair cycle,	GO:0005634~nucleus,GO:0005681~spliceosomal complex,GO:0005682~U5 snRNP,GO:0005683~U7 snRNP,GO:0005685~U1 snRNP,GO:0005686~U2 snRNP,GO:0005687~U4 snRNP,GO:0005689~U12-type spliceosomal complex,GO:0005697~telomerase holoenzyme complex,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0030529~intracellular ribonucleoprotein complex,GO:0034709~methylosome,GO:0034715~pICln-Sm protein complex,GO:0034719~SMN-Sm protein complex,GO:0046540~U4/U6 x U5 tri-snRNP complex,GO:0070062~extracellular exosome,GO:0071011~precatalytic spliceosome,GO:0071013~catalytic step 2 spliceosome,	GO:0003723~RNA binding,GO:1990446~U1 snRNP binding,	IPR001163:Ribonucleoprotein LSM domain,IPR010920:Like-Sm (LSM) domain,IPR027078:Small nuclear ribonucleoprotein E,	mmu03040:Spliceosome,	NA	SM00651:Sm,	Complete proteome,Cytoplasm,mRNA processing,mRNA splicing,Nucleus,Proteomics identification,Reference proteome,Ribonucleoprotein,RNA-binding,Spliceosome,	chain:Small nuclear ribonucleoprotein E,
Snrpa1	small nuclear ribonucleoprotein polypeptide A'(Snrpa1)	Mus musculus	NA	Function unknown,	GO:0000398~mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0008380~RNA splicing,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005686~U2 snRNP,GO:0019013~viral nucleocapsid,GO:0030529~intracellular ribonucleoprotein complex,GO:0071013~catalytic step 2 spliceosome,	GO:0003723~RNA binding,GO:0030620~U2 snRNA binding,GO:0044822~poly(A) RNA binding,	IPR001611:Leucine-rich repeat,IPR003603:U2A'/phosphoprotein 32 family A, C-terminal,	mmu03040:Spliceosome,	NA	SM00446:LRRcap,	Acetylation,Complete proteome,Leucine-rich repeat,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Ribonucleoprotein,RNA-binding,Spliceosome,Viral nucleoprotein,Virion,	chain:U2 small nuclear ribonucleoprotein A',modified residue,repeat:LRR 1,repeat:LRR 2,repeat:LRR 3,sequence conflict,
Sf1	splicing factor 1(Sf1)	Mus musculus	NA	RNA processing and modification,	GO:0000398~mRNA splicing, via spliceosome,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0030238~male sex determination,GO:0030575~nuclear body organization,GO:0033327~Leydig cell differentiation,GO:0048662~negative regulation of smooth muscle cell proliferation,GO:0050810~regulation of steroid biosynthetic process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005737~cytoplasm,GO:0016604~nuclear body,	GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0008270~zinc ion binding,GO:0044822~poly(A) RNA binding,GO:0045131~pre-mRNA branch point binding,GO:0046872~metal ion binding,	IPR001878:Zinc finger, CCHC-type,IPR004087:K Homology domain,IPR004088:K Homology domain, type 1,	NA	NA	SM00322:KH,SM00343:ZnF_C2HC,	Acetylation,Alternative splicing,Complete proteome,Metal-binding,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repressor,RNA-binding,Spliceosome,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Splicing factor 1,compositionally biased region:Pro-rich,domain:KH,modified residue,sequence conflict,short sequence motif:Nuclear localization signal,splice variant,zinc finger region:CCHC-type,
Sf3b6	splicing factor 3B, subunit 6(Sf3b6)	Mus musculus	NA	NA	GO:0000398~mRNA splicing, via spliceosome,GO:0001825~blastocyst formation,GO:0006397~mRNA processing,GO:0008380~RNA splicing,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005684~U2-type spliceosomal complex,GO:0005686~U2 snRNP,GO:0005689~U12-type spliceosomal complex,GO:0071011~precatalytic spliceosome,GO:0071013~catalytic step 2 spliceosome,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,	mmu03040:Spliceosome,	NA	SM00360:RRM,	Acetylation,Complete proteome,Isopeptide bond,mRNA processing,mRNA splicing,Nucleus,Reference proteome,RNA-binding,Ubl conjugation,	chain:Pre-mRNA branch site protein p14,domain:RRM,modified residue,
Sf3b1	splicing factor 3b, subunit 1(Sf3b1)	Mus musculus	NA	RNA processing and modification,	GO:0000245~spliceosomal complex assembly,GO:0000398~mRNA splicing, via spliceosome,GO:0001825~blastocyst formation,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0009952~anterior/posterior pattern specification,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005686~U2 snRNP,GO:0005689~U12-type spliceosomal complex,GO:0016021~integral component of membrane,GO:0016363~nuclear matrix,GO:0030532~small nuclear ribonucleoprotein complex,GO:0034693~U11/U12 snRNP,GO:0071004~U2-type prespliceosome,GO:0071013~catalytic step 2 spliceosome,	GO:0003682~chromatin binding,GO:0003729~mRNA binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR011989:Armadillo-like helical,IPR015016:Splicing factor 3B subunit 1,IPR016024:Armadillo-type fold,	mmu03040:Spliceosome,	NA	NA	Acetylation,Citrullination,Coiled coil,Complete proteome,Isopeptide bond,Membrane,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Spliceosome,Transmembrane,Transmembrane helix,Ubl conjugation,	chain:Splicing factor 3B subunit 1,modified residue,region of interest:Interaction with PPP1R8,repeat:HEAT 1,repeat:HEAT 10,repeat:HEAT 11,repeat:HEAT 2,repeat:HEAT 3,repeat:HEAT 4,repeat:HEAT 5,repeat:HEAT 6,repeat:HEAT 7,repeat:HEAT 8,repeat:HEAT 9,
Sf3b4	splicing factor 3b, subunit 4(Sf3b4)	Mus musculus	NA	NA	GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0048026~positive regulation of mRNA splicing, via spliceosome,	GO:0005634~nucleus,GO:0005681~spliceosomal complex,GO:0005689~U12-type spliceosomal complex,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,	mmu03040:Spliceosome,	NA	SM00360:RRM,	Acetylation,Complete proteome,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Reference proteome,Repeat,RNA-binding,Spliceosome,	chain:Splicing factor 3B subunit 4,compositionally biased region:Poly-Pro,domain:RRM 1,domain:RRM 2,modified residue,
Sf3b5	splicing factor 3b, subunit 5(Sf3b5)	Mus musculus	NA	NA	GO:0000398~mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0008380~RNA splicing,	GO:0005634~nucleus,GO:0005681~spliceosomal complex,GO:0005686~U2 snRNP,GO:0005689~U12-type spliceosomal complex,GO:0071011~precatalytic spliceosome,	NA	IPR009846:Splicing factor 3B subunit 5/RDS3 complex subunit 10,IPR017089:Splicing factor 3B, subunit 5,	mmu03040:Spliceosome,	PIRSF037010:splicing factor 3B, subunit 5,	NA	Acetylation,Complete proteome,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Reference proteome,Spliceosome,	chain:Splicing factor 3B subunit 5,modified residue,
Sfpq	splicing factor proline/glutamine rich (polypyrimidine tract binding protein associated)(Sfpq)	Mus musculus	m_antisensePathway:RNA polymerase III transcription,	NA	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000380~alternative mRNA splicing, via spliceosome,GO:0000724~double-strand break repair via homologous recombination,GO:0006281~DNA repair,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006397~mRNA processing,GO:0006974~cellular response to DNA damage stimulus,GO:0008380~RNA splicing,GO:0042752~regulation of circadian rhythm,GO:0042754~negative regulation of circadian rhythm,GO:0045876~positive regulation of sister chromatid cohesion,GO:0045892~negative regulation of transcription, DNA-templated,GO:0048511~rhythmic process,GO:0051276~chromosome organization,GO:0051726~regulation of cell cycle,GO:0070932~histone H3 deacetylation,GO:1902177~positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016363~nuclear matrix,GO:0031012~extracellular matrix,GO:0042382~paraspeckles,GO:0090575~RNA polymerase II transcription factor complex,	GO:0000166~nucleotide binding,GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0000980~RNA polymerase II distal enhancer sequence-specific DNA binding,GO:0001047~core promoter binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0042826~histone deacetylase binding,GO:0044212~transcription regulatory region DNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,IPR012975:NOPS,	NA	NA	SM00360:RRM,	Acetylation,Activator,Biological rhythms,Coiled coil,Complete proteome,Cytoplasm,Direct protein sequencing,DNA damage,DNA repair,DNA-binding,Isopeptide bond,Methylation,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Reference proteome,Repeat,Repressor,RNA-binding,Transcription,Transcription regulation,Ubl conjugation,	chain:Splicing factor, proline- and glutamine- rich,compositionally biased region:Gln/Glu/Pro-rich,compositionally biased region:Poly-Arg,compositionally biased region:Poly-Gln,compositionally biased region:Poly-Gly,compositionally biased region:Poly-Pro,domain:RRM 1,domain:RRM 2,modified residue,region of interest:3 X 3 AA repeats of R-G-G,repeat:1,repeat:2,repeat:3,sequence conflict,
Sart3	squamous cell carcinoma antigen recognized by T cells 3(Sart3)	Mus musculus	NA	RNA processing and modification,	GO:0000244~spliceosomal tri-snRNP complex assembly,GO:0000245~spliceosomal complex assembly,GO:0000387~spliceosomal snRNP assembly,GO:0000398~mRNA splicing, via spliceosome,GO:0000902~cell morphogenesis,GO:0006334~nucleosome assembly,GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0010468~regulation of gene expression,GO:0048872~homeostasis of number of cells,GO:0071425~hematopoietic stem cell proliferation,GO:1903586~positive regulation of histone deubiquitination,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005691~U6atac snRNP,GO:0005737~cytoplasm,GO:0015030~Cajal body,GO:0016607~nuclear speck,GO:0046540~U4/U6 x U5 tri-snRNP complex,GO:0071001~U4/U6 snRNP,GO:0071002~U4atac/U6atac snRNP,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0017070~U6 snRNA binding,GO:0030621~U4 snRNA binding,GO:0030624~U6atac snRNA binding,GO:0042393~histone binding,GO:0044822~poly(A) RNA binding,GO:1990381~ubiquitin-specific protease binding,	IPR000504:RNA recognition motif domain,IPR003107:RNA-processing protein, HAT helix,IPR008669:LSM-interacting domain,IPR011990:Tetratricopeptide-like helical,IPR012677:Nucleotide-binding, alpha-beta plait,	NA	NA	SM00360:RRM,SM00386:HAT,	Acetylation,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Methylation,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Reference proteome,Repeat,RNA-binding,	chain:Squamous cell carcinoma antigen recognized by T-cells 3,modified residue,sequence conflict,short sequence motif:Nuclear localization signal,splice variant,
Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein(Syncrip)	Mus musculus	NA	NA	GO:0001649~osteoblast differentiation,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0017148~negative regulation of translation,GO:0070934~CRD-mediated mRNA stabilization,GO:0071346~cellular response to interferon-gamma,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0016020~membrane,GO:0030529~intracellular ribonucleoprotein complex,GO:0043231~intracellular membrane-bounded organelle,GO:0070937~CRD-mediated mRNA stability complex,GO:0071013~catalytic step 2 spliceosome,GO:0071204~histone pre-mRNA 3'end processing complex,GO:0097452~GAIT complex,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0008143~poly(A) binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR006535:HnRNP R/Q splicing factor,IPR012677:Nucleotide-binding, alpha-beta plait,	NA	NA	SM00360:RRM,	Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Direct protein sequencing,Endoplasmic reticulum,Isopeptide bond,Methylation,Microsome,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Ribonucleoprotein,RNA-binding,Spliceosome,	chain:Heterogeneous nuclear ribonucleoprotein Q,compositionally biased region:Poly-Tyr,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),domain:RRM 1,domain:RRM 2,domain:RRM 3,modified residue,region of interest:3 X 4 AA repeats of Y-Y-G-Y,region of interest:8 X 3 AA repeats of R-G-G,region of interest:Interaction with APOBEC1,region of interest:Interaction with SMN,repeat:1-1,repeat:1-2,repeat:1-3,repeat:1-4,repeat:1-5,repeat:1-6,repeat:1-7,repeat:1-8,repeat:2-1,repeat:2-2,repeat:2-3,sequence conflict,short sequence motif:Bipartite nuclear localization signal,splice variant,
Tst	thiosulfate sulfurtransferase, mitochondrial(Tst)	Mus musculus	NA	Inorganic ion transport and metabolism,	GO:0030855~epithelial cell differentiation,GO:0035928~rRNA import into mitochondrion,GO:0051029~rRNA transport,	GO:0005615~extracellular space,GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005759~mitochondrial matrix,GO:0070062~extracellular exosome,	GO:0003723~RNA binding,GO:0004792~thiosulfate sulfurtransferase activity,GO:0008097~5S rRNA binding,GO:0016740~transferase activity,	IPR001307:Thiosulphate sulfurtransferase, conserved site,IPR001763:Rhodanese-like domain,	mmu00270:Cysteine and methionine metabolism,mmu00920:Sulfur metabolism,mmu01100:Metabolic pathways,mmu04122:Sulfur relay system,	NA	SM00450:RHOD,	Acetylation,Complete proteome,Glycoprotein,Mitochondrion,Phosphoprotein,Reference proteome,Repeat,RNA-binding,Transferase,	active site:Cysteine persulfide intermediate,binding site:Substrate,chain:Thiosulfate sulfurtransferase,domain:Rhodanese 1,domain:Rhodanese 2,modified residue,region of interest:Hinge,
Tsn	translin(Tsn)	Mus musculus	NA	NA	GO:0016070~RNA metabolic process,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0003677~DNA binding,GO:0003697~single-stranded DNA binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0004518~nuclease activity,GO:0004519~endonuclease activity,GO:0005515~protein binding,GO:0016787~hydrolase activity,GO:0032403~protein complex binding,GO:0043565~sequence-specific DNA binding,	IPR002848:Translin,IPR016068:Translin, N-terminal,IPR016069:Translin, C-terminal,	NA	NA	NA	3D-structure,Acetylation,Complete proteome,Cytoplasm,DNA-binding,Endonuclease,Hydrolase,Nuclease,Nucleus,Phosphoprotein,Reference proteome,RNA-binding,	chain:Translin,domain:Leucine-zipper,helix,modified residue,strand,turn,
Tnrc6b	trinucleotide repeat containing 6b(Tnrc6b)	Mus musculus	NA	NA	GO:0006417~regulation of translation,GO:0031047~gene silencing by RNA,GO:0035278~miRNA mediated inhibition of translation,GO:0060213~positive regulation of nuclear-transcribed mRNA poly(A) tail shortening,GO:1900153~positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,	GO:0000932~cytoplasmic mRNA processing body,GO:0005737~cytoplasm,GO:0016021~integral component of membrane,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,IPR019486:Argonaute hook domain,	NA	NA	NA	Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Membrane,Phosphoprotein,Reference proteome,RNA-binding,RNA-mediated gene silencing,Translation regulation,Transmembrane,Transmembrane helix,	chain:Trinucleotide repeat-containing gene 6B protein,domain:RRM,modified residue,sequence conflict,splice variant,
Tdrkh	tudor and KH domain containing protein(Tdrkh)	Mus musculus	NA	NA	GO:0007140~male meiosis,GO:0007283~spermatogenesis,GO:0009566~fertilization,GO:0030154~cell differentiation,GO:0031047~gene silencing by RNA,GO:0034587~piRNA metabolic process,GO:0043046~DNA methylation involved in gamete generation,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0016021~integral component of membrane,GO:0071546~pi-body,GO:0071547~piP-body,	GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0005515~protein binding,	IPR002999:Tudor domain,IPR004087:K Homology domain,IPR004088:K Homology domain, type 1,	NA	NA	SM00322:KH,SM00333:TUDOR,	3D-structure,Complete proteome,Cytoplasm,Differentiation,Isopeptide bond,Membrane,Mitochondrion,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,RNA-binding,RNA-mediated gene silencing,Spermatogenesis,Transmembrane,Transmembrane helix,Ubl conjugation,	chain:Tudor and KH domain-containing protein,domain:KH 1,domain:KH 2,domain:Tudor,helix,strand,turn,
Tdrd7	tudor domain containing 7(Tdrd7)	Mus musculus	NA	NA	GO:0002089~lens morphogenesis in camera-type eye,GO:0007275~multicellular organism development,GO:0007281~germ cell development,GO:0007283~spermatogenesis,GO:0010608~posttranscriptional regulation of gene expression,GO:0030154~cell differentiation,GO:0070306~lens fiber cell differentiation,	GO:0005737~cytoplasm,GO:0005759~mitochondrial matrix,GO:0030529~intracellular ribonucleoprotein complex,GO:0033391~chromatoid body,GO:0035770~ribonucleoprotein granule,GO:0043186~P granule,	GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0005515~protein binding,GO:0047485~protein N-terminus binding,	IPR002999:Tudor domain,IPR025605:OST-HTH/LOTUS domain,	NA	NA	SM00333:TUDOR,	3D-structure,Cataract,Complete proteome,Cytoplasm,Developmental protein,Differentiation,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,RNA-binding,Spermatogenesis,	chain:Tudor domain-containing protein 7,compositionally biased region:Poly-Pro,domain:Tudor 1,domain:Tudor 2,region of interest:Interacts with CABLES1,region of interest:Interacts with CDK17,
Yars	tyrosyl-tRNA synthetase(Yars)	Mus musculus	NA	NA	GO:0006412~translation,GO:0006418~tRNA aminoacylation for protein translation,GO:0006437~tyrosyl-tRNA aminoacylation,GO:0006438~valyl-tRNA aminoacylation,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0000049~tRNA binding,GO:0000166~nucleotide binding,GO:0003723~RNA binding,GO:0004812~aminoacyl-tRNA ligase activity,GO:0004831~tyrosine-tRNA ligase activity,GO:0004832~valine-tRNA ligase activity,GO:0005524~ATP binding,GO:0016874~ligase activity,GO:0044822~poly(A) RNA binding,	IPR002305:Aminoacyl-tRNA synthetase, class Ic,IPR002307:Tyrosine-tRNA ligase,IPR002547:tRNA-binding domain,IPR012340:Nucleic acid-binding, OB-fold,IPR014729:Rossmann-like alpha/beta/alpha sandwich fold,	mmu00970:Aminoacyl-tRNA biosynthesis,	NA	NA	Acetylation,Aminoacyl-tRNA synthetase,ATP-binding,Complete proteome,Cytoplasm,Ligase,Nucleotide-binding,Phosphoprotein,Protein biosynthesis,Proteomics identification,Reference proteome,RNA-binding,tRNA-binding,	"binding site:Tyrosine,chain:Tyrosyl-tRNA synthetase, cytoplasmic,domain:tRNA-binding,modified residue,sequence conflict,short sequence motif:""HIGH"" region,short sequence motif:""KMSKS"" region,"
Zranb2	zinc finger, RAN-binding domain containing 2(Zranb2)	Mus musculus	NA	NA	GO:0006397~mRNA processing,GO:0008380~RNA splicing,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0003723~RNA binding,GO:0008270~zinc ion binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR001876:Zinc finger, RanBP2-type,IPR017337:Uncharacterised conserved protein UCP037956, zinc finger Ran-binding,	NA	PIRSF037956:uncharacterized protein with zinc finger Ran-binding domain, ZRANB2 type,	SM00547:ZnF_RBZ,	Acetylation,Alternative splicing,Complete proteome,Metal-binding,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,RNA-binding,Zinc,Zinc-finger,	chain:Zinc finger Ran-binding domain-containing protein 2,compositionally biased region:Arg/Ser-rich,modified residue,region of interest:Required for nuclear targeting,sequence conflict,splice variant,zinc finger region:RanBP2-type 1,zinc finger region:RanBP2-type 2,
